The	O	DET	O
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
(	I-Disease	PUNCT	O
APC	I-Disease	NOUN	B
)	I-Disease	PUNCT	O
tumour	I-Disease	NOUN	B
-	O	PUNCT	O
suppressor	O	NOUN	B
protein	O	NOUN	I
controls	O	VERB	O
the	O	DET	O
Wnt	O	NOUN	B
signalling	O	NOUN	I
pathway	O	NOUN	I
by	O	ADP	O
forming	O	VERB	O
a	O	DET	O
complex	O	NOUN	B
with	O	ADP	O
glycogen	O	NOUN	B
synthase	O	NOUN	I
kinase	O	NOUN	I
3beta	O	NOUN	I
(	O	PUNCT	O
GSK	O	PROPN	B
-	O	PUNCT	O
3beta	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
axin	O	NOUN	B
/	O	SYM	O
conductin	O	NOUN	B
and	O	CCONJ	O
betacatenin	O	NOUN	B
.	O	PUNCT	O


Like	O	ADP	O
APC	O	NOUN	B
,	O	PUNCT	O
APC2	O	NOUN	B
regulates	O	VERB	B
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
active	O	ADJ	O
betacatenin	O	NOUN	B
-	O	PUNCT	O
Tcf	O	NOUN	B
complexes	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
demonstrated	O	VERB	O
using	O	VERB	O
transient	O	ADJ	B
transcriptional	O	ADJ	O
activation	O	NOUN	O
assays	O	NOUN	O
in	O	ADP	O
APC	O	NOUN	B
-	O	PUNCT	O
/	O	SYM	B
-	O	PUNCT	O
colon	B-Disease	NOUN	B
carcinoma	I-Disease	NOUN	I
cells	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
common	O	ADJ	O
MSH2	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
English	O	PROPN	B
and	O	CCONJ	O
North	O	ADJ	B
American	O	ADJ	I
HNPCC	B-Disease	NOUN	B
families	O	NOUN	B
:	O	PUNCT	O
origin	O	NOUN	B
,	O	PUNCT	O
phenotypic	O	ADJ	B
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
sex	O	NOUN	B
specific	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
this	O	DET	O
mutation	O	NOUN	B
was	O	AUX	O
initially	O	ADV	O
detected	O	VERB	B
in	O	ADP	O
four	O	NUM	O
of	O	ADP	O
33	O	NUM	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
families	O	NOUN	B
analysed	O	VERB	B
from	O	ADP	O
eastern	O	ADJ	B
England	O	PROPN	I
,	O	PUNCT	O
more	O	ADV	O
extensive	O	ADJ	O
analysis	O	NOUN	B
has	O	AUX	O
reduced	O	VERB	B
the	O	DET	O
frequency	O	NOUN	B
to	O	PART	O
four	O	NUM	O
of	O	ADP	O
52	O	NUM	O
(	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
English	O	ADJ	B
HNPCC	B-Disease	NOUN	B
kindreds	O	NOUN	B
analysed	O	VERB	B
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
origin	O	NOUN	B
of	O	ADP	O
this	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
families	O	NOUN	B
from	O	ADP	O
England	O	PROPN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
4	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
Newfoundland	O	NOUN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
10	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
United	O	PROPN	B
States	O	PROPN	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
3	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
haplotype	O	NOUN	B
analysis	O	NOUN	B
using	O	VERB	O
microsatellite	O	NOUN	B
markers	O	NOUN	I
linked	O	VERB	O
to	O	PART	O
MSH2	O	NOUN	B
was	O	AUX	O
performed	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
calculated	O	VERB	B
age	O	NOUN	B
related	O	ADJ	O
risks	O	NOUN	B
of	O	ADP	O
all	O	DET	O
,	O	PUNCT	O
colorectal	B-Disease	ADJ	B
,	I-Disease	PUNCT	O
endometrial	I-Disease	ADJ	B
,	I-Disease	PUNCT	O
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancers	I-Disease	NOUN	I
in	O	ADP	O
nt943	O	NOUN	B
+	O	CCONJ	O
3	O	NUM	O
A	O	NOUN	O
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
T	O	NOUN	B
MSH2	O	NOUN	O
mutation	O	NOUN	B
carriers	O	NOUN	B
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
76	O	NUM	O
)	O	PUNCT	O
for	O	ADP	O
all	O	DET	O
patients	O	NOUN	B
and	O	CCONJ	O
for	O	ADP	O
men	O	NOUN	B
and	O	CCONJ	O
women	O	NOUN	B
separately	O	ADV	B
.	O	PUNCT	O


The	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
was	O	AUX	O
significantly	O	ADV	B
higher	O	ADJ	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
in	O	ADP	O
males	O	NOUN	B
than	O	ADP	O
females	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
63	O	NUM	O
v	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
30	O	NUM	O
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
84	O	NUM	O
v	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
44	O	NUM	O
at	O	ADP	O
ages	O	NOUN	B
50	O	NUM	O
and	O	CCONJ	O
60	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
intersex	O	NOUN	B
differences	O	NOUN	O
in	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
risks	O	NOUN	B
have	O	AUX	O
implications	O	NOUN	O
for	O	ADP	O
screening	O	NOUN	B
programmes	O	NOUN	I
and	O	CCONJ	O
for	O	ADP	O
attempts	O	NOUN	O
to	O	PART	O
identify	O	VERB	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
susceptibility	O	NOUN	B
modifiers	O	NOUN	B
.	O	PUNCT	O


Age	O	NOUN	B
of	O	ADP	O
onset	O	NOUN	O
(	O	PUNCT	O
AO	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
Huntington	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
HD	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
length	O	NOUN	B
of	O	ADP	O
an	O	DET	O
expanded	O	VERB	O
CAG	O	NOUN	B
repeat	O	NOUN	I
in	O	ADP	O
the	O	DET	O
HD	B-Disease	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
determined	O	VERB	O
APOE	O	ADJ	B
genotype	O	NOUN	B
and	O	CCONJ	O
normal	O	ADJ	O
CAG	O	NOUN	B
repeat	O	NOUN	I
length	O	NOUN	B
in	O	ADP	O
the	O	DET	O
HD	B-Disease	NOUN	B
gene	O	NOUN	I
for	O	ADP	O
138	O	NUM	O
HD	B-Disease	NOUN	B
patients	O	NOUN	B
who	O	PRON	O
were	O	AUX	O
previously	O	ADV	O
analysed	O	VERB	B
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
CAG	O	NOUN	B
repeat	O	NOUN	I
length	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
subtle	O	ADJ	O
differences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
the	O	DET	O
neurodegeneration	B-Disease	NOUN	B
in	O	ADP	O
HD	B-Disease	NOUN	B
may	O	AUX	O
allow	O	VERB	O
interacting	O	VERB	B
genes	O	NOUN	I
to	O	PART	O
exert	O	VERB	O
gender	O	NOUN	B
specific	O	ADJ	O
effects	O	NOUN	B
upon	O	SCONJ	O
AO	O	PROPN	B
.	O	PUNCT	O


The	O	DET	O
serum	O	NOUN	B
of	O	ADP	O
a	O	DET	O
29	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
old	O	ADJ	O
woman	O	NOUN	B
with	O	ADP	O
a	O	DET	O
recent	O	ADJ	O
episode	O	NOUN	B
of	O	ADP	O
disseminated	B-Disease	ADJ	B
gonococcal	I-Disease	ADJ	B
infection	I-Disease	NOUN	I
and	O	CCONJ	O
a	O	DET	O
history	O	NOUN	B
of	O	ADP	O
meningococcal	B-Disease	ADJ	B
meningitis	I-Disease	NOUN	I
and	O	CCONJ	O
arthritis	B-Disease	NOUN	B
as	O	ADP	O
a	O	DET	O
child	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
lack	O	VERB	O
serum	O	NOUN	B
hemolytic	O	ADJ	O
complement	O	NOUN	O
activity	O	NOUN	O
.	O	PUNCT	O


Complete	B-Disease	ADJ	B
absence	I-Disease	NOUN	B
of	I-Disease	ADP	O
C7	I-Disease	NOUN	B
was	O	AUX	O
also	O	ADV	O
found	O	VERB	O
in	O	ADP	O
one	O	NUM	O
sibling	O	NOUN	B
who	O	PRON	O
had	O	AUX	O
the	O	DET	O
clinical	O	ADJ	B
syndrome	O	NOUN	I
of	O	ADP	O
meningococcal	B-Disease	ADJ	B
meningitis	I-Disease	NOUN	I
and	O	CCONJ	O
arthritis	B-Disease	NOUN	B
as	O	ADP	O
a	O	DET	O
child	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
this	O	DET	O
siblings	O	NOUN	B
clinically	O	ADV	B
well	O	ADV	O
eight	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
son	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
report	O	NOUN	B
represents	O	VERB	O
the	O	DET	O
first	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
C7	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
associated	O	VERB	B
with	O	ADP	I
infectious	O	ADJ	B
complications	O	NOUN	I
and	O	CCONJ	O
suggests	O	VERB	O
that	O	SCONJ	O
bactericidal	O	ADJ	B
activity	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
host	O	NOUN	B
defense	O	NOUN	B
against	O	ADP	O
bacteremic	B-Disease	ADJ	B
neisseria	I-Disease	NOUN	O
infections	I-Disease	NOUN	O
.	O	PUNCT	O


OBJECTIVE	O	VERB	O
Previous	O	ADJ	O
reports	O	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
an	O	DET	O
increased	O	VERB	B
risk	O	NOUN	B
of	O	ADP	O
cancer	B-Disease	NOUN	B
among	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
cartilage	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
hair	I-Disease	NOUN	B
hypoplasia	I-Disease	NOUN	I
(	O	PUNCT	O
CHH	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


STUDY	O	NOUN	O
DESIGN	O	NOUN	O
One	O	NUM	O
hundred	O	NUM	O
twenty	O	NUM	B
-	O	PUNCT	O
two	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
CHH	B-Disease	NOUN	B
were	O	AUX	O
identified	O	VERB	B
through	O	ADP	O
2	O	NUM	O
countrywide	O	NOUN	B
epidemiologic	O	ADJ	B
surveys	O	NOUN	O
in	O	ADP	O
1974	O	NUM	O
and	O	CCONJ	O
in	O	ADP	O
1986	O	NUM	O
.	O	PUNCT	O


RESULTS	O	VERB	B
A	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
excess	O	ADJ	B
risk	O	NOUN	B
of	O	ADP	O
cancer	B-Disease	NOUN	B
was	O	AUX	O
seen	O	VERB	O
among	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
CHH	B-Disease	NOUN	B
(	O	PUNCT	O
standardized	O	ADJ	B
incidence	O	NOUN	I
ratio	O	NOUN	I
6	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
,	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
confidence	O	NOUN	B
interval	O	NOUN	I
2	O	NUM	I
.	O	PUNCT	O
3	O	NUM	O
to	O	PART	O
16	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
was	O	AUX	O
mainly	O	ADV	O
attributable	O	ADJ	O
to	O	PART	O
non	B-Disease	ADV	B
-	I-Disease	PUNCT	O
Hodgkins	I-Disease	NOUN	B
lymphoma	I-Disease	NOUN	I
(	O	PUNCT	O
standardized	O	ADJ	B
incidence	O	NOUN	I
ratio	O	NOUN	I
90	O	NUM	O
,	O	PUNCT	O
95	O	NUM	O
%	O	NOUN	O
confidence	O	NOUN	B
interval	O	NOUN	I
18	O	NUM	O
to	O	PART	O
264	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
cancer	B-Disease	NOUN	B
incidence	O	NOUN	B
among	O	ADP	O
the	O	DET	O
siblings	O	NOUN	B
or	O	CCONJ	O
the	O	DET	O
parents	O	NOUN	B
did	O	AUX	O
not	O	PART	O
differ	O	VERB	O
from	O	ADP	O
the	O	DET	O
average	O	ADJ	B
cancer	B-Disease	NOUN	B
incidence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Finnish	O	ADJ	B
population	O	NOUN	B
.	O	PUNCT	O


Genotype	O	NOUN	B
and	O	CCONJ	O
phenotype	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
dihydropyrimidine	B-Disease	NOUN	B
dehydrogenase	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
genetic	O	ADJ	B
and	O	CCONJ	O
phenotypic	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
DPD	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
reviewed	O	VERB	B
17	O	NUM	O
families	O	NOUN	B
presenting	O	VERB	O
22	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
complete	O	ADJ	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
DPD	I-Disease	NOUN	B
.	O	PUNCT	O


A	O	DET	O
large	O	ADJ	O
phenotypic	O	ADJ	B
variability	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
observed	O	VERB	B
,	O	PUNCT	O
with	O	ADP	O
convulsive	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
,	O	PUNCT	O
motor	B-Disease	NOUN	B
retardation	I-Disease	NOUN	I
and	O	CCONJ	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
being	O	AUX	O
the	O	DET	O
most	O	ADV	O
abundant	O	ADJ	B
manifestations	O	NOUN	B
.	O	PUNCT	O


Fibroblast	O	NOUN	B
growth	O	NOUN	I
factor	O	NOUN	I
homologous	O	ADJ	I
factor	O	NOUN	I
2	O	NUM	I
(	O	PUNCT	O
FHF2	O	NOUN	B
)	O	PUNCT	O
:	O	PUNCT	O
gene	O	NOUN	B
structure	O	NOUN	I
,	O	PUNCT	O
expression	O	NOUN	B
and	O	CCONJ	O
mapping	O	NOUN	B
to	O	ADP	O
the	O	DET	O
Borjeson	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Forssman	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Lehmann	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
region	O	NOUN	I
in	O	ADP	O
Xq26	O	NOUN	B
delineated	O	VERB	O
by	O	ADP	O
a	O	DET	O
duplication	O	NOUN	B
breakpoint	O	NOUN	O
in	O	ADP	O
a	O	DET	O
BFLS	B-Disease	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
patient	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	O
a	O	DET	O
male	O	ADJ	B
patient	O	NOUN	B
with	O	ADP	O
BFLS	B-Disease	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
features	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
duplication	O	NOUN	B
,	O	PUNCT	O
46	O	NUM	O
,	O	PUNCT	O
Y	O	NOUN	B
,	O	PUNCT	O
dup	O	NOUN	O
(	O	PUNCT	O
X	O	NOUN	O
)	O	PUNCT	O
(	O	PUNCT	O
q26q28	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
inherited	O	VERB	B
from	O	ADP	O
his	O	PRON	O
phenotypically	O	ADV	B
normal	O	ADJ	I
mother	O	NOUN	B
.	O	PUNCT	O


Germline	O	NOUN	B
E	O	PROPN	I
-	O	PUNCT	O
cadherin	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
CDH1	O	NOUN	B
)	O	PUNCT	O
mutations	O	NOUN	B
predispose	O	VERB	O
to	O	PART	O
familial	B-Disease	ADJ	B
gastric	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
and	O	CCONJ	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
gastric	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
is	O	AUX	O
genetically	O	ADV	B
heterogeneous	O	ADJ	I
and	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
not	O	PART	O
clear	O	ADJ	O
what	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
susceptibility	O	NOUN	B
in	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
Maori	O	PROPN	B
populations	O	NOUN	B
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
germline	O	NOUN	B
CDH1	O	NOUN	B
mutations	O	NOUN	B
.	O	PUNCT	O


Each	O	DET	O
family	O	NOUN	B
contained	O	VERB	O
(	O	PUNCT	O
i	O	X	O
)	O	PUNCT	O
two	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
in	O	ADP	O
first	O	ADJ	O
degree	O	NOUN	O
relatives	O	NOUN	O
with	O	ADP	O
one	O	NUM	O
affected	O	VERB	B
before	O	ADP	O
age	O	NOUN	B
50	O	NUM	O
years	O	NOUN	B
;	O	PUNCT	O
or	O	CCONJ	O
(	O	PUNCT	O
ii	O	X	O
)	O	PUNCT	O
three	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
confirmed	O	VERB	O
that	O	SCONJ	O
germline	O	NOUN	B
mutations	O	NOUN	I
in	O	ADP	O
the	O	DET	O
CDH1	O	NOUN	B
gene	O	NOUN	B
cause	O	VERB	O
familial	B-Disease	ADJ	B
gastric	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
in	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
Maori	O	PROPN	B
populations	O	NOUN	B
.	O	PUNCT	O


Loss	O	NOUN	B
of	O	ADP	O
E	O	PROPN	B
-	O	PUNCT	O
cadherin	O	NOUN	B
function	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
sporadic	O	ADJ	B
colorectal	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
other	I-Disease	ADJ	O
cancers	I-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
our	O	PRON	O
findings	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
germline	O	NOUN	B
CDH1	O	NOUN	B
mutations	O	NOUN	B
predispose	O	VERB	O
to	O	PART	O
early	O	ADJ	B
onset	O	NOUN	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


A	O	DET	O
zinc	O	NOUN	B
finger	O	NOUN	I
truncation	O	NOUN	B
of	O	ADP	O
murine	O	ADJ	B
WT1	O	NOUN	B
results	O	VERB	B
in	O	ADP	O
the	O	DET	O
characteristic	O	ADJ	B
urogenital	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
of	O	ADP	O
Denys	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Drash	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
diseases	O	NOUN	B
linked	O	VERB	O
specifically	O	ADV	O
with	O	ADP	O
WT1	O	NOUN	B
mutations	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
Denys	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Drash	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
DDS	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
can	O	AUX	O
provide	O	VERB	O
valuable	O	ADJ	O
insight	O	NOUN	O
concerning	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
WT1	O	NOUN	B
in	O	ADP	O
development	O	NOUN	B
and	O	CCONJ	O
disease	O	NOUN	B
.	O	PUNCT	O


DDS	B-Disease	NOUN	B
patients	O	NOUN	B
are	O	AUX	O
constitutionally	O	ADV	O
heterozygous	O	ADJ	B
for	O	ADP	O
exonic	O	ADJ	B
point	O	NOUN	I
mutations	O	NOUN	I
in	O	ADP	O
WT1	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
include	O	VERB	O
mutations	O	NOUN	B
predicted	O	VERB	O
to	O	PART	O
truncate	O	VERB	O
the	O	DET	O
protein	O	NOUN	B
within	O	ADP	O
the	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
zinc	O	NOUN	B
finger	O	NOUN	I
(	O	PUNCT	O
ZF	O	NOUN	O
)	O	PUNCT	O
region	O	NOUN	O
.	O	PUNCT	O


Male	B-Disease	ADJ	B
genital	I-Disease	ADJ	B
defects	I-Disease	NOUN	I
also	O	ADV	O
were	O	AUX	O
evident	O	ADJ	B
and	O	CCONJ	O
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
single	O	ADJ	O
case	O	NOUN	B
of	O	ADP	O
Wilms	B-Disease	ADJ	B
tumor	I-Disease	NOUN	I
in	O	ADP	O
which	O	DET	O
the	O	DET	O
transcript	O	NOUN	B
of	O	ADP	O
the	O	DET	O
nontargeted	O	ADJ	B
allele	O	NOUN	I
showed	O	VERB	O
an	O	DET	O
exon	O	NOUN	B
9	O	NUM	I
skipping	O	NOUN	B
event	O	NOUN	I
,	O	PUNCT	O
implying	O	VERB	O
a	O	DET	O
causal	O	ADJ	O
link	O	NOUN	O
between	O	ADP	O
Wt1	B-Disease	NOUN	B
dysfunction	I-Disease	NOUN	I
and	O	CCONJ	O
Wilms	B-Disease	NOUN	B
tumorigenesis	I-Disease	NOUN	I
in	O	ADP	O
mice	O	NOUN	B
.	O	PUNCT	O


Mechanism	O	NOUN	B
of	O	ADP	O
increased	O	VERB	B
iron	O	NOUN	B
absorption	O	NOUN	I
in	O	ADP	O
murine	O	ADJ	B
model	O	NOUN	B
of	O	ADP	O
hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
:	O	PUNCT	O
increased	O	VERB	B
duodenal	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
iron	O	NOUN	B
transporter	O	NOUN	I
DMT1	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
recently	O	ADV	O
reported	O	VERB	O
that	O	SCONJ	O
HFE	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
protein	O	NOUN	B
defective	O	ADJ	B
in	O	ADP	O
HH	B-Disease	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
physically	O	ADV	B
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
transferrin	O	NOUN	B
receptor	O	NOUN	I
(	O	PUNCT	O
TfR	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
duodenal	O	ADJ	B
crypt	O	NOUN	I
cells	O	NOUN	I
and	O	CCONJ	O
proposed	O	VERB	O
that	O	SCONJ	O
mutations	O	NOUN	B
in	O	ADP	O
HFE	O	NOUN	B
attenuate	O	VERB	B
the	O	DET	O
uptake	O	NOUN	B
of	O	ADP	O
transferrin	O	NOUN	B
-	O	PUNCT	O
bound	O	VERB	B
iron	O	NOUN	B
from	O	ADP	O
plasma	O	NOUN	B
by	O	ADP	O
duodenal	O	ADJ	B
crypt	O	NOUN	I
cells	O	NOUN	I
,	O	PUNCT	O
leading	O	VERB	O
to	O	ADP	O
up	O	ADV	B
-	O	PUNCT	O
regulation	O	NOUN	B
of	O	ADP	O
transporters	O	NOUN	B
for	O	ADP	O
dietary	O	ADJ	B
iron	O	NOUN	I
.	O	PUNCT	O


Neurophysiologic	O	ADJ	B
follow	O	NOUN	B
-	O	PUNCT	O
up	O	NOUN	O
of	O	ADP	O
long	O	ADJ	B
-	O	PUNCT	O
term	O	NOUN	B
dietary	O	ADJ	B
treatment	O	NOUN	I
in	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
adrenoleukodystrophy	B-Disease	NOUN	B
.	O	PUNCT	O


BACKGROUND	O	NOUN	O
SEPs	O	NOUN	B
and	O	CCONJ	O
MEPs	O	NOUN	B
have	O	AUX	O
proved	O	VERB	O
useful	O	ADJ	O
in	O	ADP	O
revealing	O	VERB	O
signs	O	NOUN	O
of	O	ADP	O
progressively	O	ADV	O
severe	O	ADJ	B
,	O	PUNCT	O
central	O	ADJ	B
dying	B-Disease	NOUN	I
-	I-Disease	PUNCT	O
back	I-Disease	NOUN	B
axonopathy	I-Disease	NOUN	I
in	O	ADP	O
early	O	ADJ	B
stages	O	NOUN	I
of	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
ALD	B-Disease	NOUN	B
.	O	PUNCT	O


Three	O	NUM	O
of	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
had	O	AUX	O
pure	O	ADJ	O
spinal	B-Disease	ADJ	B
SEP	I-Disease	NOUN	O
abnormalities	I-Disease	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
two	O	NUM	O
patients	O	NOUN	B
SEPs	O	NOUN	B
showed	O	VERB	O
signs	O	NOUN	O
of	O	ADP	O
involvement	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
spinal	O	ADJ	B
and	O	CCONJ	O
cerebral	O	ADJ	B
somatosensory	O	ADJ	I
tracts	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
Lorenzos	O	PROPN	B
oil	O	NOUN	I
therapy	O	NOUN	I
had	O	AUX	O
no	O	DET	B
effect	O	NOUN	I
on	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
evidence	O	NOUN	B
of	O	ADP	O
inflammatory	B-Disease	ADJ	B
brain	I-Disease	NOUN	B
lesions	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
authors	O	NOUN	B
report	O	VERB	O
a	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
5	O	NUM	I
of	O	ADP	O
GCH1	O	NOUN	B
in	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
oromandibular	B-Disease	ADJ	B
dystonia	I-Disease	NOUN	I
and	O	CCONJ	O
no	O	DET	O
obvious	O	ADJ	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	O
dystonia	B-Disease	NOUN	B
.	O	PUNCT	O


Germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
Korean	O	ADJ	B
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
patients	O	NOUN	B
.	O	PUNCT	O


Nineteen	O	NUM	O
of	O	ADP	O
the	O	DET	O
detected	O	VERB	B
mutations	O	NOUN	B
were	O	AUX	O
presumed	O	VERB	O
to	O	PART	O
be	O	AUX	O
novel	O	ADJ	B
,	O	PUNCT	O
thus	O	ADV	O
emphasizing	O	VERB	O
the	O	DET	O
heterogeneity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
mutational	O	ADJ	B
spectrum	O	NOUN	I
in	O	ADP	O
Korean	O	ADJ	B
FAP	B-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
confirm	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
mutation	O	NOUN	B
detection	O	NOUN	O
rate	O	NOUN	B
with	O	ADP	O
PTT	O	PROPN	B
was	O	AUX	O
superior	O	ADJ	O
to	O	PART	O
that	O	DET	O
with	O	ADP	O
SSCP	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
PTT	O	PROPN	B
would	O	AUX	O
be	O	AUX	O
a	O	DET	O
more	O	ADV	O
practical	O	ADJ	O
screening	O	NOUN	B
method	O	NOUN	I
to	O	PART	O
detect	O	VERB	B
germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
FAP	B-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
ninth	I-Disease	ADJ	O
component	I-Disease	NOUN	B
of	I-Disease	ADP	O
human	I-Disease	ADJ	B
complement	I-Disease	NOUN	O
(	O	PUNCT	O
C9	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
complement	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
in	O	ADP	O
Japan	O	PROPN	B
,	O	PUNCT	O
with	O	ADP	O
an	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
approximately	O	ADV	O
one	O	NUM	O
homozygote	O	NOUN	B
in	O	ADP	O
1000	O	NUM	O
,	O	PUNCT	O
but	O	CCONJ	O
is	O	AUX	O
very	O	ADV	O
rare	O	ADJ	O
in	O	ADP	O
other	O	ADJ	O
countries	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
estimated	O	ADJ	B
frequency	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
12	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
complete	O	ADJ	B
C9	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
due	O	ADJ	O
to	O	PART	O
homozygous	O	ADJ	B
Arg95Stop	O	ADJ	B
mutation	O	NOUN	I
was	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
frequencies	O	NOUN	B
determined	O	VERB	O
by	O	ADP	O
serological	O	ADJ	B
studies	O	NOUN	I


HFE	O	NOUN	B
is	O	AUX	O
the	O	DET	O
protein	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
mutated	O	VERB	I
in	O	ADP	O
the	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
disease	I-Disease	NOUN	I
hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
Feder	O	PROPN	B
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O


Mutation	O	NOUN	B
and	O	CCONJ	O
haplotype	O	NOUN	B
studies	O	NOUN	B
of	O	ADP	O
familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	B
fever	I-Disease	NOUN	I
reveal	O	VERB	O
new	O	ADJ	O
ancestral	O	ADJ	B
relationships	O	NOUN	B
and	O	CCONJ	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
high	O	ADJ	B
carrier	O	NOUN	I
frequency	O	NOUN	O
with	O	ADP	O
reduced	O	VERB	B
penetrance	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Ashkenazi	O	PROPN	B
Jewish	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
FMF	B-Disease	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
MEFV	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
cloned	O	VERB	B
recently	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
four	O	NUM	O
missense	O	NOUN	B
mutations	O	NOUN	I
were	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
E148Q	O	NOUN	B
helps	O	VERB	O
account	O	NOUN	O
for	O	ADP	O
recessive	O	ADJ	B
inheritance	O	NOUN	I
in	O	ADP	O
an	O	DET	O
Ashkenazi	O	ADJ	B
family	O	NOUN	B
previously	O	ADV	O
reported	O	VERB	O
as	O	ADP	O
an	O	DET	O
unusual	O	ADJ	B
case	O	NOUN	B
of	O	ADP	O
dominantly	O	ADV	O
inherited	O	VERB	B
FMF	B-Disease	NOUN	B
.	O	PUNCT	O


Autoimmune	B-Disease	ADJ	B
lymphoproliferative	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
ALPS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
disorder	B-Disease	NOUN	B
of	I-Disease	ADP	O
lymphocyte	I-Disease	NOUN	B
homeostasis	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
immunological	I-Disease	ADJ	B
tolerance	I-Disease	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
missense	O	NOUN	B
Fas	O	NOUN	B
variants	O	NOUN	B
,	O	PUNCT	O
not	O	PART	O
restricted	O	ADJ	O
to	O	PART	O
patients	O	NOUN	B
with	O	ADP	O
ALPS	B-Disease	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Mutations	O	NOUN	B
causing	O	VERB	O
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intracellular	O	ADJ	B
Fas	O	NOUN	B
death	O	NOUN	I
domain	O	NOUN	O
also	O	ADV	O
showed	O	VERB	O
a	O	DET	O
higher	O	ADJ	O
penetrance	O	NOUN	B
of	O	ADP	O
ALPS	B-Disease	NOUN	B
phenotype	O	NOUN	B
features	O	NOUN	B
in	O	ADP	O
mutation	O	NOUN	B
-	O	PUNCT	O
bearing	O	VERB	B
relatives	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
location	O	NOUN	B
of	O	ADP	O
mutations	O	NOUN	B
within	O	ADP	O
APT1	O	NOUN	B
strongly	O	ADV	O
influences	O	VERB	B
the	O	DET	O
development	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
severity	O	NOUN	B
of	O	ADP	O
ALPS	B-Disease	NOUN	B
.	O	PUNCT	O


Genetic	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
GH	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
disease	O	NOUN	B
restricted	O	ADJ	B
to	O	PART	O
those	O	DET	O
of	O	ADP	O
European	O	ADJ	B
ancestry	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
GH	B-Disease	NOUN	B
patients	O	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
mutations	O	NOUN	B
are	O	AUX	O
present	O	ADJ	O
,	O	PUNCT	O
C282Y	O	NOUN	B
and	O	CCONJ	O
H63D	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
retrospectively	O	ADV	B
analyzed	O	VERB	I
837	O	NUM	O
random	O	ADJ	B
anonymized	O	VERB	B
dried	O	VERB	O
blood	O	NOUN	O
spot	O	NOUN	O
(	O	PUNCT	O
DBS	O	NOUN	B
)	O	PUNCT	O
samples	O	NOUN	B
from	O	ADP	O
neonatal	O	ADJ	B
screening	O	NOUN	B
programs	O	NOUN	I
in	O	ADP	O
Scandinavia	O	PROPN	B
for	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
HFE	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
candidate	O	NOUN	O
gene	O	NOUN	B
for	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
.	O	PUNCT	O


Alkaptonuria	B-Disease	NOUN	B
(	O	PUNCT	O
aku	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
inborn	B-Disease	ADJ	B
error	I-Disease	NOUN	I
of	I-Disease	ADP	O
metabolism	I-Disease	NOUN	B
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
homogentisate	O	NOUN	B
1	O	NUM	I
,	O	PUNCT	O
2	O	NUM	B
-	O	PUNCT	O
dioxygenase	O	NOUN	B
(	O	PUNCT	O
HGD	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
in	O	ADP	O
a	O	DET	O
mouse	O	NOUN	B
model	O	NOUN	I
created	O	VERB	O
by	O	ADP	O
ethylnitrosourea	O	NOUN	B
mutagenesis	O	NOUN	I
but	O	CCONJ	O
the	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
these	O	DET	O
mice	O	NOUN	B
has	O	AUX	O
not	O	PART	O
previously	O	ADV	O
been	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Enlarged	B-Disease	ADJ	B
vestibular	I-Disease	ADJ	I
aqueduct	I-Disease	NOUN	I
(	O	PUNCT	O
EVA	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
known	O	VERB	O
as	O	ADP	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
inner	B-Disease	ADJ	B
ear	I-Disease	NOUN	I
abnormality	I-Disease	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
of	O	ADP	O
particular	O	ADJ	O
genetic	O	ADJ	B
interest	O	NOUN	O
because	O	SCONJ	O
this	O	DET	O
anomaly	O	NOUN	B
is	O	AUX	O
inherited	O	VERB	B
in	O	ADP	O
a	O	DET	O
recessive	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
seven	O	NUM	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
PDS	B-Disease	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
PDS	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
in	O	ADP	O
families	O	NOUN	B
of	O	ADP	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
sensorineural	I-Disease	ADJ	O
hearing	I-Disease	NOUN	O
loss	I-Disease	NOUN	O
with	O	ADP	O
EVA	B-Disease	NOUN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
analysis	O	NOUN	I
and	O	CCONJ	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlation	O	NOUN	B
of	O	ADP	O
29	O	NUM	O
unrelated	O	ADJ	O
Japanese	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
adrenoleukodystrophy	I-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
classic	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
ALD	B-Disease	NOUN	B
usually	O	ADV	O
has	O	AUX	O
onset	O	NOUN	O
in	O	ADP	O
childhood	O	NOUN	O
(	O	PUNCT	O
childhood	B-Disease	NOUN	B
cerebral	I-Disease	ADJ	I
ALD	I-Disease	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
rapid	O	ADJ	O
neurologic	B-Disease	ADJ	B
deterioration	I-Disease	NOUN	B
leading	O	VERB	O
to	O	PART	O
a	O	DET	O
vegetative	O	ADJ	B
state	O	NOUN	I
.	O	PUNCT	O


Milder	O	ADJ	B
phenotypes	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
adrenomyeloneuropathy	B-Disease	ADJ	B
and	O	CCONJ	O
Addison	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
only	O	ADV	O
also	O	ADV	O
have	O	AUX	O
been	O	AUX	O
recognized	O	VERB	O
.	O	PUNCT	O


METHODS	O	NOUN	O
The	O	DET	O
29	O	NUM	O
patients	O	NOUN	B
comprised	O	VERB	O
13	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
childhood	B-Disease	NOUN	B
cerebral	I-Disease	ADJ	I
ALD	I-Disease	NOUN	I
,	O	PUNCT	O
11	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
cerebral	B-Disease	ADJ	B
ALD	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
5	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adrenomyeloneuropathy	B-Disease	NOUN	B
.	O	PUNCT	O


RESULTS	O	VERB	O
Three	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
cerebral	B-Disease	ADJ	B
ALD	I-Disease	NOUN	I
were	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
having	O	VERB	O
large	O	ADJ	O
genomic	O	ADJ	B
rearrangements	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
There	O	PRON	O
are	O	AUX	O
no	O	DET	O
obvious	O	ADJ	O
correlations	O	NOUN	B
between	O	ADP	O
the	O	DET	O
phenotypes	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
ALD	B-Disease	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
genotypes	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
genetic	O	ADJ	B
or	O	CCONJ	O
environmental	O	ADJ	B
factors	O	NOUN	I
modify	O	VERB	B
the	O	DET	O
phenotypic	O	ADJ	B
expressions	O	NOUN	B
of	O	ADP	O
ALD	B-Disease	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
target	O	NOUN	B
genes	O	NOUN	O
for	O	ADP	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	PROPN	B
/	O	SYM	O
TCF	O	PROPN	B
encodes	O	VERB	O
c	O	X	O
-	O	PUNCT	O
MYC	O	NOUN	B
,	O	PUNCT	O
explaining	O	VERB	O
why	O	SCONJ	O
constitutive	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
WNT	O	NOUN	B
pathway	O	NOUN	I
can	O	AUX	O
lead	O	VERB	O
to	O	ADP	O
cancer	B-Disease	NOUN	B
,	O	PUNCT	O
particularly	O	ADV	O
in	O	ADP	O
the	O	DET	O
colon	O	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
discovered	O	VERB	O
that	O	SCONJ	O
transgenic	O	ADJ	B
mice	O	NOUN	I
expressing	O	VERB	B
an	O	DET	O
activated	O	VERB	B
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
are	O	AUX	O
predisposed	O	VERB	O
to	O	ADP	O
developing	O	VERB	O
skin	B-Disease	NOUN	B
tumours	I-Disease	NOUN	I
resembling	O	VERB	O
pilomatricomas	B-Disease	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
explore	O	VERB	O
the	O	DET	O
cell	O	NOUN	B
origin	O	NOUN	I
and	O	CCONJ	O
aetiology	O	NOUN	B
of	O	ADP	O
this	O	DET	O
common	O	ADJ	O
human	O	ADJ	B
skin	B-Disease	NOUN	B
tumour	I-Disease	NOUN	I
.	O	PUNCT	O


At	O	ADV	O
least	O	ADV	O
75	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
these	O	DET	O
tumours	B-Disease	NOUN	B
possess	O	VERB	O
mutations	O	NOUN	B
affecting	O	VERB	B
the	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
segment	O	NOUN	B
,	O	PUNCT	O
normally	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
phosphorylation	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
,	O	PUNCT	O
ubiquitin	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
degradation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
gene	O	NOUN	B
encodes	O	VERB	O
a	O	DET	O
chloride	O	NOUN	B
-	O	PUNCT	O
iodide	O	NOUN	B
transport	O	NOUN	I
protein	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
disorder	O	NOUN	B
was	O	AUX	O
mapped	O	VERB	O
to	O	PART	O
chromosome	O	NOUN	B
7	O	NUM	I
and	O	CCONJ	O
the	O	DET	O
gene	O	NOUN	B
causing	O	VERB	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
PDS	B-Disease	PROPN	B
)	O	PUNCT	O
was	O	AUX	O
subsequently	O	ADV	O
identified	O	VERB	B
by	O	ADP	O
positional	O	ADJ	B
cloning	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
pendrin	O	NOUN	B
functions	O	VERB	B
as	O	ADP	O
a	O	DET	O
transporter	O	NOUN	B
of	O	ADP	O
chloride	O	NOUN	B
and	O	CCONJ	O
iodide	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
sulfate	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
provide	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
thyroid	O	NOUN	B
physiology	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
pathophysiology	O	NOUN	B
of	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
HH	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
common	O	ADJ	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	O
genetic	I-Disease	ADJ	B
disorder	I-Disease	NOUN	I
of	O	ADP	O
iron	O	NOUN	B
metabolism	O	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
missense	O	NOUN	B
mutations	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
C282Y	O	NOUN	B
,	O	PUNCT	O
accounting	O	VERB	O
for	O	ADP	O
80	O	NUM	O
%	O	NOUN	O
to	O	PART	O
90	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
H63D	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
milder	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
representing	O	VERB	O
40	O	NUM	O
%	O	NOUN	O
to	O	PART	O
70	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
C282Y	O	NOUN	B
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
.	O	PUNCT	O


8	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
neither	O	CCONJ	O
C282Y	O	NOUN	B
nor	O	CCONJ	O
H63D	O	NOUN	B
.	O	PUNCT	O


Germline	O	NOUN	B
BRCA1	O	NOUN	B
alterations	O	NOUN	B
in	O	ADP	O
a	O	DET	O
population	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
series	O	NOUN	B
of	O	ADP	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
cases	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
achieve	O	VERB	O
this	O	DET	O
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
the	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
BRCA1	O	NOUN	B
alterations	O	NOUN	B
in	O	ADP	O
a	O	DET	O
population	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
series	O	NOUN	B
of	O	ADP	O
consecutive	O	ADJ	B
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
cases	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
hundred	O	NUM	O
and	O	CCONJ	O
seven	O	NUM	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
cases	O	NOUN	B
were	O	AUX	O
analyzed	O	VERB	B
for	O	ADP	O
BRCA1	O	NOUN	B
alterations	O	NOUN	B
using	O	VERB	O
the	O	DET	O
RNase	O	NOUN	B
mismatch	O	NOUN	B
cleavage	O	NOUN	I
assay	O	NOUN	I
followed	O	VERB	O
by	O	ADP	O
direct	O	ADJ	B
sequencing	O	NOUN	I
.	O	PUNCT	O


Several	O	ADJ	O
novel	O	ADJ	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
previously	O	ADV	O
reported	O	VERB	O
uncharacterized	O	ADJ	B
variants	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
identified	O	VERB	B
,	O	PUNCT	O
some	O	DET	O
of	O	ADP	O
which	O	DET	O
were	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	I
cancer	B-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
rare	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
Q356R	O	NOUN	B
polymorphism	O	NOUN	B
was	O	AUX	O
significantly	O	ADV	O
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
0	O	NUM	O
.	O	PUNCT	O
03	O	NUM	O
)	O	PUNCT	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
polymorphism	O	NOUN	B
may	O	AUX	O
influence	O	VERB	B
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
risk	O	NOUN	B
.	O	PUNCT	O


Adrenoleukodystrophy	O	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
protein	O	NOUN	B
can	O	AUX	O
compensate	O	VERB	O
functionally	O	ADV	O
for	O	ADP	O
adrenoleukodystrophy	B-Disease	NOUN	B
protein	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
(	O	PUNCT	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	PROPN	B
)	O	PUNCT	O
:	O	PUNCT	O
implications	O	NOUN	O
for	O	ADP	O
therapy	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
transient	O	ADJ	B
and	O	CCONJ	O
stable	O	ADJ	B
overexpression	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
cDNAs	O	NOUN	B
encoding	O	VERB	B
ALDP	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
closest	O	ADJ	O
relative	O	ADJ	O
ALDRP	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
could	O	AUX	O
restore	O	VERB	B
the	O	DET	O
impaired	O	ADJ	B
peroxisomal	O	ADJ	B
beta	O	NOUN	I
-	O	PUNCT	O
oxidation	O	NOUN	B
in	O	ADP	O
fibroblasts	O	NOUN	B
of	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Brca1	O	NOUN	B
tumor	B-Disease	NOUN	B
suppressor	O	NOUN	I
gene	O	NOUN	I
predispose	O	VERB	O
women	O	NOUN	B
to	O	ADP	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancers	I-Disease	NOUN	I
.	O	PUNCT	O


Mutant	O	ADJ	B
fibroblasts	O	NOUN	B
contain	O	VERB	O
multiple	O	ADJ	B
,	O	PUNCT	O
functional	O	ADJ	B
centrosomes	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
lead	O	VERB	O
to	O	PART	O
unequal	O	ADJ	O
chromosome	O	NOUN	B
segregation	O	NOUN	I
,	O	PUNCT	O
abnormal	O	ADJ	B
nuclear	O	ADJ	O
division	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
aneuploidy	B-Disease	NOUN	B
.	O	PUNCT	O


Heterozygous	O	ADJ	B
mutations	O	NOUN	I
in	O	ADP	O
the	O	DET	O
CD95	O	NOUN	B
(	O	PUNCT	O
APO	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
/	O	SYM	O
Fas	O	NOUN	B
)	O	PUNCT	O
receptor	O	NOUN	O
occur	O	VERB	O
in	O	ADP	O
most	O	ADJ	O
individuals	O	NOUN	B
with	O	ADP	O
autoimmune	B-Disease	ADJ	B
lymphoproliferative	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
ALPS	B-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
dominantly	O	ADV	O
interfere	O	VERB	B
with	O	ADP	I
apoptosis	O	NOUN	B
by	O	ADP	O
an	O	DET	O
unknown	O	ADJ	O
mechanism	O	NOUN	B
.	O	PUNCT	O


Despite	O	SCONJ	O
heterozygosity	O	NOUN	B
for	O	ADP	O
the	O	DET	O
abnormal	O	ADJ	B
allele	O	NOUN	B
,	O	PUNCT	O
lymphocytes	O	NOUN	B
from	O	ADP	O
ALPS	B-Disease	NOUN	B
patients	O	NOUN	B
showed	O	VERB	O
markedly	O	ADV	O
decreased	O	VERB	B
FADD	O	NOUN	B
association	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
caspase	O	NOUN	B
recruitment	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
after	O	ADP	O
CD95	O	NOUN	B
crosslinking	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
alkaptonuria	B-Disease	NOUN	B
(	O	PUNCT	O
AKU	B-Disease	NOUN	B
)	O	PUNCT	O
mutations	O	NOUN	B
and	O	CCONJ	O
polymorphisms	O	NOUN	B
reveals	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
CCC	O	NOUN	B
sequence	O	NOUN	I
motif	O	NOUN	B
is	O	AUX	O
a	O	DET	O
mutational	O	ADJ	B
hot	O	ADJ	O
spot	O	NOUN	O
in	O	ADP	O
the	O	DET	O
homogentisate	O	NOUN	B
1	O	NUM	I
,	O	PUNCT	O
2	O	NUM	O
dioxygenase	O	NOUN	O
gene	O	NOUN	O
(	O	PUNCT	O
HGO	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Herein	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
haplotype	O	NOUN	B
and	O	CCONJ	O
mutational	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
HGO	O	NOUN	B
in	O	ADP	O
seven	O	NUM	O
new	O	ADJ	O
AKU	B-Disease	NOUN	B
pedigrees	O	NOUN	B
.	O	PUNCT	O


Fabry	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
:	O	PUNCT	O
identification	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	B
alpha	O	NOUN	B
-	O	PUNCT	O
galactosidase	O	NOUN	B
A	O	NOUN	O
mutations	O	NOUN	B
and	O	CCONJ	O
molecular	O	ADJ	B
carrier	O	NOUN	I
detection	O	NOUN	I
by	O	ADP	O
use	O	NOUN	O
of	O	ADP	O
fluorescent	O	ADJ	B
chemical	O	ADJ	I
cleavage	O	NOUN	I
of	O	ADP	O
mismatches	O	NOUN	B
.	O	PUNCT	O


Clinically	O	ADV	B
,	O	PUNCT	O
affected	O	VERB	B
hemizygous	O	ADJ	B
males	O	NOUN	O
have	O	AUX	O
angiokeratoma	B-Disease	NOUN	B
,	O	PUNCT	O
severe	B-Disease	ADJ	B
acroparesthesia	I-Disease	NOUN	I
,	O	PUNCT	O
renal	B-Disease	ADJ	B
failure	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
vasculopathy	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
heart	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
brain	I-Disease	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
use	O	NOUN	O
of	O	ADP	O
chemical	O	ADJ	B
cleavage	O	NOUN	I
of	O	ADP	O
mismatches	O	NOUN	B
adapted	O	VERB	O
to	O	ADP	O
fluorescence	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
detection	O	NOUN	B
systems	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
characterized	O	VERB	B
the	O	DET	O
mutations	O	NOUN	B
underlying	O	VERB	O
alpha	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Gal	I-Disease	NOUN	B
A	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	B
in	O	ADP	O
16	O	NUM	O
individuals	O	NOUN	B
from	O	ADP	O
six	O	NUM	O
unrelated	O	ADJ	O
families	O	NOUN	B
with	O	ADP	O
FD	B-Disease	PROPN	B
.	O	PUNCT	O


A	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
Pelizaeus	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Merzbacher	I-Disease	PROPN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
MIM	O	NOUN	B
312080	O	NUM	I
)	O	PUNCT	O
was	O	AUX	O
made	O	VERB	O
in	O	ADP	O
a	O	DET	O
young	O	ADJ	B
boy	O	NOUN	B
.	O	PUNCT	O


Dominant	O	ADJ	B
negative	O	ADJ	O
effect	O	NOUN	B
of	O	ADP	O
the	O	DET	O
APC1309	O	NOUN	B
mutation	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
possible	O	ADJ	O
explanation	O	NOUN	O
for	O	ADP	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlations	O	NOUN	B
in	O	ADP	O
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
.	O	PUNCT	O


Patients	O	NOUN	B
with	O	ADP	O
familial	B-Disease	ADJ	B
APC	I-Disease	NOUN	O
(	O	PUNCT	O
FAP	B-Disease	NOUN	B
)	O	PUNCT	O
carry	O	VERB	O
germ	O	NOUN	B
-	O	PUNCT	O
line	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
and	O	CCONJ	O
develop	O	VERB	O
multiple	O	ADJ	B
colorectal	B-Disease	ADJ	B
adenomas	I-Disease	NOUN	I
and	O	CCONJ	O
subsequent	O	ADJ	O
carcinomas	B-Disease	NOUN	B
early	O	ADV	B
in	O	ADP	O
life	O	NOUN	B
.	O	PUNCT	O


Together	O	ADV	O
with	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
both	O	CCONJ	O
germ	O	NOUN	B
-	O	PUNCT	O
line	O	NOUN	B
and	O	CCONJ	O
sporadic	O	ADJ	B
APC	B-Disease	NOUN	B
mutations	O	NOUN	O
cluster	O	VERB	O
in	O	ADP	O
the	O	DET	O
central	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
this	O	DET	O
points	O	VERB	O
to	O	PART	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
APC	B-Disease	NOUN	B
mutants	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
provide	O	VERB	O
experimental	O	ADJ	B
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
products	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
severe	O	ADJ	B
polyposis	B-Disease	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
mutant	O	ADJ	B
APC	B-Disease	NOUN	O
gene	O	NOUN	O
products	O	NOUN	O
that	O	PRON	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
attenuated	B-Disease	VERB	B
polyposis	I-Disease	NOUN	B
(	O	PUNCT	O
codon	O	NOUN	B
386	O	NUM	O
or	O	CCONJ	O
1465	O	NUM	O
)	O	PUNCT	O
interfered	O	VERB	B
only	O	ADV	O
weakly	O	ADV	O
with	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
APC	B-Disease	NOUN	B
activity	O	NOUN	B
.	O	PUNCT	O


Germ	O	NOUN	B
-	O	PUNCT	O
line	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
BRCA1	O	NOUN	B
tumor	O	NOUN	B
-	O	PUNCT	O
suppressor	O	NOUN	B
gene	O	NOUN	I
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
an	O	DET	O
increased	O	VERB	B
susceptibility	O	NOUN	B
to	O	PART	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
routine	O	ADJ	O
screening	O	NOUN	B
of	O	ADP	O
sera	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
subject	O	NOUN	B
was	O	AUX	O
discovered	O	VERB	O
who	O	PRON	O
showed	O	VERB	O
a	O	DET	O
sub	B-Disease	ADV	B
-	I-Disease	PUNCT	O
total	I-Disease	ADJ	B
deficiency	I-Disease	NOUN	B
of	I-Disease	ADP	O
C6	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
C7	I-Disease	NOUN	B
.	O	PUNCT	O


Changes	O	NOUN	B
at	O	ADP	O
P183	O	NOUN	B
of	O	ADP	O
emerin	O	NOUN	B
weaken	O	VERB	O
its	O	PRON	O
protein	O	NOUN	B
-	O	PUNCT	O
protein	O	NOUN	B
interactions	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
spanning	O	VERB	O
the	O	DET	O
emerin	O	NOUN	B
gene	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
EDMD	B-Disease	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
comparison	O	NOUN	B
with	O	ADP	O
the	O	DET	O
usual	O	ADJ	O
EDMD	B-Disease	NOUN	B
phenotype	O	NOUN	B
,	O	PUNCT	O
patients	O	NOUN	B
with	O	ADP	O
P183	O	NOUN	B
missense	O	NOUN	I
mutations	O	NOUN	I
have	O	AUX	O
a	O	DET	O
later	O	ADJ	O
age	O	NOUN	B
at	O	ADP	O
onset	O	NOUN	O
of	O	ADP	O
first	O	ADJ	O
symptoms	O	NOUN	B
,	O	PUNCT	O
elbow	B-Disease	NOUN	B
contractures	I-Disease	NOUN	I
,	O	PUNCT	O
ankle	B-Disease	NOUN	B
contractures	I-Disease	NOUN	I
,	O	PUNCT	O
upper	B-Disease	ADJ	B
limb	I-Disease	NOUN	I
weakness	I-Disease	NOUN	I
and	O	CCONJ	O
lower	B-Disease	ADJ	B
limb	I-Disease	NOUN	I
weakness	I-Disease	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
there	O	PRON	O
is	O	AUX	O
no	O	DET	O
difference	O	NOUN	O
for	O	ADP	O
the	O	DET	O
age	O	NOUN	B
at	O	ADP	O
onset	O	NOUN	O
of	O	ADP	O
cardiac	B-Disease	ADJ	B
involvement	I-Disease	NOUN	B
.	O	PUNCT	O


Microdeletions	O	NOUN	B
at	O	ADP	O
chromosome	O	NOUN	B
bands	O	NOUN	I
1q32	O	NOUN	I
-	O	PUNCT	O
q41	O	NOUN	B
as	O	ADP	O
a	O	DET	O
cause	O	NOUN	O
of	O	ADP	O
Van	B-Disease	PROPN	B
der	I-Disease	NOUN	I
Woude	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


Along	O	ADP	O
with	O	ADP	O
cleft	B-Disease	NOUN	B
lip	I-Disease	NOUN	I
/	I-Disease	SYM	O
palate	I-Disease	ADJ	B
and	O	CCONJ	O
lip	B-Disease	NOUN	B
pits	I-Disease	NOUN	I
,	O	PUNCT	O
affected	O	VERB	B
relatives	O	NOUN	B
exhibit	O	VERB	O
developmental	B-Disease	ADJ	B
delays	I-Disease	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
nearby	O	ADV	I
may	O	AUX	O
also	O	ADV	O
be	O	AUX	O
disrupted	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
family	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
phenotype	O	NOUN	B
in	O	ADP	O
three	O	NUM	O
generations	O	NOUN	B
of	O	ADP	O
affected	O	VERB	B
individuals	O	NOUN	B
was	O	AUX	O
confined	O	VERB	O
to	O	PART	O
the	O	DET	O
cardinal	O	ADJ	O
signs	O	NOUN	B
of	O	ADP	O
VWS	B-Disease	NOUN	B
.	O	PUNCT	O


Splicing	O	NOUN	B
defects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
ATM	O	NOUN	B
:	O	PUNCT	O
underlying	O	VERB	O
mutations	O	NOUN	B
and	O	CCONJ	O
consequences	O	NOUN	B
.	O	PUNCT	O


No	O	DET	O
ATM	O	NOUN	B
protein	O	NOUN	I
was	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
western	O	NOUN	B
blotting	O	NOUN	I
in	O	ADP	O
any	O	DET	O
AT	B-Disease	ADP	B
cell	O	NOUN	I
line	O	NOUN	I
in	O	ADP	O
which	O	DET	O
splicing	O	NOUN	B
mutations	O	NOUN	I
were	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
identified	O	VERB	B
the	O	DET	O
alpha	O	NOUN	B
-	O	PUNCT	O
cardiac	O	ADJ	B
actin	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
ACTC	O	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
disease	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
a	O	DET	O
pedigree	O	NOUN	B
suffering	O	NOUN	I
from	O	ADP	O
familial	B-Disease	ADJ	B
hypertrophic	I-Disease	ADJ	I
cardiomyopathy	I-Disease	NOUN	I
(	O	PUNCT	O
FHC	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Mutation	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
ACTC	O	NOUN	B
revealed	O	VERB	O
an	O	DET	O
Ala295Ser	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
5	O	NUM	I
close	O	ADV	O
to	O	PART	O
2	O	NUM	O
missense	O	NOUN	B
mutations	O	NOUN	I
recently	O	ADV	O
described	O	VERB	O
to	O	PART	O
cause	O	VERB	O
the	O	DET	O
inherited	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
idiopathic	B-Disease	ADJ	B
dilated	I-Disease	ADJ	I
cardiomyopathy	I-Disease	NOUN	I
(	O	PUNCT	O
IDC	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Aspartylglucosaminuria	B-Disease	NOUN	B
(	O	PUNCT	O
AGU	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
lysosomal	B-Disease	ADJ	B
storage	I-Disease	NOUN	I
disorder	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
aspartylglucosaminidase	I-Disease	NOUN	B
(	O	PUNCT	O
AGA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
examine	O	VERB	O
66	O	NUM	O
Finnish	O	ADJ	B
AGU	B-Disease	NOUN	B
patients	O	NOUN	B
for	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
oral	O	ADJ	B
mucosa	O	NOUN	I
and	O	CCONJ	O
44	O	NUM	O
of	O	ADP	O
these	O	DET	O
for	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
facial	O	ADJ	B
skin	O	NOUN	I
.	O	PUNCT	O


Skin	O	NOUN	B
was	O	AUX	O
seborrhoeic	O	ADJ	B
in	O	ADP	O
adolescent	O	ADJ	B
and	O	CCONJ	O
adult	O	ADJ	B
patients	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
erythema	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
facial	I-Disease	ADJ	B
skin	I-Disease	NOUN	I
already	O	ADV	O
common	O	ADJ	O
in	O	ADP	O
childhood	O	NOUN	B
.	O	PUNCT	O


Oedemic	B-Disease	ADJ	B
buccal	I-Disease	ADJ	I
mucosa	I-Disease	NOUN	I
(	O	PUNCT	O
leucoedema	B-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
gingival	B-Disease	ADJ	B
overgrowths	I-Disease	NOUN	B
were	O	AUX	O
more	O	ADV	O
frequent	O	ADJ	B
in	O	ADP	O
AGU	B-Disease	NOUN	B
patients	O	NOUN	B
than	O	ADP	O
in	O	ADP	O
controls	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Immunohistochemically	O	ADV	B
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
AGA	O	NOUN	B
in	O	ADP	O
AGU	B-Disease	NOUN	B
patients	O	NOUN	B
mucosal	B-Disease	ADJ	B
lesions	I-Disease	NOUN	I
did	O	AUX	O
not	O	PART	O
differ	O	VERB	O
from	O	ADP	O
that	O	DET	O
seen	O	VERB	O
in	O	ADP	O
corresponding	O	ADJ	O
lesions	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	B
subjects	O	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
germline	O	NOUN	B
mosaicism	O	NOUN	O
in	O	ADP	O
families	O	NOUN	B
with	O	ADP	O
Lowe	B-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
identification	O	NOUN	B
of	O	ADP	O
seven	O	NUM	O
novel	O	ADJ	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
OCRL1	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
OCRL1	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
eight	O	NUM	O
unrelated	O	ADJ	O
patients	O	NOUN	B
with	O	ADP	O
OCRL	B-Disease	NOUN	B
and	O	CCONJ	O
have	O	AUX	O
found	O	VERB	O
seven	O	NUM	O
new	O	ADJ	O
mutations	O	NOUN	B
and	O	CCONJ	O
one	O	NUM	O
recurrent	O	ADJ	B
in	O	ADP	O
-	O	PUNCT	O
frame	O	NOUN	B
deletion	O	NOUN	B
.	O	PUNCT	O


MEFV	O	NOUN	B
-	O	PUNCT	O
Gene	O	NOUN	B
analysis	O	NOUN	I
in	O	ADP	O
armenian	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
Familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	I
fever	I-Disease	NOUN	I
:	O	PUNCT	O
diagnostic	O	ADJ	B
value	O	NOUN	I
and	O	CCONJ	O
unfavorable	O	ADJ	B
renal	O	ADJ	B
prognosis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
M694V	O	NOUN	B
homozygous	O	ADJ	B
genotype	O	NOUN	B
-	O	PUNCT	O
genetic	O	ADJ	B
and	O	CCONJ	O
therapeutic	O	ADJ	B
implications	O	NOUN	B
.	O	PUNCT	O


To	O	ADP	O
date	O	NOUN	O
,	O	PUNCT	O
its	O	PRON	O
diagnosis	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
can	O	AUX	O
be	O	AUX	O
made	O	VERB	O
only	O	ADV	O
retrospectively	O	ADV	B
,	O	PUNCT	O
is	O	AUX	O
one	O	NUM	O
of	O	ADP	O
exclusion	O	NOUN	B
,	O	PUNCT	O
based	O	VERB	O
entirely	O	ADV	O
on	O	ADP	O
nonspecific	O	ADJ	B
clinical	O	ADJ	B
signs	O	NOUN	O
that	O	PRON	O
result	O	VERB	O
from	O	ADP	O
serosal	B-Disease	ADJ	B
inflammation	I-Disease	NOUN	I
and	O	CCONJ	O
that	O	DET	O
may	O	AUX	O
lead	O	VERB	O
to	O	ADP	O
unnecessary	O	ADJ	O
surgery	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
evaluate	O	VERB	B
the	O	DET	O
diagnostic	O	ADJ	B
and	O	CCONJ	O
prognostic	O	ADJ	B
value	O	NOUN	I
of	O	ADP	O
MEFV	O	NOUN	B
-	O	PUNCT	O
gene	O	NOUN	B
analysis	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
investigated	O	VERB	B
90	O	NUM	O
Armenian	O	ADJ	B
FMF	B-Disease	NOUN	B
patients	O	NOUN	B
from	O	ADP	O
77	O	NUM	O
unrelated	O	ADJ	O
families	O	NOUN	B
that	O	PRON	O
were	O	AUX	O
not	O	PART	O
selected	O	VERB	O
through	O	ADP	O
genetic	O	ADJ	B
-	O	PUNCT	O
linkage	O	NOUN	B
analysis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
M694V	O	NOUN	B
homozygous	O	ADJ	B
genotype	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
higher	O	ADJ	O
prevalence	O	NOUN	B
of	O	ADP	O
renal	B-Disease	ADJ	B
amyloidosis	I-Disease	NOUN	I
and	O	CCONJ	O
arthritis	B-Disease	NOUN	B
,	O	PUNCT	O
compared	O	VERB	B
with	O	ADP	O
other	O	ADJ	O
genotypes	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
0002	O	NUM	O
and	O	CCONJ	O
P	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
006	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
FMR1	O	NOUN	B
gene	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
repeat	O	NOUN	B
-	O	PUNCT	O
amplification	O	NOUN	B
mechanism	O	NOUN	B
causing	O	VERB	O
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
led	O	VERB	O
to	O	PART	O
development	O	NOUN	B
of	O	ADP	O
reliable	O	ADJ	O
DNA	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
diagnostic	O	ADJ	B
methods	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
Southern	O	NOUN	B
blot	O	NOUN	I
hybridization	O	NOUN	I
and	O	CCONJ	O
PCR	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
a	O	DET	O
new	O	ADJ	O
diagnostic	O	ADJ	B
test	O	NOUN	I
to	O	PART	O
identify	O	VERB	O
male	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
lack	O	NOUN	B
of	O	ADP	O
FMRP	O	NOUN	B
in	O	ADP	O
their	O	PRON	O
hair	O	NOUN	B
roots	O	NOUN	I
.	O	PUNCT	O


Control	O	ADJ	B
individuals	O	NOUN	B
showed	O	VERB	O
clear	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
FMRP	O	NOUN	B
in	O	ADP	O
nearly	O	ADV	O
every	O	DET	O
hair	O	NOUN	B
root	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
male	O	NOUN	B
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
patients	O	NOUN	B
lacked	O	VERB	O
expression	O	NOUN	B
of	O	ADP	O
FMRP	O	NOUN	B
in	O	ADP	O
almost	O	ADV	O
all	O	DET	O
their	O	PRON	O
hair	O	NOUN	B
roots	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
advantages	O	NOUN	O
of	O	ADP	O
this	O	DET	O
test	O	NOUN	B
are	O	AUX	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
plucking	O	NOUN	B
of	O	ADP	O
hair	O	NOUN	B
follicles	O	NOUN	I
does	O	AUX	O
no	O	DET	O
appreciable	O	ADJ	O
harm	O	NOUN	O
to	O	ADP	O
the	O	DET	O
mentally	B-Disease	ADV	B
retarded	I-Disease	VERB	B
patient	O	NOUN	B
,	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
hairs	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
sent	O	VERB	O
in	O	ADP	O
a	O	DET	O
simple	O	ADJ	O
envelope	O	NOUN	O
to	O	PART	O
a	O	DET	O
diagnostic	O	ADJ	B
center	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
the	O	DET	O
result	O	NOUN	O
of	O	ADP	O
the	O	DET	O
test	O	NOUN	B
is	O	AUX	O
available	O	ADJ	O
within	O	ADP	O
5	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
plucking	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
Swedish	O	ADJ	B
families	O	NOUN	B
with	O	ADP	O
hereditary	B-Disease	ADJ	B
prostate	I-Disease	NOUN	I
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
linkage	O	NOUN	B
to	O	PART	O
the	O	DET	O
HPC1	O	NOUN	B
locus	O	NOUN	I
on	O	ADP	O
chromosome	O	NOUN	B
1q24	O	NOUN	I
-	O	PUNCT	O
25	O	NUM	O
is	O	AUX	O
restricted	O	ADJ	O
to	O	PART	O
families	O	NOUN	B
with	O	ADP	O
early	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
reported	O	VERB	O
evidence	O	NOUN	B
of	O	ADP	O
linkage	O	NOUN	B
to	O	PART	O
the	O	DET	O
1q24	O	NOUN	B
-	O	PUNCT	O
25	O	NUM	O
region	O	NOUN	B
(	O	PUNCT	O
HPC1	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
91	O	NUM	O
North	O	ADJ	B
American	O	ADJ	I
and	O	CCONJ	O
Swedish	O	ADJ	B
families	O	NOUN	B
each	O	DET	O
with	O	ADP	O
multiple	O	ADJ	B
cases	O	NOUN	B
of	O	ADP	O
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
(	O	PUNCT	O
Smith	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
1996	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
are	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
hypothesis	O	NOUN	B
of	O	ADP	O
linkage	O	NOUN	B
to	O	PART	O
HPC1	O	NOUN	B
in	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
families	O	NOUN	B
with	O	ADP	O
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
particularly	O	ADV	O
those	O	DET	O
with	O	ADP	O
an	O	DET	O
early	O	ADJ	B
age	O	NOUN	I
at	O	ADP	O
diagnosis	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
family	O	NOUN	B
of	O	ADP	O
domestic	O	ADJ	B
cats	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
that	O	PRON	O
exhibited	O	VERB	O
clinical	O	ADJ	B
and	O	CCONJ	O
biochemical	O	ADJ	B
abnormalities	O	NOUN	I
consistent	O	ADJ	B
with	O	ADP	I
mucopolysaccharidosis	B-Disease	NOUN	B
VII	I-Disease	NOUN	I
,	O	PUNCT	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
lysosomal	I-Disease	ADJ	B
storage	I-Disease	NOUN	I
disorder	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
beta	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
glucuronidase	I-Disease	NOUN	B
deficiency	I-Disease	NOUN	B
.	O	PUNCT	O


A	O	DET	O
common	O	ADJ	O
molecular	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
rearrangement	B-Disease	NOUN	B
disorders	I-Disease	NOUN	I
on	O	ADP	O
chromosome	O	NOUN	B
22q11	O	NOUN	I
.	O	PUNCT	O


Three	O	NUM	O
congenital	B-Disease	ADJ	B
anomaly	I-Disease	NOUN	I
disorders	I-Disease	NOUN	I
,	O	PUNCT	O
cat	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
eye	I-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
der	B-Disease	NOUN	B
(	I-Disease	PUNCT	O
)	I-Disease	PUNCT	O
syndrome	I-Disease	NOUN	O
and	O	CCONJ	O
velo	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
cardio	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
facial	I-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
/	O	SYM	O
DiGeorge	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
VCFS	B-Disease	NOUN	B
/	O	SYM	O
DGS	B-Disease	PROPN	B
)	O	PUNCT	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
tetrasomy	O	NOUN	B
,	O	PUNCT	O
trisomy	O	NOUN	B
or	O	CCONJ	O
monosomy	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
part	O	NOUN	O
of	O	ADP	O
chromosome	O	NOUN	O
22q11	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
there	O	PRON	O
are	O	AUX	O
particular	O	ADJ	O
regions	O	NOUN	B
on	O	ADP	O
22q11	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
prone	O	ADJ	O
to	O	ADP	O
rearrangements	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
deletion	O	NOUN	B
end	O	NOUN	O
-	O	PUNCT	O
points	O	NOUN	B
in	O	ADP	O
a	O	DET	O
large	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
VCFS	B-Disease	PROPN	B
/	O	SYM	O
DGS	B-Disease	PROPN	B
patients	O	NOUN	B
were	O	AUX	O
defined	O	VERB	O
by	O	ADP	O
haplotype	O	NOUN	B
analysis	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
this	O	DET	O
hypothesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
developed	O	VERB	O
hamster	O	NOUN	B
-	O	PUNCT	O
human	O	ADJ	B
somatic	O	ADJ	B
hybrid	O	NOUN	O
cell	O	NOUN	O
lines	O	NOUN	O
from	O	ADP	O
VCFS	B-Disease	PROPN	B
/	O	SYM	O
DGS	B-Disease	PROPN	B
patients	O	NOUN	B
with	O	ADP	O
all	O	DET	O
three	O	NUM	O
classes	O	NOUN	B
of	O	ADP	O
deletions	O	NOUN	B
and	O	CCONJ	O
we	O	PRON	O
now	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
breakpoints	O	NOUN	B
occur	O	VERB	O
within	O	ADP	O
similar	O	ADJ	O
low	O	ADJ	B
copy	O	NOUN	B
repeats	O	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
LCR22s	O	ADJ	B
.	O	PUNCT	O


We	O	PRON	O
present	O	VERB	O
models	O	NOUN	B
to	O	PART	O
explain	O	VERB	O
how	O	SCONJ	O
the	O	DET	O
LCR22s	O	NOUN	B
can	O	AUX	O
mediate	O	VERB	O
different	O	ADJ	O
homologous	O	ADJ	B
recombination	O	NOUN	I
events	O	NOUN	O
,	O	PUNCT	O
thereby	O	ADV	O
generating	O	VERB	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
rearrangements	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
congenital	B-Disease	ADJ	B
anomaly	I-Disease	NOUN	I
disorders	I-Disease	NOUN	I
.	O	PUNCT	O


This	O	DET	O
idea	O	NOUN	O
is	O	AUX	O
based	O	VERB	O
partly	O	ADV	O
on	O	ADP	O
the	O	DET	O
phenotype	O	NOUN	B
of	O	ADP	O
homozygous	O	ADJ	B
Krox20	O	NOUN	B
(	O	PUNCT	O
Egr2	O	NOUN	B
)	O	PUNCT	O
knockout	O	NOUN	B
mice	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
display	O	VERB	O
hypomyelination	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
PNS	I-Disease	NOUN	B
and	O	CCONJ	O
a	O	DET	O
block	O	NOUN	B
of	O	ADP	O
Schwann	O	NOUN	B
cells	O	NOUN	I
at	O	ADP	O
an	O	DET	O
early	O	ADJ	B
stage	O	NOUN	I
of	O	ADP	O
differentiation	O	NOUN	B
.	O	PUNCT	O


Autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
familial	I-Disease	ADJ	B
neurohypophyseal	I-Disease	ADJ	O
diabetes	I-Disease	NOUN	O
insipidus	I-Disease	NOUN	B
with	O	ADP	O
continued	O	ADJ	O
secretion	O	NOUN	B
of	O	ADP	O
mutant	O	ADJ	B
weakly	O	ADV	O
active	O	ADJ	O
vasopressin	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
published	O	VERB	B
mutations	O	NOUN	I
affect	O	VERB	O
the	O	DET	O
signal	O	NOUN	B
peptide	O	NOUN	I
or	O	CCONJ	O
the	O	DET	O
neurophysin	O	NOUN	B
-	O	PUNCT	O
II	O	NUM	B
carrier	O	NOUN	I
protein	O	NOUN	I
and	O	CCONJ	O
are	O	AUX	O
presumed	O	VERB	O
to	O	PART	O
interfere	O	VERB	B
with	O	ADP	I
processing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
preprohormone	O	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
neuronal	B-Disease	ADJ	B
damage	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
youngest	O	ADJ	O
child	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
years	O	NOUN	O
old	O	ADJ	O
)	O	PUNCT	O
was	O	AUX	O
only	O	ADV	O
mildly	O	ADV	B
affected	O	VERB	B
but	O	CCONJ	O
had	O	AUX	O
Leu	O	NOUN	B
-	O	PUNCT	O
AVP	O	NOUN	B
levels	O	NOUN	B
similar	O	ADJ	O
to	O	ADP	O
her	O	PRON	O
severely	O	ADV	B
affected	O	VERB	B
8	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
brother	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
unknown	O	ADJ	O
mechanisms	O	NOUN	B
may	O	AUX	O
partially	O	ADV	O
compensate	O	VERB	B
for	O	ADP	O
a	O	DET	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
active	I-Disease	ADJ	B
AVP	I-Disease	NOUN	B
in	O	ADP	O
very	O	ADV	O
young	O	ADJ	B
children	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


No	O	DET	O
inherited	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
GPI	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
anchor	I-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


PIGA	O	NOUN	B
(	O	PUNCT	O
-	O	PUNCT	O
)	O	PUNCT	O
cells	O	NOUN	B
had	O	AUX	O
no	O	DET	O
growth	O	NOUN	B
advantage	O	NOUN	O
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
other	O	ADJ	O
factors	O	NOUN	B
are	O	AUX	O
needed	O	VERB	O
for	O	ADP	O
their	O	PRON	O
clonal	O	ADJ	B
dominance	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
paroxysmal	B-Disease	ADJ	B
nocturnal	I-Disease	ADJ	I
hemoglobinuria	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Targeted	O	VERB	B
mutagenesis	O	NOUN	I
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
produce	O	VERB	O
two	O	NUM	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
murine	O	ADJ	B
hemochromatosis	B-Disease	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
Hfe	O	NOUN	B
)	O	PUNCT	O
locus	O	NOUN	B
.	O	PUNCT	O


Genotype	O	ADJ	B
-	O	PUNCT	O
phenotype	O	NOUN	B
analysis	O	NOUN	B
in	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
and	O	CCONJ	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
missense	O	NOUN	B
mutation	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
milder	O	ADJ	B
phenotype	O	NOUN	B
.	O	PUNCT	O


Age	O	NOUN	B
at	O	ADP	O
onset	O	NOUN	O
was	O	AUX	O
later	O	ADV	O
for	O	ADP	O
first	O	ADJ	O
symptoms	O	NOUN	B
and	O	CCONJ	O
for	O	ADP	O
development	O	NOUN	B
of	O	ADP	O
ankle	B-Disease	NOUN	B
contractures	I-Disease	NOUN	I
and	O	CCONJ	O
muscle	B-Disease	NOUN	B
weakness	I-Disease	NOUN	I
.	O	PUNCT	O


X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	I
dystrophy	I-Disease	NOUN	I
(	O	PUNCT	O
EDMD	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
relatively	O	ADV	O
rare	O	ADJ	O
benign	B-Disease	ADJ	B
neuromuscular	I-Disease	ADJ	O
disorder	I-Disease	NOUN	O
which	O	DET	O
can	O	AUX	O
vary	O	VERB	O
remarkably	O	ADV	O
in	O	ADP	O
onset	O	NOUN	O
,	O	PUNCT	O
course	O	NOUN	B
and	O	CCONJ	O
severity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
interfamilial	O	ADJ	B
heterogeneity	O	NOUN	B
in	O	ADP	O
distribution	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
severity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
features	O	NOUN	B
in	O	ADP	O
the	O	DET	O
two	O	NUM	O
families	O	NOUN	B
point	O	VERB	O
to	O	ADP	O
environmental	O	ADJ	B
or	O	CCONJ	O
genetic	O	ADJ	B
modification	O	NOUN	I
as	O	ADP	O
the	O	DET	O
cause	O	NOUN	O
of	O	ADP	O
clinical	O	ADJ	B
variability	O	NOUN	B
in	O	ADP	O
Emery	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


BACKGROUND	O	NOUN	O
Families	O	NOUN	B
with	O	ADP	O
a	O	DET	O
high	O	ADJ	O
incidence	O	NOUN	B
of	O	ADP	O
hereditary	B-Disease	ADJ	B
breast	I-Disease	NOUN	I
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
subsequently	O	ADV	O
shown	O	VERB	O
to	O	PART	O
have	O	AUX	O
terminating	O	VERB	O
mutations	O	NOUN	B
in	O	ADP	O
BRCA1	O	NOUN	B
or	O	CCONJ	O
BRCA2	O	NOUN	B
,	O	PUNCT	O
appear	O	VERB	O
to	O	PART	O
have	O	AUX	O
a	O	DET	O
higher	O	ADJ	O
incidence	O	NOUN	B
of	O	ADP	O
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
among	O	ADP	O
male	O	NOUN	B
relatives	O	NOUN	I
.	O	PUNCT	O


METHODS	O	NOUN	O
We	O	PRON	O
examined	O	VERB	O
genomic	O	ADJ	B
DNA	O	NOUN	I
from	O	ADP	O
83	O	NUM	O
(	O	PUNCT	O
for	O	ADP	O
BRCA1	O	NOUN	B
185delAG	O	NOUN	O
)	O	PUNCT	O
or	O	CCONJ	O
82	O	NUM	O
(	O	PUNCT	O
for	O	ADP	O
BRCA2	O	NOUN	B
6174delT	O	NOUN	I
)	O	PUNCT	O
Ashkenazi	O	ADJ	B
Jewish	O	ADJ	B
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
patients	O	NOUN	B
,	O	PUNCT	O
most	O	ADJ	O
of	O	ADP	O
whom	O	PRON	O
were	O	AUX	O
treated	O	VERB	B
at	O	ADP	O
a	O	DET	O
relatively	O	ADV	O
young	O	ADJ	B
age	O	NOUN	B
,	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
germline	O	NOUN	B
mutation	O	NOUN	I
in	O	ADP	O
each	O	DET	O
gene	O	NOUN	B
seen	O	VERB	O
in	O	ADP	O
the	O	DET	O
Ashkenazi	O	ADJ	B
population	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
The	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
each	O	DET	O
of	O	ADP	O
the	O	DET	O
germline	O	NOUN	B
mutations	O	NOUN	I
in	O	ADP	O
these	O	DET	O
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
patients	O	NOUN	B
closely	O	ADV	O
matched	O	VERB	O
their	O	PRON	O
incidence	O	NOUN	B
(	O	PUNCT	O
about	O	ADV	O
1	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
general	O	ADJ	O
Ashkenazi	O	PROPN	B
Jewish	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


Beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
accumulation	O	NOUN	B
and	O	CCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CTNNB1	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
hepatoblastoma	B-Disease	NOUN	B
.	O	PUNCT	O


Epidemiologic	O	ADJ	B
studies	O	NOUN	I
have	O	AUX	O
shown	O	VERB	O
an	O	DET	O
increased	O	VERB	B
frequency	O	NOUN	B
of	O	ADP	O
this	O	DET	O
tumor	B-Disease	NOUN	B
type	O	NOUN	I
in	O	ADP	O
families	O	NOUN	B
affected	O	VERB	B
by	O	ADP	O
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
ongoing	O	ADJ	O
immunohistochemical	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
sporadic	O	ADJ	B
cases	O	NOUN	B
of	O	ADP	O
tumor	B-Disease	NOUN	B
types	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
increased	O	VERB	B
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
investigated	O	VERB	B
hepatoblastomas	B-Disease	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
indicate	O	VERB	O
for	O	ADP	O
the	O	DET	O
first	O	ADJ	O
time	O	NOUN	O
that	O	SCONJ	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
accumulation	O	NOUN	B
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
hepatoblastoma	B-Disease	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
activating	O	VERB	B
mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
gene	O	NOUN	B
may	O	AUX	O
substitute	O	VERB	O
biallelic	O	ADJ	B
APC	O	NOUN	B
inactivation	O	NOUN	B
in	O	ADP	O
this	O	DET	O
tumor	B-Disease	NOUN	B
type	O	NOUN	I
.	O	PUNCT	O


Hereditary	B-Disease	ADJ	B
progressive	I-Disease	ADJ	I
dystonia	I-Disease	NOUN	I
with	O	ADP	O
marked	O	ADJ	O
diurnal	O	ADJ	B
fluctuation	O	NOUN	O
(	O	PUNCT	O
HPD	B-Disease	NOUN	B
;	O	PUNCT	O
dopa	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
responsive	I-Disease	ADJ	B
dystonia	I-Disease	NOUN	B
,	O	PUNCT	O
DRD	B-Disease	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
a	O	DET	O
genetic	B-Disease	ADJ	B
defect	I-Disease	NOUN	I
in	O	ADP	O
the	O	DET	O
GTP	O	NOUN	B
cyclohydrolase	O	NOUN	I
I	O	NUM	I
(	O	PUNCT	O
GCH1	O	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	O
.	O	PUNCT	O


Sulfate	O	NOUN	B
transport	O	NOUN	I
is	O	AUX	O
not	O	PART	O
impaired	O	ADJ	B
in	O	ADP	O
pendred	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
thyrocytes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
(	O	PUNCT	O
PDS	B-Disease	PROPN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
cloned	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
its	O	PRON	O
function	O	NOUN	B
is	O	AUX	O
as	O	ADP	O
yet	O	ADV	O
unknown	O	ADJ	B
and	O	CCONJ	O
the	O	DET	O
connection	O	NOUN	B
between	O	ADP	O
thyroid	B-Disease	NOUN	B
goiter	I-Disease	NOUN	I
and	O	CCONJ	O
sensory	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
neural	I-Disease	ADJ	B
deafness	I-Disease	NOUN	I
remains	O	VERB	O
an	O	DET	O
enigma	O	NOUN	O
.	O	PUNCT	O


Small	O	ADJ	B
deletions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
type	O	NOUN	B
II	O	NUM	I
collagen	O	NOUN	I
triple	O	ADJ	I
helix	O	NOUN	I
produce	O	VERB	O
kniest	B-Disease	ADJ	B
dysplasia	I-Disease	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
type	O	NOUN	B
II	O	NUM	I
collagen	O	NOUN	I
(	O	PUNCT	O
COL2A1	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
predominant	O	ADJ	O
protein	O	NOUN	B
of	O	ADP	O
cartilage	O	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
Kniest	B-Disease	NOUN	B
dysplasia	I-Disease	NOUN	I
.	O	PUNCT	O


Sequencing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
index	O	NOUN	O
patients	O	NOUN	B
genomic	O	ADJ	B
DNA	O	NOUN	I
identified	O	VERB	O
four	O	NUM	O
new	O	ADJ	O
dominant	O	ADJ	B
mutations	O	NOUN	B
in	O	ADP	O
COL2A1	O	NOUN	B
that	O	PRON	O
result	O	VERB	O
in	O	ADP	O
Kniest	B-Disease	NOUN	B
dysplasia	I-Disease	NOUN	I
a	O	DET	O
21	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
deletion	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
16	O	NUM	O
,	O	PUNCT	O
an	O	DET	O
18	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
deletion	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
19	O	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
4	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
deletions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
splice	O	NOUN	B
donor	O	NOUN	I
sites	O	NOUN	I
of	O	ADP	O
introns	O	NOUN	B
14	O	NUM	O
and	O	CCONJ	O
20	O	NUM	O
.	O	PUNCT	O


Classical	B-Disease	ADJ	O
galactosemia	I-Disease	NOUN	B
and	O	CCONJ	O
mutations	O	NOUN	B
at	O	ADP	O
the	O	DET	O
galactose	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
-	O	PUNCT	O
phosphate	O	NOUN	B
uridyl	O	ADJ	I
transferase	O	NOUN	I
(	O	PUNCT	O
GALT	O	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
considerable	O	ADJ	O
genetic	O	ADJ	B
heterogeneity	O	NOUN	I
documented	O	VERB	B
to	O	PART	O
date	O	NOUN	O
undoubtedly	O	ADV	O
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
phenotypic	O	ADJ	B
heterogeneity	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
galactosemia	B-Disease	NOUN	B
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
the	O	DET	O
nature	O	NOUN	O
of	O	ADP	O
somatic	O	ADJ	B
von	B-Disease	NOUN	I
Hippel	I-Disease	PROPN	I
-	I-Disease	PUNCT	O
Lindau	I-Disease	PROPN	B
(	O	PUNCT	O
VHL	B-Disease	NOUN	B
)	O	PUNCT	O
mutations	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
analyzed	O	VERB	B
173	O	NUM	O
primary	O	ADJ	B
sporadic	O	ADJ	B
human	O	ADJ	B
renal	B-Disease	ADJ	O
cell	I-Disease	NOUN	O
carcinomas	I-Disease	NOUN	O
for	O	ADP	O
mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VHL	B-Disease	NOUN	B
tumor	I-Disease	NOUN	O
suppressor	O	NOUN	O
gene	O	NOUN	O
,	O	PUNCT	O
using	O	VERB	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
PCR	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
single	O	ADJ	B
-	O	PUNCT	O
strand	O	NOUN	B
conformational	O	ADJ	B
polymorphism	O	NOUN	O
analysis	O	NOUN	O
(	O	PUNCT	O
SSCP	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
DNA	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
compare	O	VERB	B
somatic	O	ADJ	B
and	O	CCONJ	O
germline	O	NOUN	B
mutations	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
the	O	DET	O
VHL	B-Disease	NOUN	B
database	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
includes	O	VERB	O
507	O	NUM	O
mutations	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
then	O	ADV	O
analyzed	O	VERB	B
the	O	DET	O
occurrence	O	NOUN	B
of	O	ADP	O
RCC	B-Disease	NOUN	B
in	O	ADP	O
VHL	B-Disease	NOUN	B
families	O	NOUN	B
,	O	PUNCT	O
based	O	VERB	O
on	O	ADP	O
the	O	DET	O
nature	O	NOUN	O
of	O	ADP	O
mutations	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
mutations	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
truncated	O	VERB	B
proteins	O	NOUN	I
may	O	AUX	O
lead	O	VERB	O
to	O	PART	O
a	O	DET	O
higher	O	ADJ	O
risk	O	NOUN	B
of	O	ADP	O
RCC	B-Disease	NOUN	B
in	O	ADP	O
VHL	B-Disease	NOUN	B
patients	O	NOUN	B


Chediak	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Higashi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
CHS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
inherited	B-Disease	VERB	B
disorder	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
lysosomal	O	ADJ	B
trafficking	O	NOUN	I
regulator	O	NOUN	I
gene	O	NOUN	I
,	O	PUNCT	O
LYST	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
murine	O	ADJ	B
equivalent	O	NOUN	B
of	O	ADP	O
CHS	B-Disease	NOUN	B
,	O	PUNCT	O
beige	O	NOUN	B
mice	O	NOUN	I
,	O	PUNCT	O
present	O	VERB	O
similar	O	ADJ	O
characteristics	O	NOUN	B
but	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
develop	O	VERB	O
the	O	DET	O
lymphoproliferative	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
therefore	O	ADV	O
proposed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
defective	O	ADJ	B
surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
CTLA	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
by	O	ADP	O
CHS	B-Disease	NOUN	B
T	O	NOUN	B
cells	O	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
lymphoproliferative	B-Disease	ADJ	B
disease	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
Clinical	O	ADJ	B
European	O	PROPN	I
Network	O	PROPN	I
on	O	ADP	O
Brain	B-Disease	PROPN	B
Dysmyelinating	I-Disease	PROPN	I
Disease	I-Disease	PROPN	I
.	O	PUNCT	O


Investigating	O	VERB	B
82	O	NUM	O
strictly	O	ADV	O
selected	O	VERB	O
sporadic	O	ADJ	B
cases	O	NOUN	B
of	O	ADP	O
PMD	B-Disease	PROPN	B
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
PLP	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
77	O	NUM	O
%	O	NOUN	O
;	O	PUNCT	O
complete	O	ADJ	O
PLP	O	NOUN	B
-	O	PUNCT	O
gene	O	NOUN	B
duplications	O	NOUN	I
were	O	AUX	O
the	O	DET	O
most	O	ADV	O
frequent	O	ADJ	B
abnormality	O	NOUN	B
(	O	PUNCT	O
62	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
whereas	O	SCONJ	O
point	O	NOUN	O
mutations	O	NOUN	B
in	O	ADP	O
coding	O	VERB	B
or	O	CCONJ	O
splice	O	NOUN	B
-	O	PUNCT	O
site	O	NOUN	B
regions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
were	O	AUX	O
involved	O	VERB	O
less	O	ADV	O
frequently	O	ADV	O
(	O	PUNCT	O
38	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Prader	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
PWS	B-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
Angelman	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
AS	B-Disease	NOUN	B
)	O	PUNCT	O
are	O	AUX	O
distinct	O	ADJ	O
neurobehavioral	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
that	O	PRON	O
most	O	ADV	O
often	O	ADV	O
arise	O	VERB	O
from	O	ADP	O
a	O	DET	O
4	O	NUM	O
-	O	PUNCT	O
Mb	O	NOUN	B
deletion	O	NOUN	B
of	O	ADP	O
chromosome	O	NOUN	B
15q11	O	NOUN	I
-	O	PUNCT	O
q13	O	NOUN	B
during	O	ADP	O
paternal	O	ADJ	B
or	O	CCONJ	O
maternal	O	ADJ	B
gametogenesis	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


Linkage	O	NOUN	B
analysis	O	NOUN	I
in	O	ADP	O
a	O	DET	O
large	O	ADJ	O
Brazilian	O	ADJ	B
family	O	NOUN	O
with	O	ADP	O
van	B-Disease	X	B
der	I-Disease	NOUN	I
Woude	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
suggests	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
a	O	DET	O
susceptibility	O	NOUN	B
locus	O	NOUN	I
for	O	ADP	O
cleft	B-Disease	ADJ	B
palate	I-Disease	NOUN	I
at	O	ADP	I
17p11	O	NOUN	I
.	O	PUNCT	O
2	O	NUM	O
-	O	SYM	O
11	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
VWS	B-Disease	NOUN	B
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
incomplete	O	ADJ	B
penetrance	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
highly	O	ADV	O
variable	O	ADJ	B
.	O	PUNCT	O


To	O	PART	O
test	O	VERB	O
this	O	DET	O
hypothesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
conducted	O	VERB	O
linkage	O	NOUN	B
analysis	O	NOUN	I
in	O	ADP	O
a	O	DET	O
large	O	ADJ	O
Brazilian	O	ADJ	B
kindred	O	NOUN	B
with	O	ADP	O
VWS	B-Disease	NOUN	B
,	O	PUNCT	O
considering	O	VERB	O
as	O	ADP	O
affected	O	VERB	B
the	O	DET	O
individuals	O	NOUN	B
with	O	ADP	O
CP	B-Disease	NOUN	B
,	O	PUNCT	O
regardless	O	ADV	O
of	O	ADP	O
whether	O	SCONJ	O
it	O	PRON	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
other	O	ADJ	O
clinical	O	ADJ	B
signs	O	NOUN	O
of	O	ADP	O
VWS	B-Disease	NOUN	B
.	O	PUNCT	O


If	O	SCONJ	O
this	O	DET	O
hypothesis	O	NOUN	B
is	O	AUX	O
confirmed	O	VERB	O
in	O	ADP	O
other	O	ADJ	O
VWS	B-Disease	NOUN	B
pedigrees	O	NOUN	B
,	O	PUNCT	O
it	O	PRON	O
will	O	AUX	O
represent	O	VERB	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
first	O	ADJ	O
examples	O	NOUN	B
of	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
,	O	PUNCT	O
mapped	O	VERB	B
through	O	ADP	O
linkage	O	NOUN	B
analysis	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
modifies	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
major	O	ADJ	O
gene	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
DNA	O	NOUN	B
as	O	ADP	O
the	O	DET	O
starting	O	NOUN	O
material	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
screened	O	VERB	B
the	O	DET	O
ATM	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
92	O	NUM	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
an	O	DET	O
optimized	O	ADJ	B
single	O	ADJ	B
-	O	PUNCT	O
strand	O	NOUN	B
conformation	O	NOUN	O
polymorphism	O	NOUN	O
(	O	PUNCT	O
SSCP	O	NOUN	B
)	O	PUNCT	O
technique	O	NOUN	O
that	O	PRON	O
detected	O	VERB	B
all	O	DET	O
previously	O	ADV	O
known	O	VERB	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
PCR	O	NOUN	B
)	O	PUNCT	O
segments	O	NOUN	B
being	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
XK	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
XK	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
Japanese	O	ADJ	B
patient	O	NOUN	B
with	O	ADP	O
McLeod	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
this	O	DET	O
single	O	ADJ	B
-	O	PUNCT	O
base	O	NOUN	B
deletion	O	NOUN	B
causes	O	VERB	O
defective	O	ADJ	B
Kx	O	NOUN	B
protein	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
McLeod	B-Disease	NOUN	B
phenotype	O	NOUN	B
in	O	ADP	O
this	O	DET	O
patient	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Formation	O	NOUN	B
of	O	ADP	O
irradiation	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
foci	O	NOUN	B
positive	O	ADJ	B
for	O	ADP	O
BRCA1	O	NOUN	B
,	O	PUNCT	O
hRad50	O	ADJ	B
,	O	PUNCT	O
hMre11	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
p95	O	NOUN	B
was	O	AUX	O
dramatically	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
HCC	O	NOUN	B
/	O	SYM	O
1937	O	NUM	B
breast	B-Disease	NOUN	I
cancer	I-Disease	NOUN	I
cells	O	NOUN	O
carrying	O	VERB	O
a	O	DET	O
homozygous	O	ADJ	B
mutation	O	NOUN	B
in	O	ADP	O
BRCA1	O	NOUN	B
but	O	CCONJ	O
was	O	AUX	O
restored	O	VERB	B
by	O	ADP	O
transfection	O	NOUN	B
of	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
BRCA1	O	NOUN	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
To	O	PART	O
examine	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
of	O	ADP	O
phenylalanine	O	NOUN	B
hydroxylase	O	NOUN	I
(	O	PUNCT	O
PAH	O	NOUN	B
)	O	PUNCT	O
genotypes	O	NOUN	B
to	O	PART	O
biochemical	O	ADJ	B
phenotype	O	NOUN	B
and	O	CCONJ	O
cognitive	O	ADJ	B
development	O	NOUN	I
in	O	ADP	O
maternal	B-Disease	ADJ	B
phenylketonuria	I-Disease	NOUN	I
(	O	PUNCT	O
PKU	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Based	O	VERB	O
on	O	ADP	O
previous	O	ADJ	O
knowledge	O	NOUN	B
about	O	ADP	O
mutation	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
associations	O	NOUN	B
,	O	PUNCT	O
78	O	NUM	O
of	O	ADP	O
the	O	DET	O
mutations	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
assigned	O	VERB	O
to	O	ADP	O
one	O	NUM	O
of	O	ADP	O
four	O	NUM	O
classes	O	NOUN	B
of	O	ADP	O
severity	O	NOUN	B
(	O	PUNCT	O
severe	O	ADJ	B
PKU	B-Disease	NOUN	B
,	O	PUNCT	O
moderate	O	ADJ	B
PKU	B-Disease	NOUN	B
,	O	PUNCT	O
mild	O	ADJ	B
PKU	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mild	B-Disease	ADJ	B
hyperphenylalaninemia	I-Disease	NOUN	B
[	O	PUNCT	O
MHP	B-Disease	PROPN	B
]	O	PUNCT	O
)	O	PUNCT	O
.	O	PUNCT	O


Of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
PKU	B-Disease	NOUN	B
,	O	PUNCT	O
92	O	NUM	O
%	O	NOUN	O
had	O	AUX	O
been	O	AUX	O
treated	O	VERB	B
during	O	ADP	O
childhood	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
The	O	DET	O
reproductive	O	ADJ	B
outcome	O	NOUN	I
in	O	ADP	O
maternal	B-Disease	ADJ	B
phenylketonuria	I-Disease	NOUN	I
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
prenatal	O	ADJ	B
metabolic	O	ADJ	B
control	O	NOUN	I
and	O	CCONJ	O
postnatal	O	ADJ	B
environmental	O	ADJ	B
circumstances	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
significant	O	ADJ	B
relationship	O	NOUN	B
among	O	ADP	O
genotype	O	NOUN	B
,	O	PUNCT	O
biochemical	O	ADJ	B
phenotype	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
cognitive	O	ADJ	B
performance	O	NOUN	I
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
is	O	AUX	O
of	O	ADP	O
importance	O	NOUN	O
for	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
an	O	DET	O
optimal	O	ADJ	B
strategy	O	NOUN	O
for	O	ADP	O
future	O	ADJ	B
treatment	O	NOUN	B
of	O	ADP	O
females	O	NOUN	B
with	O	ADP	O
PKU	B-Disease	NOUN	B
who	O	PRON	O
plan	O	VERB	B
pregnancy	O	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
seven	O	NUM	O
Dutch	O	ADJ	B
patients	O	NOUN	B
from	O	ADP	O
six	O	NUM	O
families	O	NOUN	B
with	O	ADP	O
a	O	DET	O
slowly	O	ADV	O
progressive	O	ADJ	B
,	O	PUNCT	O
mainly	O	ADV	O
spinal	B-Disease	ADJ	B
cord	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
that	O	PRON	O
remained	O	VERB	O
for	O	ADP	O
many	O	ADJ	O
years	O	NOUN	B
the	O	DET	O
sole	O	NOUN	O
expression	O	NOUN	B
of	O	ADP	O
cerebrotendinous	B-Disease	ADJ	B
xanthomatosis	I-Disease	NOUN	I
(	O	PUNCT	O
CTX	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
spinal	B-Disease	ADJ	B
xanthomatosis	I-Disease	NOUN	I
is	O	AUX	O
a	O	DET	O
clinical	O	ADJ	B
and	O	CCONJ	O
radiological	O	ADJ	B
separate	O	ADJ	O
entity	O	NOUN	B
of	O	ADP	O
CTX	B-Disease	NOUN	B
that	O	PRON	O
should	O	AUX	O
be	O	AUX	O
included	O	VERB	O
in	O	ADP	O
the	O	DET	O
differential	O	ADJ	B
diagnosis	O	NOUN	I
of	O	ADP	O
chronic	B-Disease	ADJ	B
myelopathy	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Prader	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
PWS	B-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
Angelman	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
AS	B-Disease	ADJ	B
)	O	PUNCT	O
result	O	VERB	O
from	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	I
function	O	NOUN	I
of	O	ADP	O
imprinted	O	ADJ	B
genes	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
chromosome	O	NOUN	I
15q11	O	NOUN	I
-	O	PUNCT	O
q13	O	NOUN	B
.	O	PUNCT	O


Epigenotype	O	NOUN	B
(	O	PUNCT	O
allelic	O	ADJ	B
expression	O	NOUN	I
and	O	CCONJ	O
DNA	O	NOUN	B
methylation	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
fluorescence	O	NOUN	B
in	O	X	I
situ	O	X	I
hybridization	O	NOUN	I
analyses	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transgene	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
mutation	O	NOUN	B
has	O	AUX	O
generated	O	VERB	O
a	O	DET	O
complete	O	ADJ	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PWS	B-Disease	PROPN	B
/	O	PUNCT	O
AS	B-Disease	ADJ	B
-	O	PUNCT	O
homologous	O	ADJ	B
region	O	NOUN	I
but	O	CCONJ	O
has	O	AUX	O
not	O	PART	O
deleted	O	VERB	O
flanking	O	ADJ	O
loci	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
heritable	O	ADJ	B
-	O	PUNCT	O
deletion	O	NOUN	B
mouse	O	NOUN	O
model	O	NOUN	O
will	O	AUX	O
be	O	AUX	O
particularly	O	ADV	O
useful	O	ADJ	O
for	O	ADP	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
etiological	O	ADJ	B
genes	O	NOUN	I
and	O	CCONJ	O
mechanisms	O	NOUN	B
,	O	PUNCT	O
phenotypic	O	ADJ	B
basis	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
investigation	O	NOUN	B
of	O	ADP	O
therapeutic	O	ADJ	B
approaches	O	NOUN	I
for	O	ADP	O
PWS	B-Disease	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


van	B-Disease	X	O
der	I-Disease	NOUN	O
Woude	I-Disease	NOUN	O
syndrome	I-Disease	NOUN	O
(	O	PUNCT	O
vWS	B-Disease	NOUN	B
,	O	PUNCT	O
MIM	O	NOUN	B
119300	O	NUM	I
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
rare	O	ADJ	B
autosomal	B-Disease	ADJ	B
dominant	I-Disease	ADJ	O
clefting	I-Disease	NOUN	B
condition	I-Disease	NOUN	O
with	O	ADP	O
cardinal	O	ADJ	O
features	O	NOUN	B
of	O	ADP	O
mucous	B-Disease	ADJ	B
cysts	I-Disease	NOUN	I
(	O	PUNCT	O
lower	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
lip	I-Disease	NOUN	B
pits	I-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
clefts	B-Disease	NOUN	B
to	I-Disease	ADP	O
the	I-Disease	DET	O
lip	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
/	I-Disease	SYM	O
or	I-Disease	CCONJ	O
palate	I-Disease	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
5	O	NUM	O
novel	O	ADJ	O
vWS	B-Disease	NOUN	B
families	O	NOUN	B
through	O	ADP	O
probands	O	NOUN	B
attended	O	VERB	O
for	O	ADP	O
cleft	B-Disease	NOUN	B
lip	I-Disease	NOUN	I
and	I-Disease	CCONJ	O
/	I-Disease	SYM	O
or	I-Disease	CCONJ	O
palate	I-Disease	ADJ	B
repair	O	NOUN	I
at	O	ADP	O
the	O	DET	O
Department	O	PROPN	B
of	O	ADP	I
Maxillofacial	O	PROPN	I
Surgery	O	PROPN	I
of	O	ADP	O
Hopital	O	PROPN	B
Trousseau	O	PROPN	I
,	O	PUNCT	O
Paris	O	PROPN	B
,	O	PUNCT	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
tentatively	O	ADV	O
refine	O	VERB	O
the	O	DET	O
genetic	O	ADJ	B
map	O	NOUN	I
of	O	ADP	O
the	O	DET	O
vWS	B-Disease	NOUN	B
region	O	NOUN	B
in	O	ADP	O
1q32	O	NOUN	B
-	O	PUNCT	O
q41	O	NOUN	B
and	O	CCONJ	O
possibly	O	ADV	O
identify	O	VERB	O
unlinked	O	ADJ	O
pedigrees	O	NOUN	B
.	O	PUNCT	O


Null	O	NOUN	B
mutation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
murine	O	NOUN	B
ATP7B	O	NOUN	B
(	O	PUNCT	O
Wilson	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
)	O	PUNCT	O
gene	O	NOUN	B
results	O	VERB	I
in	O	ADP	O
intracellular	B-Disease	ADJ	B
copper	I-Disease	NOUN	B
accumulation	I-Disease	NOUN	B
and	O	CCONJ	O
late	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
onset	I-Disease	NOUN	B
hepatic	I-Disease	ADJ	B
nodular	I-Disease	ADJ	I
transformation	I-Disease	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
homologous	O	ADJ	B
recombination	O	NOUN	I
to	O	PART	O
disrupt	O	VERB	B
the	O	DET	O
normal	O	ADJ	B
translation	O	NOUN	B
of	O	ADP	O
ATP7B	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
generated	O	VERB	O
a	O	DET	O
strain	O	NOUN	B
of	O	ADP	O
mice	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
homozygous	O	ADJ	B
mutants	O	NOUN	B
(	O	PUNCT	O
null	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
Wilson	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
gene	O	NOUN	I
.	O	PUNCT	O


Morphological	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	O
resembling	O	VERB	O
cirrhosis	B-Disease	NOUN	B
developed	O	VERB	O
in	O	ADP	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
the	O	DET	O
livers	O	NOUN	B
from	O	ADP	O
homozygous	O	ADJ	B
mutants	O	NOUN	B
older	O	ADJ	B
than	O	ADP	O
7	O	NUM	O
months	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
summary	O	NOUN	O
,	O	PUNCT	O
inactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
murine	O	NOUN	B
ATP7B	O	NOUN	B
gene	O	NOUN	I
produces	O	VERB	O
a	O	DET	O
form	O	NOUN	O
of	O	ADP	O
cirrhotic	B-Disease	ADJ	B
liver	I-Disease	NOUN	B
disease	I-Disease	NOUN	I
that	O	PRON	O
resembles	O	VERB	O
Wilson	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
in	O	ADP	O
humans	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
toxic	O	ADJ	B
milk	O	NOUN	B
phenotype	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Segregation	O	NOUN	B
distortion	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
to	O	PART	O
occur	O	VERB	O
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
the	O	DET	O
trinucleotide	B-Disease	NOUN	B
repeat	I-Disease	NOUN	I
disorders	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
performed	O	VERB	O
a	O	DET	O
sperm	O	NOUN	B
typing	O	NOUN	I
study	O	NOUN	B
of	O	ADP	O
five	O	NUM	O
MJD	B-Disease	NOUN	B
patients	O	NOUN	B
of	O	ADP	O
French	O	ADJ	B
descent	O	NOUN	I
and	O	CCONJ	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
pooled	O	VERB	B
data	O	NOUN	B
shows	O	VERB	O
a	O	DET	O
ratio	O	NOUN	B
of	O	ADP	O
mutant	O	NOUN	B
to	O	PART	O
normal	O	ADJ	O
alleles	O	NOUN	B
of	O	ADP	O
379	O	NUM	O
436	O	NUM	O
(	O	PUNCT	O
46	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
53	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
does	O	AUX	O
not	O	PART	O
support	O	VERB	O
meiotic	O	ADJ	B
segregation	O	NOUN	I
distortion	O	NOUN	B
.	O	PUNCT	O


Missense	O	NOUN	B
mutation	O	NOUN	I
in	O	ADP	O
the	O	DET	O
alternative	O	ADJ	B
splice	O	NOUN	O
region	O	NOUN	O
of	O	ADP	O
the	O	DET	O
PAX6	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
eye	B-Disease	NOUN	B
anomalies	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
ascertained	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
missense	O	NOUN	B
mutation	O	NOUN	I
in	O	ADP	O
four	O	NUM	O
pedigrees	O	NOUN	B
with	O	ADP	O
Peters	B-Disease	PROPN	B
anomaly	I-Disease	NOUN	I
,	O	PUNCT	O
congenital	B-Disease	ADJ	B
cataract	I-Disease	NOUN	I
,	O	PUNCT	O
Axenfeldt	B-Disease	PROPN	B
anomaly	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
foveal	B-Disease	ADJ	B
hypoplasia	I-Disease	NOUN	I
,	O	PUNCT	O
which	O	DET	O
,	O	PUNCT	O
to	O	PART	O
our	O	PRON	O
knowledge	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
mutation	O	NOUN	B
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
splice	O	NOUN	B
-	O	PUNCT	O
variant	O	ADJ	B
region	O	NOUN	B
.	O	PUNCT	O


For	O	ADP	O
genetic	O	ADJ	B
counseling	O	NOUN	I
and	O	CCONJ	O
predictive	O	ADJ	B
testing	O	NOUN	I
in	O	ADP	O
families	O	NOUN	B
with	O	ADP	O
inherited	B-Disease	VERB	B
breast	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
penetrances	O	NOUN	B
and	O	CCONJ	O
expressions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
underlying	O	VERB	O
mutations	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
known	O	VERB	O
.	O	PUNCT	O


Their	O	PRON	O
relatives	O	NOUN	B
were	O	AUX	O
described	O	VERB	O
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
absence	O	NOUN	B
/	O	SYM	O
presence	O	NOUN	B
of	O	ADP	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
/	I-Disease	SYM	O
or	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


More	O	ADV	O
ovarian	B-Disease	ADJ	B
cancers	I-Disease	NOUN	I
than	O	ADP	O
breast	B-Disease	NOUN	B
cancers	I-Disease	NOUN	I
were	O	AUX	O
recorded	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
dermatofibrosarcoma	B-Disease	ADJ	B
protuberans	I-Disease	NOUN	I
-	O	PUNCT	O
associated	O	VERB	B
collagen	O	NOUN	B
type	O	NOUN	O
Ialpha1	O	NOUN	B
/	O	PUNCT	O
platelet	O	NOUN	B
-	O	PUNCT	O
derived	O	VERB	B
growth	O	NOUN	B
factor	O	NOUN	I
(	O	PUNCT	O
PDGF	O	NOUN	B
)	O	PUNCT	O
B	O	NOUN	B
-	O	PUNCT	O
chain	O	NOUN	B
fusion	O	NOUN	I
gene	O	NOUN	I
generates	O	VERB	O
a	O	DET	O
transforming	O	VERB	B
protein	O	NOUN	I
that	O	PRON	O
is	O	AUX	O
processed	O	VERB	O
to	O	PART	O
functional	O	ADJ	B
PDGF	O	NOUN	B
-	O	PUNCT	O
BB	O	NOUN	B
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
COLIA1	O	PROPN	B
/	O	PUNCT	O
PDGFB	O	NOUN	B
-	O	PUNCT	O
expressing	O	VERB	B
cells	O	NOUN	B
generated	O	VERB	O
tumors	B-Disease	NOUN	B
after	O	ADP	O
s	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
COLIA1	O	NOUN	B
/	O	PUNCT	O
PDGFB	O	NOUN	B
fusion	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
DFSP	B-Disease	NOUN	B
contributes	O	VERB	O
to	O	PART	O
tumor	B-Disease	NOUN	B
development	O	NOUN	I
through	O	ADP	O
ectopic	O	ADJ	B
production	O	NOUN	I
of	O	ADP	O
PDGF	O	NOUN	B
-	O	PUNCT	O
BB	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
autocrine	O	NOUN	B
loop	O	NOUN	O
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
common	O	ADJ	O
PEX1	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
Zellweger	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
focused	O	VERB	O
on	O	ADP	O
mildly	O	ADV	B
affected	O	VERB	B
patients	O	NOUN	B
and	O	CCONJ	O
there	O	PRON	O
is	O	AUX	O
still	O	ADV	O
no	O	DET	O
report	O	NOUN	O
of	O	ADP	O
two	O	NUM	O
mutant	O	ADJ	B
PEX1	O	NOUN	B
alleles	O	NOUN	B
in	O	ADP	O
any	O	DET	O
Zellweger	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
patient	O	NOUN	B
.	O	PUNCT	O


To	O	PART	O
address	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
of	O	ADP	O
disease	O	NOUN	B
in	O	ADP	O
Zellweger	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
patients	O	NOUN	B
from	O	ADP	O
CG1	O	PROPN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
all	O	DET	O
24	O	NUM	O
PEX1	O	NOUN	B
exons	O	NOUN	B
in	O	ADP	O
four	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
both	O	DET	O
patients	O	NOUN	B
that	O	PRON	O
have	O	AUX	O
mutations	O	NOUN	B
in	O	ADP	O
PMP70	O	NOUN	B
.	O	PUNCT	O


As	O	ADP	O
this	O	DET	O
mutation	O	NOUN	B
leads	O	VERB	O
to	O	PART	O
a	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
function	O	VERB	I
its	O	PRON	O
frequency	O	NOUN	B
makes	O	VERB	O
it	O	PRON	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
Zellweger	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
helping	O	VERB	O
to	O	PART	O
explain	O	VERB	O
the	O	DET	O
high	O	ADJ	O
percentage	O	NOUN	B
of	O	ADP	O
patients	O	NOUN	B
that	O	PRON	O
belong	O	VERB	O
to	O	ADP	O
CG1	O	NOUN	B
.	O	PUNCT	O


Wiskott	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Aldrich	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
WAS	B-Disease	AUX	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
recessive	I-Disease	ADJ	B
immunodeficiency	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
thrombocytopenia	B-Disease	NOUN	B
,	O	PUNCT	O
eczema	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
recurrent	O	ADJ	B
infections	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
WAS	B-Disease	NOUN	B
protein	O	NOUN	I
(	O	PUNCT	O
WASP	O	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	O
.	O	PUNCT	O


Reduced	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
a	O	DET	O
normal	O	ADJ	B
-	O	PUNCT	O
size	O	NOUN	B
WASP	O	PROPN	B
with	O	ADP	O
a	O	DET	O
missense	O	NOUN	B
mutation	O	NOUN	I
were	O	AUX	O
seen	O	VERB	O
in	O	ADP	O
two	O	NUM	O
individuals	O	NOUN	B
with	O	ADP	O
XLT	B-Disease	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
the	O	DET	O
observation	O	NOUN	B
that	O	SCONJ	O
aminoglycoside	O	ADJ	B
treatment	O	NOUN	B
can	O	AUX	O
suppress	O	VERB	B
stop	O	VERB	B
codons	O	NOUN	I
in	O	ADP	O
cultured	O	VERB	B
cells	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
tested	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
gentamicin	O	NOUN	B
on	O	ADP	O
cultured	O	VERB	B
muscle	O	NOUN	I
cells	O	NOUN	I
from	O	ADP	O
the	O	DET	O
mdx	O	NOUN	B
mouse	O	NOUN	B
-	O	PUNCT	O
an	O	DET	O
animal	O	NOUN	B
model	O	NOUN	I
for	O	ADP	O
DMD	B-Disease	PROPN	B
that	O	PRON	O
possesses	O	VERB	O
a	O	DET	O
premature	O	ADJ	B
stop	O	NOUN	I
codon	O	NOUN	I
in	O	ADP	O
the	O	DET	O
dystrophin	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
raise	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
of	O	ADP	O
a	O	DET	O
novel	O	ADJ	B
treatment	O	NOUN	B
regimen	O	NOUN	O
for	O	ADP	O
muscular	B-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
diseases	O	NOUN	B
caused	O	VERB	O
by	O	ADP	O
premature	O	ADJ	B
stop	O	NOUN	I
codon	O	NOUN	O
mutations	O	NOUN	B
.	O	PUNCT	O


Loss	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
gene	O	NOUN	I
product	O	NOUN	I
causes	O	VERB	O
oxidative	O	ADJ	B
damage	O	NOUN	I
in	O	ADP	O
target	O	NOUN	B
organs	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
hypothesized	O	VERB	B
that	O	SCONJ	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
oxidative	O	ADJ	B
damage	O	NOUN	I
resulting	O	VERB	O
from	O	ADP	O
loss	O	NOUN	B
of	O	ADP	I
function	O	NOUN	I
of	O	ADP	O
the	O	DET	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
gene	O	NOUN	I
product	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
observations	O	NOUN	B
provide	O	VERB	O
a	O	DET	O
mechanistic	O	ADJ	O
basis	O	NOUN	O
for	O	ADP	O
the	O	DET	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
phenotype	O	NOUN	B
and	O	CCONJ	O
lay	O	VERB	O
a	O	DET	O
rational	O	ADJ	O
foundation	O	NOUN	O
for	O	ADP	O
therapeutic	O	ADJ	B
intervention	O	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
observed	O	VERB	O
over	O	ADP	O
25	O	NUM	O
different	O	ADJ	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
diastrophic	B-Disease	ADJ	B
dysplasia	I-Disease	NOUN	I
sulphate	O	NOUN	B
transporter	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
DTDST	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	I
the	O	DET	O
recessive	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
achondrogenesis	B-Disease	NOUN	I
1B	I-Disease	NOUN	I
,	O	PUNCT	O
atelosteogenesis	B-Disease	NOUN	B
2	I-Disease	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
diastrophic	B-Disease	ADJ	B
dysplasia	I-Disease	NOUN	I
.	O	PUNCT	O


He	O	PRON	O
was	O	AUX	O
treated	O	VERB	B
for	O	ADP	O
club	B-Disease	NOUN	B
foot	I-Disease	NOUN	I
and	O	CCONJ	O
hip	B-Disease	NOUN	B
dysplasia	I-Disease	NOUN	I
at	O	ADP	O
birth	O	NOUN	B
.	O	PUNCT	O


Cleft	B-Disease	ADJ	B
palate	I-Disease	NOUN	I
,	O	PUNCT	O
swelling	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
ear	I-Disease	NOUN	B
pinna	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
hitch	B-Disease	ADJ	B
hiker	I-Disease	NOUN	I
thumb	I-Disease	NOUN	I
were	O	AUX	O
absent	O	ADJ	B
.	O	PUNCT	O


Counselling	O	NOUN	B
was	O	AUX	O
given	O	VERB	O
for	O	ADP	O
a	O	DET	O
recessive	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
,	O	PUNCT	O
thereby	O	ADV	O
considerably	O	ADV	O
reducing	O	VERB	B
the	O	DET	O
probability	O	NOUN	B
of	O	ADP	O
affected	O	VERB	B
offspring	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
few	O	ADJ	O
other	O	ADJ	O
patients	O	NOUN	B
and	O	CCONJ	O
families	O	NOUN	B
with	O	ADP	O
features	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
our	O	PRON	O
proband	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
previously	O	ADV	O
and	O	CCONJ	O
considered	O	VERB	O
to	O	PART	O
have	O	AUX	O
autosomal	O	ADJ	B
recessive	O	ADJ	I
MED	B-Disease	NOUN	I
(	O	PUNCT	O
EDM4	B-Disease	NOUN	B
,	O	PUNCT	O
McKusick	O	NOUN	O
226900	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Atypical	O	ADJ	B
or	O	CCONJ	O
variant	O	ADJ	B
forms	O	NOUN	O
of	O	ADP	O
well	O	ADV	O
-	O	PUNCT	O
known	O	VERB	B
chondrodysplasias	B-Disease	NOUN	B
may	O	AUX	O
pose	O	VERB	O
diagnostic	O	ADJ	B
problems	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
type	O	NOUN	O
of	O	ADP	O
somatic	O	ADJ	B
mutation	O	NOUN	O
at	O	ADP	O
APC	O	NOUN	B
in	O	ADP	O
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
is	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
the	O	DET	O
site	O	NOUN	B
of	O	ADP	O
the	O	DET	O
germline	O	NOUN	B
mutation	O	NOUN	I
:	O	PUNCT	O
a	O	DET	O
new	O	ADJ	O
facet	O	NOUN	B
to	O	ADP	O
Knudson	O	PROPN	B
'	O	PART	I
s	O	NOUN	I
'	O	PUNCT	O
two	O	NUM	O
-	O	PUNCT	O
hit	O	NOUN	B
'	O	PUNCT	O
hypothesis	O	NOUN	B
.	O	PUNCT	O


Truncating	O	NOUN	B
germline	O	NOUN	B
and	O	CCONJ	O
somatic	O	ADJ	B
mutations	O	NOUN	I
(	O	PUNCT	O
or	O	CCONJ	O
,	O	PUNCT	O
infrequently	O	ADV	O
,	O	PUNCT	O
allelic	O	ADJ	B
loss	O	NOUN	I
)	O	PUNCT	O
occur	O	VERB	O
in	O	ADP	O
tumors	B-Disease	NOUN	B
in	O	ADP	O
FAP	B-Disease	NOUN	B
(	O	PUNCT	O
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Clues	O	NOUN	B
from	O	ADP	O
attenuated	B-Disease	VERB	B
polyposis	I-Disease	NOUN	B
,	O	PUNCT	O
missense	O	NOUN	B
germline	O	NOUN	I
variants	O	NOUN	I
with	O	ADP	O
mild	O	ADJ	B
disease	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
somatic	O	ADJ	B
mutation	O	NOUN	O
cluster	O	NOUN	O
region	O	NOUN	O
(	O	PUNCT	O
codons	O	NOUN	B
1	O	NUM	O
,	O	PUNCT	O
250	O	NUM	O
-	O	SYM	O
1	O	NUM	O
,	O	PUNCT	O
450	O	NUM	O
)	O	PUNCT	O
indicate	O	VERB	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
that	O	SCONJ	O
APC	B-Disease	NOUN	B
mutations	O	NOUN	B
might	O	AUX	O
not	O	PART	O
result	O	VERB	O
in	O	ADP	O
simple	O	ADJ	O
loss	O	NOUN	O
of	O	ADP	O
protein	O	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
different	O	ADJ	O
APC	B-Disease	NOUN	B
mutations	O	NOUN	B
provide	O	VERB	O
cells	O	NOUN	B
with	O	ADP	O
different	O	ADJ	O
selective	O	ADJ	O
advantages	O	NOUN	O
,	O	PUNCT	O
with	O	ADP	O
mutations	O	NOUN	B
close	O	ADV	O
to	O	PART	O
codon	O	NOUN	B
1	O	NUM	I
,	O	PUNCT	O
300	O	NUM	O
providing	O	VERB	O
the	O	DET	O
greatest	O	ADJ	O
advantage	O	NOUN	O
.	O	PUNCT	O


APC	O	NOUN	B
is	O	AUX	O
not	O	PART	O
,	O	PUNCT	O
therefore	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
classical	O	ADJ	O
tumor	B-Disease	NOUN	B
suppressor	O	NOUN	I
.	O	PUNCT	O


Mxi1	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
neurofibrosarcomas	B-Disease	NOUN	B
.	O	PUNCT	O


Little	O	ADJ	O
effort	O	NOUN	O
has	O	AUX	O
yet	O	ADV	O
been	O	AUX	O
made	O	VERB	O
to	O	PART	O
find	O	VERB	O
alterations	O	NOUN	B
involving	O	VERB	O
this	O	DET	O
gene	O	NOUN	B
in	O	ADP	O
human	O	ADJ	B
solid	B-Disease	ADJ	B
tumors	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
examined	O	VERB	O
29	O	NUM	O
human	O	ADJ	B
tumor	B-Disease	NOUN	O
cell	O	NOUN	O
lines	O	NOUN	O
consisting	O	VERB	O
of	O	ADP	O
12	O	NUM	O
esophageal	B-Disease	NOUN	B
cancers	I-Disease	NOUN	I
,	O	PUNCT	O
7	O	NUM	O
glioma	B-Disease	NOUN	B
/	O	PUNCT	O
glioblastomas	B-Disease	NOUN	B
and	O	CCONJ	O
10	O	NUM	O
others	O	NOUN	O
for	O	ADP	O
Mxi1	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
exons	O	NOUN	B
1	O	NUM	I
,	O	PUNCT	O
2	O	NUM	O
,	O	PUNCT	O
4	O	NUM	O
(	O	PUNCT	O
HLH	O	ADJ	B
domain	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
5	O	NUM	O
and	O	CCONJ	O
6	O	NUM	O
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
mutations	O	NOUN	B
occur	O	VERB	O
in	O	ADP	O
the	O	DET	O
Mxi1	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
neurofibrosarcoma	B-Disease	NOUN	B
.	O	PUNCT	O


A	O	DET	O
population	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
study	O	NOUN	B
of	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
expression	O	NOUN	O
of	O	ADP	O
the	O	DET	O
hemochromatosis	B-Disease	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Four	O	NUM	O
of	O	ADP	O
the	O	DET	O
homozygous	O	ADJ	B
subjects	O	NOUN	B
had	O	AUX	O
previously	O	ADV	O
been	O	AUX	O
given	O	VERB	O
a	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
12	O	NUM	O
had	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


Eight	O	NUM	O
of	O	ADP	O
the	O	DET	O
16	O	NUM	O
homozygous	O	ADJ	B
subjects	O	NOUN	B
had	O	AUX	O
clinical	O	ADJ	B
findings	O	NOUN	I
that	O	PRON	O
were	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
hepatomegaly	B-Disease	NOUN	B
,	O	PUNCT	O
skin	B-Disease	NOUN	B
pigmentation	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
arthritis	B-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
clinical	O	ADJ	B
use	O	NOUN	O
of	O	ADP	O
molecular	O	ADJ	B
analyses	O	NOUN	I
in	O	ADP	O
recessive	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
relies	O	VERB	O
on	O	ADP	O
the	O	DET	O
exact	O	ADJ	O
characterization	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
mutant	O	ADJ	B
alleles	O	NOUN	O
in	O	ADP	O
the	O	DET	O
affected	O	VERB	B
patient	O	NOUN	B
.	O	PUNCT	O


Early	O	ADJ	B
onset	O	NOUN	I
of	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
in	O	ADP	O
a	O	DET	O
boy	O	NOUN	B
with	O	ADP	O
emerin	O	NOUN	B
gene	O	NOUN	I
deletion	O	NOUN	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	O
confirmed	O	VERB	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	I
dystrophy	I-Disease	NOUN	I
(	O	PUNCT	O
EDMD	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
reinforce	O	VERB	O
the	O	DET	O
necessity	O	NOUN	O
of	O	ADP	O
molecular	O	ADJ	B
genetic	O	ADJ	I
diagnosis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
membrane	O	NOUN	B
protein	O	NOUN	I
emerin	O	NOUN	B
in	O	ADP	O
younger	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
possible	O	ADJ	O
EDMD	B-Disease	NOUN	B
before	O	ADP	O
appearance	O	NOUN	B
of	O	ADP	O
the	O	DET	O
typical	O	ADJ	O
symptoms	O	NOUN	B
,	O	PUNCT	O
to	O	PART	O
avoid	O	VERB	O
sudden	B-Disease	ADJ	B
cardiac	I-Disease	ADJ	I
death	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
dark	O	ADV	B
-	O	PUNCT	O
adapted	O	VERB	B
electroretinogram	O	NOUN	B
(	O	PUNCT	O
ERG	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
Duchenne	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
Becker	I-Disease	PROPN	B
muscular	I-Disease	ADJ	I
dystrophy	I-Disease	NOUN	I
(	O	PUNCT	O
DMD	B-Disease	PROPN	B
/	O	PUNCT	O
BMD	B-Disease	PROPN	B
)	O	PUNCT	O
shows	O	VERB	O
a	O	DET	O
marked	O	ADJ	O
reduction	O	NOUN	B
in	O	ADP	O
b	O	X	B
-	O	PUNCT	O
wave	O	NOUN	B
amplitude	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
undertaken	O	VERB	O
a	O	DET	O
systematic	O	ADJ	B
evaluation	O	NOUN	I
of	O	ADP	O
DMD	B-Disease	PROPN	B
/	O	SYM	O
BMD	B-Disease	NOUN	B
patients	O	NOUN	B
through	O	ADP	O
clinical	O	ADJ	B
examination	O	NOUN	I
and	O	CCONJ	O
review	O	NOUN	B
of	O	ADP	O
the	O	DET	O
literature	O	NOUN	B
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
position	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
mutations	O	NOUN	B
noted	O	VERB	O
in	O	ADP	O
the	O	DET	O
mouse	O	NOUN	B
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
man	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
most	O	ADV	O
important	O	ADJ	O
determinant	O	NOUN	O
in	O	ADP	O
the	O	DET	O
ERG	O	NOUN	B
b	O	NOUN	O
-	O	PUNCT	O
wave	O	NOUN	B
phenotype	O	NOUN	B
is	O	AUX	O
the	O	DET	O
mutation	O	NOUN	B
position	O	NOUN	O
,	O	PUNCT	O
rather	O	ADV	O
than	O	ADP	O
muscle	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
severity	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
mutation	O	NOUN	B
causing	O	VERB	O
myotonic	B-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
(	O	PUNCT	O
DM	B-Disease	NOUN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
a	O	DET	O
CTG	O	NOUN	B
expansion	O	NOUN	B
in	O	ADP	O
the	O	DET	O
3	O	NUM	O
-	O	PUNCT	O
untranslated	O	ADJ	B
region	O	NOUN	I
(	O	PUNCT	O
3	O	NUM	O
-	O	PUNCT	O
UTR	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
DM	B-Disease	NOUN	B
protein	O	NOUN	I
kinase	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
DMPK	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
but	O	CCONJ	O
the	O	DET	O
mechanism	O	NOUN	B
(	O	PUNCT	O
s	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
pathogenesis	O	NOUN	B
remain	O	VERB	O
unknown	O	ADJ	O
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
to	O	PART	O
study	O	VERB	B
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
the	O	DET	O
DM	B-Disease	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
controlled	O	VERB	B
environment	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
established	O	VERB	O
a	O	DET	O
cell	O	NOUN	B
culture	O	NOUN	I
model	O	NOUN	I
system	O	NOUN	I
using	O	VERB	O
C2C12	O	NOUN	B
mouse	O	NOUN	B
myoblasts	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
DM	B-Disease	NOUN	B
mutation	O	NOUN	O
acts	O	VERB	O
in	O	ADP	O
cis	O	NOUN	O
to	O	PART	O
reduce	O	VERB	O
protein	O	NOUN	B
production	O	NOUN	I
(	O	PUNCT	O
consistent	O	ADJ	B
with	O	ADP	I
DMPK	B-Disease	NOUN	B
haploinsufficiency	I-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
trans	O	ADJ	O
as	O	ADP	O
a	O	DET	O
riboregulator	O	NOUN	B
to	O	PART	O
inhibit	O	VERB	B
myogenesis	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Coats	B-Disease	ADJ	B
disease	I-Disease	NOUN	I
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
abnormal	B-Disease	ADJ	B
retinal	I-Disease	ADJ	B
vascular	I-Disease	ADJ	O
development	I-Disease	NOUN	O
(	O	PUNCT	O
so	O	ADV	O
-	O	PUNCT	O
called	O	VERB	B
retinal	B-Disease	ADJ	B
telangiectasis	I-Disease	NOUN	O
)	O	PUNCT	O
which	O	DET	O
results	O	VERB	B
in	O	ADP	O
massive	O	ADJ	B
intraretinal	B-Disease	ADJ	B
and	I-Disease	CCONJ	O
subretinal	I-Disease	ADJ	B
lipid	I-Disease	NOUN	O
accumulation	I-Disease	NOUN	O
(	O	PUNCT	O
exudative	B-Disease	ADJ	B
retinal	I-Disease	ADJ	I
detachment	I-Disease	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
female	O	NOUN	B
with	O	ADP	O
a	O	DET	O
unilateral	O	ADJ	B
variant	O	NOUN	B
of	O	ADP	O
Coats	B-Disease	PROPN	B
disease	I-Disease	NOUN	I
gave	O	VERB	O
birth	O	NOUN	B
to	O	ADP	O
a	O	DET	O
son	O	NOUN	B
affected	O	VERB	B
by	O	ADP	O
Norrie	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
suggest	O	VERB	O
that	O	SCONJ	O
Coats	B-Disease	ADJ	B
telangiectasis	I-Disease	NOUN	B
is	O	AUX	O
secondary	O	ADJ	O
to	O	PART	O
somatic	O	ADJ	B
mutation	O	NOUN	O
in	O	ADP	O
the	O	DET	O
NDP	O	NOUN	B
gene	O	NOUN	I
which	O	DET	O
results	O	VERB	B
in	O	ADP	O
a	O	DET	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
norrin	I-Disease	NOUN	B
(	O	PUNCT	O
the	O	DET	O
protein	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
the	O	DET	O
NDP	O	NOUN	B
gene	O	NOUN	I
)	O	PUNCT	O
within	O	ADP	O
the	O	DET	O
developing	O	VERB	O
retina	O	NOUN	B
.	O	PUNCT	O


Li	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Fraumeni	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
dominant	I-Disease	ADJ	O
disorder	I-Disease	NOUN	O
that	O	PRON	O
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
various	O	ADJ	O
types	O	NOUN	O
of	O	ADP	O
cancer	B-Disease	NOUN	B
in	O	ADP	O
childhood	O	NOUN	B
and	O	CCONJ	O
adult	O	ADJ	B
cases	O	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
hereditary	O	ADJ	B
mutations	O	NOUN	I
of	O	ADP	O
TP57KIP2	O	NOUN	B
,	O	PUNCT	O
P15INK4B	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
P16INK4A	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
affect	O	VERB	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
similar	O	ADJ	O
to	O	PART	O
TP53	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
some	O	DET	O
types	O	NOUN	O
of	O	ADP	O
cancer	B-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
propositus	O	NOUN	B
had	O	AUX	O
a	O	DET	O
seminoma	B-Disease	NOUN	B
,	O	PUNCT	O
his	O	PRON	O
daughter	O	NOUN	B
a	O	DET	O
medulloblastoma	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
one	O	NUM	O
of	O	ADP	O
his	O	PRON	O
healthy	O	ADJ	B
cousins	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
TP53	O	NOUN	B
codon	O	NOUN	B
292	O	NUM	I
missense	O	NOUN	B
point	O	NOUN	I
mutation	O	NOUN	I
(	O	PUNCT	O
AAA	O	PROPN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
ATA	O	NOUN	B
;	O	PUNCT	O
Lys	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
Ile	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
peripheral	O	ADJ	B
blood	O	NOUN	I
cells	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
analyses	O	NOUN	B
of	O	ADP	O
tumor	B-Disease	NOUN	B
tissues	O	NOUN	I
from	O	ADP	O
the	O	DET	O
propositus	O	NOUN	B
and	O	CCONJ	O
his	O	PRON	O
daughter	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
P16INK4A	O	NOUN	B
codon	O	NOUN	O
94	O	NUM	O
missense	O	NOUN	B
point	O	NOUN	I
mutation	O	NOUN	I
(	O	PUNCT	O
GCG	O	NOUN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
GAG	O	NOUN	B
;	O	PUNCT	O
Ala	O	PROPN	B
-	O	PUNCT	O
-	O	PUNCT	O
>	O	X	O
Glu	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
the	O	DET	O
hereditary	O	ADJ	B
TP53	O	NOUN	B
mutation	O	NOUN	B
.	O	PUNCT	O


Existence	O	NOUN	B
of	O	ADP	O
the	O	DET	O
P16INK4A	O	NOUN	B
mutation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
hereditary	O	ADJ	B
TP53	O	NOUN	B
mutation	O	NOUN	B
with	O	ADP	O
or	O	CCONJ	O
without	O	ADP	O
loss	O	NOUN	B
of	O	ADP	O
heterozygosity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
TP53	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
seminoma	B-Disease	NOUN	B
/	O	SYM	O
medulloblastoma	B-Disease	NOUN	B
)	O	PUNCT	O
may	O	AUX	O
be	O	AUX	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
common	O	ADJ	O
mechanism	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
tumorogenesis	B-Disease	NOUN	B
.	O	PUNCT	O


A	O	DET	O
novel	O	ADJ	B
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
sodium	O	NOUN	B
/	O	PUNCT	O
iodide	O	NOUN	B
symporter	O	NOUN	I
gene	O	NOUN	I
in	O	ADP	O
the	O	DET	O
largest	O	ADJ	O
family	O	NOUN	B
with	O	ADP	O
iodide	B-Disease	NOUN	B
transport	I-Disease	NOUN	I
defect	I-Disease	NOUN	I
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
original	O	ADJ	B
report	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
diagnosed	O	VERB	B
congenital	B-Disease	ADJ	B
hypothyroidism	I-Disease	NOUN	I
by	O	ADP	O
newborn	O	ADJ	B
TSH	O	NOUN	B
screening	O	NOUN	B
in	O	ADP	O
9	O	NUM	O
additional	O	ADJ	O
children	O	NOUN	B
from	O	ADP	O
the	O	DET	O
family	O	NOUN	B
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
now	O	ADV	O
possible	O	ADJ	O
to	O	PART	O
use	O	VERB	O
gene	O	NOUN	B
diagnostics	O	NOUN	I
of	O	ADP	O
this	O	DET	O
unique	O	ADJ	O
NIS	O	NOUN	B
mutation	O	NOUN	B
to	O	PART	O
identify	O	VERB	O
patients	O	NOUN	B
with	O	ADP	O
congenital	B-Disease	ADJ	B
hypothyroidism	I-Disease	NOUN	I
due	O	ADJ	O
to	O	PART	O
an	O	DET	O
iodide	B-Disease	NOUN	B
transport	I-Disease	NOUN	I
defect	I-Disease	NOUN	I
in	O	ADP	O
this	O	DET	O
family	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
carrier	O	NOUN	B
state	O	NOUN	I
of	O	ADP	O
potential	O	ADJ	B
parents	O	NOUN	B
for	O	ADP	O
genetic	O	ADJ	B
counseling	O	NOUN	I
and	O	CCONJ	O
arranging	O	VERB	O
rapid	O	ADJ	B
and	O	CCONJ	O
early	O	ADJ	B
diagnosis	O	NOUN	I
of	O	ADP	O
their	O	PRON	O
infants	O	NOUN	B
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
neurohypophyseal	I-Disease	ADJ	B
diabetes	I-Disease	NOUN	I
insipidus	I-Disease	NOUN	I
(	O	PUNCT	O
FNDI	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
inherited	O	VERB	B
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
hormone	I-Disease	NOUN	B
arginine	I-Disease	NOUN	I
vasopressin	I-Disease	NOUN	I
(	O	PUNCT	I
AVP	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
transmitted	O	VERB	B
as	O	ADP	O
an	O	DET	O
autosomal	O	ADJ	B
dominant	O	ADJ	O
trait	O	NOUN	O
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
defect	O	NOUN	I
underlying	O	VERB	O
FNDI	B-Disease	NOUN	B
in	O	ADP	O
affected	O	VERB	B
families	O	NOUN	B
is	O	AUX	O
a	O	DET	O
powerful	O	ADJ	O
tool	O	NOUN	O
for	O	ADP	O
early	O	ADJ	B
asymptomatic	O	ADJ	B
diagnosis	O	NOUN	B
in	O	ADP	O
infants	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Friedreich	B-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
(	O	PUNCT	O
FRDA	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
of	O	ADP	O
the	O	DET	O
inherited	B-Disease	VERB	B
ataxias	I-Disease	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
degenerative	I-Disease	ADJ	B
disorder	I-Disease	NOUN	I
,	O	PUNCT	O
characterized	O	VERB	B
clinically	O	ADV	B
by	O	ADP	O
onset	O	NOUN	O
before	O	ADP	O
the	O	DET	O
age	O	NOUN	B
of	O	ADP	O
25	O	NUM	O
of	O	ADP	O
progressive	B-Disease	ADJ	B
gait	I-Disease	NOUN	I
and	I-Disease	CCONJ	O
limb	I-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
,	O	PUNCT	O
absence	B-Disease	NOUN	B
of	I-Disease	ADP	O
deep	I-Disease	ADJ	B
tendon	I-Disease	NOUN	I
reflexes	I-Disease	NOUN	I
,	O	PUNCT	O
extensor	B-Disease	ADJ	B
plantar	I-Disease	NOUN	I
responses	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
loss	B-Disease	NOUN	B
of	I-Disease	ADP	I
position	I-Disease	NOUN	I
and	I-Disease	CCONJ	O
vibration	I-Disease	NOUN	B
sense	I-Disease	NOUN	O
in	O	ADP	O
the	O	DET	O
lower	O	ADJ	B
limbs	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
FRDA	B-Disease	NOUN	B
gene	O	NOUN	O
encodes	O	VERB	B
a	O	DET	O
widely	O	ADV	O
expressed	O	VERB	B
210	O	NUM	O
-	O	PUNCT	O
aa	O	NOUN	B
protein	O	NOUN	I
,	O	PUNCT	O
frataxin	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
located	O	ADJ	O
in	O	ADP	O
mitochondria	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
severely	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
FRDA	B-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
phosphorus	O	NOUN	B
magnetic	O	ADJ	I
resonance	O	NOUN	I
spectroscopy	O	NOUN	I
we	O	PRON	O
demonstrated	O	VERB	O
a	O	DET	O
maximum	O	ADJ	O
rate	O	NOUN	B
of	O	ADP	O
muscle	O	NOUN	B
mitochondrial	O	ADJ	B
ATP	O	NOUN	O
production	O	NOUN	B
(	O	PUNCT	O
V	O	NOUN	O
(	O	PUNCT	O
max	O	NOUN	B
)	O	PUNCT	O
)	O	PUNCT	O
below	O	ADP	O
the	O	DET	O
normal	O	ADJ	O
range	O	NOUN	O
in	O	ADP	O
all	O	DET	O
12	O	NUM	O
FRDA	B-Disease	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
strong	O	ADJ	O
negative	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
mitochondrial	O	ADJ	B
V	O	NOUN	I
(	O	PUNCT	O
max	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
GAA	O	NOUN	B
repeats	O	NOUN	O
in	O	ADP	O
the	O	DET	O
smaller	O	ADJ	O
allele	O	NOUN	B
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
novel	O	ADJ	B
R21X	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
-	O	PUNCT	O
type	O	NOUN	B
arginase	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
ARG1	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
four	O	NUM	O
Portuguese	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
argininemia	B-Disease	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
investigate	O	VERB	B
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
for	O	ADP	O
argininemia	B-Disease	NOUN	B
in	O	ADP	O
four	O	NUM	O
unrelated	O	ADJ	O
Portuguese	O	ADJ	B
patients	O	NOUN	B
(	O	PUNCT	O
two	O	NUM	O
from	O	ADP	O
northern	O	ADJ	B
Portugal	O	PROPN	I
and	O	CCONJ	O
two	O	NUM	O
from	O	ADP	O
Madeira	O	PROPN	B
Island	O	PROPN	I
)	O	PUNCT	O
we	O	PRON	O
performed	O	VERB	O
a	O	DET	O
DNA	O	NOUN	B
sequence	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
all	O	DET	O
the	O	DET	O
exons	O	NOUN	B
and	O	CCONJ	O
exon	O	NOUN	B
/	O	SYM	O
intron	O	NOUN	B
boundaries	O	NOUN	B
of	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
-	O	PUNCT	O
type	O	NOUN	B
arginase	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
ARG1	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


OBJECTIVES	O	VERB	O
A	O	DET	O
Japanese	O	ADJ	B
family	O	NOUN	B
with	O	ADP	O
cerebrotendinous	B-Disease	ADJ	B
xanthomatosis	I-Disease	NOUN	I
(	O	PUNCT	O
CTX	B-Disease	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
investigated	O	VERB	B
for	O	ADP	O
a	O	DET	O
sequence	O	NOUN	B
alteration	O	NOUN	B
in	O	ADP	O
the	O	DET	O
sterol	O	NOUN	B
27	O	NUM	I
-	O	PUNCT	O
hydroxylase	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
CYP27	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Clinical	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
genetic	O	ADJ	I
analysis	O	NOUN	I
of	O	ADP	O
19	O	NUM	O
Wolfram	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
kindreds	O	NOUN	B
demonstrating	O	VERB	O
a	O	DET	O
wide	O	ADJ	O
spectrum	O	NOUN	O
of	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
WFS1	O	NOUN	B
.	O	PUNCT	O


Direct	O	ADJ	B
DNA	O	NOUN	I
sequencing	O	NOUN	I
was	O	AUX	O
done	O	VERB	O
to	O	PART	O
screen	O	VERB	B
the	O	DET	O
entire	O	ADJ	O
coding	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
WFS1	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
30	O	NUM	O
patients	O	NOUN	B
from	O	ADP	O
19	O	NUM	O
British	O	ADJ	B
kindreds	O	NOUN	B
with	O	ADP	O
Wolfram	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


Late	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	O
fever	I-Disease	NOUN	O
(	O	PUNCT	O
FMF	B-Disease	NOUN	B
)	O	PUNCT	O
:	O	PUNCT	O
a	O	DET	O
subset	O	NOUN	O
with	O	ADP	O
distinct	O	ADJ	O
clinical	O	ADJ	B
,	O	PUNCT	O
demographic	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
molecular	O	ADJ	B
genetic	O	ADJ	I
characteristics	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
control	O	ADJ	B
group	O	NOUN	I
consisted	O	VERB	O
of	O	ADP	O
40	O	NUM	O
consecutive	O	ADJ	B
FMF	B-Disease	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
who	O	PRON	O
arrived	O	VERB	O
at	O	ADP	O
the	O	DET	O
FMF	B-Disease	NOUN	B
clinic	O	NOUN	B
for	O	ADP	O
their	O	PRON	O
regular	O	ADJ	O
follow	O	NOUN	B
-	O	PUNCT	O
up	O	ADP	B
visit	O	NOUN	I
and	O	CCONJ	O
were	O	AUX	O
40	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
age	O	NOUN	B
or	O	CCONJ	O
older	O	ADJ	B
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
the	O	DET	O
examination	O	NOUN	B
.	O	PUNCT	O


Only	O	ADV	O
20	O	NUM	O
of	O	ADP	O
4000	O	NUM	O
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
patients	O	NOUN	B
had	O	AUX	O
late	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
FMF	B-Disease	NOUN	B
.	O	PUNCT	O


01	O	NUM	O
,	O	PUNCT	O
compared	O	VERB	O
to	O	PART	O
our	O	PRON	O
regular	O	ADJ	O
FMF	B-Disease	NOUN	B
population	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
hereditary	B-Disease	ADJ	B
breast	I-Disease	NOUN	I
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
high	O	ADJ	O
frequency	O	NOUN	B
of	O	ADP	O
BRCA1	O	NOUN	B
mutations	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
on	O	ADP	O
a	O	DET	O
boy	O	NOUN	B
with	O	ADP	O
a	O	DET	O
maternal	B-Disease	ADJ	B
uniparental	I-Disease	ADJ	B
disomy	I-Disease	NOUN	I
for	I-Disease	ADP	O
chromosome	I-Disease	NOUN	O
14	I-Disease	NUM	O
(	O	PUNCT	O
UPD	B-Disease	NOUN	B
(	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
)	O	PUNCT	O
.	O	PUNCT	O


He	O	PRON	O
showed	O	VERB	O
short	B-Disease	ADJ	B
stature	I-Disease	NOUN	I
,	O	PUNCT	O
obesity	B-Disease	NOUN	B
,	O	PUNCT	O
mild	O	ADJ	B
developmental	B-Disease	ADJ	I
delay	I-Disease	NOUN	I
,	O	PUNCT	O
cryptorchidism	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
some	O	DET	O
mild	O	ADJ	B
dysmorphic	B-Disease	ADJ	B
features	I-Disease	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
birth	O	NOUN	B
he	O	PRON	O
showed	O	VERB	O
hypotonia	B-Disease	NOUN	B
with	O	ADP	O
poor	O	ADJ	B
sucking	O	NOUN	I
,	O	PUNCT	O
for	O	ADP	O
which	O	DET	O
gavage	O	NOUN	B
feeding	O	NOUN	B
was	O	AUX	O
needed	O	VERB	O
.	O	PUNCT	O


Recurrent	O	ADJ	B
middle	B-Disease	ADJ	B
ear	I-Disease	NOUN	I
infections	I-Disease	NOUN	I
,	O	PUNCT	O
a	O	DET	O
high	O	ADJ	B
pain	O	NOUN	I
threshold	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
great	O	ADJ	O
skill	O	NOUN	B
with	O	ADP	O
jigsaw	O	NOUN	O
puzzles	O	NOUN	B
were	O	AUX	O
reported	O	VERB	O
.	O	PUNCT	O


Two	O	NUM	O
years	O	NOUN	B
later	O	ADV	O
he	O	PRON	O
was	O	AUX	O
re	O	ADP	B
-	O	PUNCT	O
examined	O	VERB	B
because	O	SCONJ	O
we	O	PRON	O
thought	O	VERB	O
his	O	PRON	O
features	O	NOUN	B
fitted	O	VERB	O
the	O	DET	O
PWS	B-Disease	PROPN	B
-	O	PUNCT	O
like	O	ADJ	B
phenotype	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
maternal	O	ADJ	B
UPD	B-Disease	NOUN	B
(	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
all	O	DET	O
the	O	DET	O
previously	O	ADV	O
described	O	VERB	O
11	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
maternal	O	ADJ	B
UPD	B-Disease	NOUN	B
(	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
Robertsonian	O	ADJ	B
translocation	O	NOUN	B
involving	O	VERB	O
chromosome	O	NOUN	B
14	O	NUM	I
was	O	AUX	O
detected	O	VERB	B
cytogenetically	O	ADV	B
before	O	ADP	O
DNA	O	NOUN	B
analysis	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
finding	O	NOUN	B
underlines	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
DNA	O	NOUN	B
analysis	O	NOUN	I
for	O	ADP	O
maternal	O	ADJ	B
UPD	O	NOUN	B
(	O	PUNCT	O
14	O	NUM	O
)	O	PUNCT	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
similar	O	ADJ	O
PWS	B-Disease	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
phenotype	O	NOUN	B
even	O	ADV	O
without	O	ADP	O
previous	O	ADJ	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
Robertsonian	O	ADJ	B
translocation	O	NOUN	B
involving	O	VERB	O
chromosome	O	NOUN	B
14	O	NUM	I
.	O	PUNCT	O
.	O	PUNCT	O


Friedreich	B-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
disorder	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
FRDA	B-Disease	NOUN	B
gene	O	NOUN	I
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
210	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
acid	O	NOUN	I
protein	O	NOUN	I
called	O	VERB	O
frataxin	O	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
no	O	DET	O
significant	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
the	O	DET	O
size	O	NOUN	B
of	O	ADP	O
the	O	DET	O
smaller	O	ADJ	O
allele	O	NOUN	B
and	O	CCONJ	O
cardiomyopathy	B-Disease	NOUN	B
,	O	PUNCT	O
diabetes	B-Disease	NOUN	B
mellitus	I-Disease	NOUN	I
,	O	PUNCT	O
loss	B-Disease	NOUN	B
of	I-Disease	ADP	I
proprioception	I-Disease	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
bladder	B-Disease	NOUN	B
symptoms	I-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
duration	O	NOUN	B
of	O	ADP	I
disease	O	NOUN	O
is	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
wheelchair	O	NOUN	B
use	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
diabetes	B-Disease	NOUN	B
,	O	PUNCT	O
scoliosis	B-Disease	NOUN	B
,	O	PUNCT	O
bladder	B-Disease	NOUN	B
symptoms	I-Disease	NOUN	B
and	O	CCONJ	O
impaired	B-Disease	ADJ	B
proprioception	I-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
vibration	O	NOUN	B
sense	O	NOUN	O
but	O	CCONJ	O
no	O	DET	O
other	O	ADJ	O
complications	O	NOUN	B
studied	O	VERB	O
.	O	PUNCT	O
.	O	PUNCT	O


Juvenile	B-Disease	ADJ	B
retinoschisis	I-Disease	NOUN	I
is	O	AUX	O
an	O	DET	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
recessive	I-Disease	ADJ	B
disease	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
XLRS1	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Growth	O	NOUN	B
hormone	O	NOUN	I
treatment	O	NOUN	B
increases	O	VERB	B
CO	O	NOUN	B
(	O	PUNCT	O
2	O	NUM	O
)	O	PUNCT	O
response	O	NOUN	B
,	O	PUNCT	O
ventilation	O	NOUN	B
and	O	CCONJ	O
central	O	ADJ	B
inspiratory	O	ADJ	I
drive	O	NOUN	O
in	O	ADP	O
children	O	NOUN	B
with	O	ADP	O
Prader	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


CONCLUSION	O	NOUN	O
Treatment	O	NOUN	B
of	O	ADP	O
children	O	NOUN	B
with	O	ADP	O
Prader	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
PWS	B-Disease	NOUN	B
)	O	PUNCT	O
seems	O	VERB	O
to	O	PART	O
have	O	AUX	O
a	O	DET	O
stimulatory	O	ADJ	B
effect	O	NOUN	I
on	O	ADP	O
central	O	ADJ	B
respiratory	O	ADJ	I
structures	O	NOUN	I
.	O	PUNCT	O


G130V	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
common	O	ADJ	O
FRDA	B-Disease	NOUN	B
point	O	NOUN	B
mutation	O	NOUN	I
,	O	PUNCT	O
appears	O	VERB	O
to	O	PART	O
have	O	AUX	O
arisen	O	VERB	O
from	O	ADP	O
a	O	DET	O
common	O	ADJ	O
founder	O	NOUN	B
.	O	PUNCT	O


G130V	O	NOUN	B
,	O	PUNCT	O
when	O	SCONJ	O
present	O	ADJ	O
with	O	ADP	O
an	O	DET	O
expanded	O	VERB	O
GAA	O	NOUN	B
repeat	O	NOUN	O
on	O	ADP	O
the	O	DET	O
other	O	ADJ	O
allele	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
an	O	DET	O
atypical	O	ADJ	B
FRDA	B-Disease	NOUN	B
phenotype	O	NOUN	B
.	O	PUNCT	O


Constitutional	O	ADJ	B
von	B-Disease	NOUN	I
Hippel	I-Disease	PROPN	I
-	I-Disease	PUNCT	O
Lindau	I-Disease	PROPN	B
(	O	PUNCT	O
VHL	B-Disease	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	B
deletions	O	NOUN	I
detected	O	VERB	B
in	O	ADP	O
VHL	B-Disease	NOUN	B
families	O	NOUN	B
by	O	ADP	O
fluorescence	O	NOUN	B
in	O	X	I
situ	O	X	I
hybridization	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
VHL	B-Disease	NOUN	B
gene	O	NOUN	I
was	O	AUX	O
localized	O	ADJ	B
to	O	PART	O
chromosome	O	NOUN	B
3p25	O	NOUN	I
-	O	PUNCT	O
26	O	NUM	O
and	O	CCONJ	O
cloned	O	VERB	B
[	O	PUNCT	O
F	O	PROPN	B
.	O	PUNCT	O
Latif	O	NOUN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
Science	O	PROPN	B
(	O	PUNCT	O
Washington	O	PROPN	O
DC	O	PROPN	O
)	O	PUNCT	O
,	O	PUNCT	O
260	O	NUM	O
1317	O	NUM	O
-	O	SYM	O
1320	O	NUM	O
,	O	PUNCT	O
1993	O	NUM	O
]	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
reported	O	ADJ	O
frequency	O	NOUN	B
of	O	ADP	O
detection	O	NOUN	B
of	O	ADP	O
VHL	B-Disease	NOUN	B
germline	O	NOUN	B
mutations	O	NOUN	I
has	O	AUX	O
varied	O	VERB	O
from	O	ADP	O
39	O	NUM	O
to	O	PART	O
80	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
J	O	NOUN	O
.	O	PUNCT	O
M	O	NOUN	B
.	O	PUNCT	O
Whaley	O	NOUN	O
et	O	X	O
al	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
Am	O	NOUN	O
.	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
Hum	O	NOUN	O
.	O	PUNCT	O
Genet	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
55	O	NUM	O
1092	O	NUM	O
-	O	SYM	O
1102	O	NUM	O
,	O	PUNCT	O
1994	O	NUM	O
;	O	PUNCT	O
Clinical	O	PROPN	B
Research	O	PROPN	I
Group	O	PROPN	I
for	O	ADP	O
Japan	O	PROPN	B
,	O	PUNCT	O
Hum	O	PROPN	B
.	O	PUNCT	O
Mol	O	PROPN	O
.	O	PUNCT	O
Genet	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
4	O	NUM	O
2233	O	NUM	O
-	O	SYM	O
2237	O	NUM	O
,	O	PUNCT	O
1995	O	NUM	O
;	O	PUNCT	O
F	O	PROPN	B
.	O	PUNCT	O
Chen	O	PROPN	O
et	O	X	O
al	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
Hum	O	PROPN	O
.	O	PUNCT	O
Mutat	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
5	O	NUM	O
66	O	NUM	O
-	O	SYM	O
75	O	NUM	O
,	O	PUNCT	O
1995	O	NUM	O
;	O	PUNCT	O
E	O	NOUN	B
.	O	PUNCT	O
R	O	NOUN	B
.	O	PUNCT	O
Maher	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
J	O	PROPN	O
.	O	PUNCT	O
Med	O	PROPN	O
.	O	PUNCT	O
Genet	O	NOUN	B
.	O	PUNCT	O
,	O	PUNCT	O
33	O	NUM	O
328	O	NUM	O
-	O	SYM	O
332	O	NUM	O
,	O	PUNCT	O
1996	O	NUM	O
;	O	PUNCT	O
B	O	NOUN	B
.	O	PUNCT	O
Zbar	O	PROPN	B
,	O	PUNCT	O
Cancer	O	PROPN	O
Surv	O	PROPN	O
.	O	PUNCT	O
,	O	PUNCT	O
25	O	NUM	O
219	O	NUM	O
-	O	SYM	O
232	O	NUM	O
,	O	PUNCT	O
1995	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
reexamined	O	VERB	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
VHL	B-Disease	NOUN	B
patients	O	NOUN	B
shown	O	VERB	O
previously	O	ADV	O
by	O	ADP	O
single	O	ADJ	B
-	O	PUNCT	O
strand	O	NOUN	B
conformation	O	NOUN	B
and	O	CCONJ	O
sequencing	O	NOUN	B
analysis	O	NOUN	I
not	O	PART	O
to	O	PART	O
harbor	O	VERB	O
point	O	NOUN	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
VHL	B-Disease	NOUN	B
locus	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
then	O	ADV	O
tested	O	VERB	B
six	O	NUM	O
phenotypically	O	ADV	B
normal	O	ADJ	O
offspring	O	NOUN	B
from	O	ADP	O
four	O	NUM	O
of	O	ADP	O
these	O	DET	O
VHL	B-Disease	NOUN	B
families	O	NOUN	B
two	O	NUM	O
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
carry	O	VERB	O
the	O	DET	O
deletion	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
other	O	ADJ	O
four	O	NUM	O
were	O	AUX	O
deletion	O	NOUN	B
-	O	PUNCT	O
free	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
sum	O	NOUN	O
,	O	PUNCT	O
FISH	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
simple	O	ADJ	O
and	O	CCONJ	O
reliable	O	ADJ	O
method	O	NOUN	B
to	O	PART	O
detect	O	VERB	B
VHL	B-Disease	NOUN	B
germline	O	NOUN	B
deletions	O	NOUN	I
and	O	CCONJ	O
practically	O	ADV	O
useful	O	ADJ	O
in	O	ADP	O
cases	O	NOUN	B
where	O	SCONJ	O
other	O	ADJ	O
methods	O	NOUN	B
of	O	ADP	O
screening	O	NOUN	B
have	O	AUX	O
failed	O	VERB	B
to	O	PART	O
detect	O	VERB	B
a	O	DET	O
VHL	B-Disease	NOUN	B
gene	I-Disease	NOUN	I
abnormality	I-Disease	NOUN	O


The	O	DET	O
hSNF5	O	NOUN	B
/	O	SYM	O
INI1	O	NOUN	B
gene	O	NOUN	I
which	O	DET	O
encodes	O	VERB	B
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SWI	O	PROPN	B
/	O	SYM	O
SNF	O	NOUN	B
chromatin	O	NOUN	B
ATP	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
remodeling	O	NOUN	B
complex	O	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
new	O	ADJ	O
tumor	B-Disease	NOUN	B
suppressor	O	NOUN	I
gene	O	NOUN	I
localized	O	VERB	B
on	O	ADP	O
chromosome	O	NOUN	B
22q11	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
searched	O	VERB	O
for	O	ADP	O
hSNF5	O	NOUN	B
/	O	PUNCT	O
INI1	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
229	O	NUM	O
tumors	B-Disease	NOUN	B
of	O	ADP	O
various	O	ADJ	O
origins	O	NOUN	B
using	O	VERB	O
a	O	DET	O
screening	O	NOUN	B
method	O	NOUN	I
based	O	VERB	O
on	O	ADP	O
denaturing	O	VERB	B
high	O	ADJ	B
-	O	PUNCT	O
performance	O	NOUN	B
liquid	O	ADJ	B
chromatography	O	NOUN	I
.	O	PUNCT	O


Recurrent	O	ADJ	B
hSNF5	O	NOUN	B
/	O	SYM	O
INI1	O	NOUN	B
alterations	O	NOUN	B
were	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
choroid	B-Disease	ADJ	B
plexus	I-Disease	NOUN	I
carcinomas	I-Disease	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
central	O	ADJ	B
primitive	O	ADJ	I
neuroectodermal	B-Disease	ADJ	I
tumors	I-Disease	NOUN	I
(	O	PUNCT	O
cPNETs	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
medulloblastomas	B-Disease	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
rhabdoid	B-Disease	ADJ	B
tumors	I-Disease	NOUN	I
,	O	PUNCT	O
choroid	B-Disease	ADJ	B
plexus	I-Disease	NOUN	I
carcinomas	I-Disease	NOUN	I
and	O	CCONJ	O
a	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
medulloblastomas	B-Disease	NOUN	B
and	O	CCONJ	O
cPNETs	O	NOUN	B
share	O	VERB	O
common	O	ADJ	O
pathways	O	NOUN	B
of	O	ADP	O
oncogenesis	O	NOUN	B
related	O	ADJ	O
to	O	PART	O
hSNF5	O	NOUN	B
/	O	SYM	O
INI1	O	NOUN	B
alteration	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
hSNF5	O	NOUN	B
/	O	PUNCT	O
INI1	O	NOUN	B
mutations	O	NOUN	B
define	O	VERB	O
a	O	DET	O
genetically	O	ADV	B
homogeneous	O	ADJ	O
family	O	NOUN	O
of	O	ADP	O
highly	O	ADV	O
aggressive	O	ADJ	B
cancers	B-Disease	NOUN	I
mainly	O	ADV	O
occurring	O	VERB	O
in	O	ADP	O
young	O	ADJ	B
children	O	NOUN	B
and	O	CCONJ	O
frequently	O	ADV	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
always	O	ADV	O
,	O	PUNCT	O
exhibiting	O	VERB	O
a	O	DET	O
rhabdoid	B-Disease	ADJ	B
phenotype	O	NOUN	B


Experimental	O	ADJ	B
models	O	NOUN	I
of	O	ADP	O
polyglutamine	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
implicate	O	VERB	O
the	O	DET	O
nucleus	O	NOUN	B
in	O	ADP	O
pathogenesis	O	NOUN	B
;	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
link	O	NOUN	O
between	O	ADP	O
intranuclear	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
expanded	O	VERB	O
polyglutamine	O	NOUN	B
and	O	CCONJ	O
neuronal	B-Disease	ADJ	B
dysfunction	I-Disease	NOUN	I
remains	O	VERB	O
unclear	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
early	O	ADJ	B
event	O	NOUN	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
SCA3	B-Disease	NOUN	B
/	O	SYM	O
MJD	B-Disease	NOUN	B
may	O	AUX	O
be	O	AUX	O
an	O	DET	O
altered	O	ADJ	O
conformation	O	NOUN	B
of	O	ADP	O
ataxin	O	NOUN	B
-	O	PUNCT	O
3	O	NUM	O
within	O	ADP	O
the	O	DET	O
nucleus	O	NOUN	B
that	O	PRON	O
exposes	O	VERB	O
the	O	DET	O
polyglutamine	O	NOUN	B
domain	O	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Prader	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
PWS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
complex	O	ADJ	O
neurogenetic	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
.	O	PUNCT	O


Four	O	NUM	O
mouse	O	NOUN	B
models	O	NOUN	I
of	O	ADP	O
PWS	B-Disease	NOUN	B
have	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
but	O	CCONJ	O
these	O	DET	O
do	O	AUX	O
not	O	PART	O
definitively	O	ADV	O
allow	O	VERB	O
the	O	DET	O
delineation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
critical	O	ADJ	B
region	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
associated	O	VERB	B
genes	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
aetiology	O	NOUN	B
of	O	ADP	O
PWS	B-Disease	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
isolation	O	NOUN	B
of	O	ADP	O
new	O	ADJ	O
genes	O	NOUN	B
in	O	ADP	O
this	O	DET	O
region	O	NOUN	B
remains	O	VERB	O
crucial	O	ADJ	O
for	O	ADP	O
a	O	DET	O
better	O	ADJ	O
understanding	O	NOUN	O
of	O	ADP	O
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
of	O	ADP	O
PWS	B-Disease	NOUN	B
.	O	PUNCT	O


Alveolar	B-Disease	ADJ	B
rhabdomyosarcoma	I-Disease	NOUN	I
is	O	AUX	O
an	O	DET	O
aggressive	O	ADJ	B
pediatric	B-Disease	ADJ	O
cancer	I-Disease	NOUN	O
of	I-Disease	ADP	O
striated	I-Disease	ADJ	B
muscle	I-Disease	NOUN	I
characterized	O	VERB	B
in	O	ADP	O
60	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
cases	O	NOUN	B
by	O	ADP	O
a	O	DET	O
t	O	NOUN	O
(	O	PUNCT	O
2	O	NUM	O
;	O	PUNCT	O
13	O	NUM	O
)	O	PUNCT	O
(	O	PUNCT	O
q35	O	NOUN	B
;	O	PUNCT	O
q14	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Experimental	O	ADJ	B
hemochromatosis	B-Disease	NOUN	B
due	O	ADP	O
to	O	PART	O
MHC	O	NOUN	B
class	O	NOUN	B
I	O	NUM	I
HFE	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	B
:	O	PUNCT	O
immune	O	ADJ	B
status	O	NOUN	I
and	O	CCONJ	O
iron	O	NOUN	B
metabolism	O	NOUN	I
.	O	PUNCT	O


HFE	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
deficient	I-Disease	ADJ	B
animals	O	NOUN	B
were	O	AUX	O
analyzed	O	VERB	B
for	O	ADP	O
a	O	DET	O
comprehensive	O	ADJ	B
set	O	NOUN	O
of	O	ADP	O
metabolic	O	ADJ	B
and	O	CCONJ	O
immune	O	ADJ	B
parameters	O	NOUN	I
.	O	PUNCT	O


Ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
is	O	AUX	O
a	O	DET	O
rare	O	ADJ	O
genetic	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
associated	O	VERB	B
with	O	ADP	I
immune	B-Disease	ADJ	B
deficiency	I-Disease	NOUN	I
,	O	PUNCT	O
chromosome	B-Disease	NOUN	B
instability	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
predisposition	O	NOUN	B
to	O	PART	O
lymphoid	B-Disease	ADJ	B
malignancy	I-Disease	NOUN	I
.	O	PUNCT	O


Chromosomes	O	NOUN	B
of	O	ADP	O
lymphocytes	O	NOUN	B
from	O	ADP	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
were	O	AUX	O
studied	O	VERB	O
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
the	O	DET	O
onset	O	NOUN	O
of	O	ADP	O
chronic	B-Disease	ADJ	B
lymphocytic	I-Disease	ADJ	I
leukemia	I-Disease	NOUN	I
.	O	PUNCT	O


This	O	DET	O
clone	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
have	O	AUX	O
given	O	VERB	O
rise	O	NOUN	O
to	O	PART	O
the	O	DET	O
leukemic	B-Disease	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


Increasing	O	VERB	B
evidence	O	NOUN	B
,	O	PUNCT	O
provided	O	VERB	O
by	O	ADP	O
others	O	NOUN	O
,	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
nonrandom	O	ADJ	B
involvement	O	NOUN	B
of	O	ADP	O
14q	O	NOUN	B
in	O	ADP	O
African	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
Burkitts	B-Disease	PROPN	B
lymphoma	I-Disease	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
lymphoid	B-Disease	ADJ	B
neoplasms	I-Disease	NOUN	B
further	O	ADV	O
strengthens	O	VERB	O
this	O	DET	O
hypothesis	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
new	O	ADJ	O
mutations	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
9	O	NUM	I
of	O	ADP	O
the	O	DET	O
WT1	O	NOUN	B
gene	O	NOUN	I
that	O	PRON	O
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
ratio	O	NOUN	B
of	O	ADP	O
+	O	CCONJ	O
/	O	SYM	B
-	O	PUNCT	O
KTS	O	NOUN	B
splice	O	NOUN	B
isoforms	O	NOUN	I
in	O	ADP	O
two	O	NUM	O
unrelated	O	ADJ	O
patients	O	NOUN	B
with	O	ADP	O
Frasier	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
FS	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
syndromes	O	NOUN	B
originate	O	VERB	O
from	O	ADP	O
the	O	DET	O
same	O	ADJ	O
WT1	B-Disease	NOUN	B
gene	I-Disease	NOUN	B
abnormality	I-Disease	NOUN	I
.	O	PUNCT	O


Splice	O	NOUN	B
-	O	PUNCT	O
site	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
PDS	B-Disease	NOUN	B
gene	O	NOUN	I
may	O	AUX	O
result	O	VERB	O
in	O	ADP	O
intrafamilial	O	ADJ	B
variability	O	NOUN	B
for	O	ADP	O
deafness	B-Disease	NOUN	B
in	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


This	O	DET	O
disorder	O	NOUN	B
may	O	AUX	O
account	O	VERB	O
for	O	ADP	O
up	O	ADV	O
to	O	PART	O
10	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
cases	O	NOUN	B
of	O	ADP	O
hereditary	B-Disease	ADJ	B
deafness	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
performed	O	VERB	O
mutation	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
individual	O	ADJ	B
exons	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PDS	B-Disease	PROPN	B
gene	O	NOUN	I
in	O	ADP	O
one	O	NUM	O
Spanish	O	ADJ	B
family	O	NOUN	B
that	O	PRON	O
shows	O	VERB	O
intrafamilial	O	ADJ	B
variability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
deafness	B-Disease	NOUN	B
phenotype	O	NOUN	B
(	O	PUNCT	O
two	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
profound	O	ADJ	O
and	O	CCONJ	O
one	O	NUM	O
with	O	ADP	O
moderate	O	ADJ	B
-	O	PUNCT	O
severe	O	ADJ	B
deafness	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Since	O	SCONJ	O
the	O	DET	O
newly	O	ADV	O
created	O	VERB	O
donor	O	NOUN	B
splice	O	NOUN	I
site	O	NOUN	I
is	O	AUX	O
likely	O	ADJ	O
to	O	PART	O
compete	O	VERB	B
with	O	ADP	O
the	O	DET	O
normal	O	ADJ	B
one	O	NOUN	O
,	O	PUNCT	O
variations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	B
and	O	CCONJ	O
aberrant	O	ADJ	B
transcripts	O	NOUN	B
of	O	ADP	O
the	O	DET	O
PDS	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
the	O	DET	O
cochlea	O	NOUN	B
may	O	AUX	O
explain	O	VERB	O
the	O	DET	O
variability	O	NOUN	B
in	O	ADP	O
the	O	DET	O
deafness	B-Disease	NOUN	B
presentation	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Sjogren	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Larsson	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
SLS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
disorder	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
ichthyosis	B-Disease	NOUN	B
,	O	PUNCT	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
,	O	PUNCT	O
spasticity	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
deficient	B-Disease	ADJ	B
activity	I-Disease	NOUN	B
of	I-Disease	ADP	O
fatty	I-Disease	ADJ	B
aldehyde	I-Disease	NOUN	I
dehydrogenase	I-Disease	NOUN	I
(	O	PUNCT	O
FALDH	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


All	O	DET	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
SLS	B-Disease	PROPN	B
were	O	AUX	O
found	O	VERB	O
to	O	PART	O
carry	O	VERB	O
mutations	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
SLS	B-Disease	PROPN	B
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
a	O	DET	O
strikingly	O	ADV	O
heterogeneous	O	ADJ	B
group	O	NOUN	B
of	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
FALDH	O	NOUN	B
gene	O	NOUN	O
and	O	CCONJ	O
provide	O	VERB	O
a	O	DET	O
framework	O	NOUN	B
for	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
genetic	O	ADJ	B
basis	O	NOUN	O
of	O	ADP	O
SLS	B-Disease	PROPN	B
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
diagnostic	O	ADJ	B
tests	O	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Papillon	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Lefevre	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
or	O	CCONJ	O
keratosis	B-Disease	NOUN	B
palmoplantaris	I-Disease	NOUN	I
with	O	ADP	I
periodontopathia	B-Disease	NOUN	B
(	O	PUNCT	O
PLS	B-Disease	PROPN	B
,	O	PUNCT	O
MIM	O	NOUN	B
245000	O	NUM	I
)	O	PUNCT	O
,	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	B
disorder	I-Disease	NOUN	I
that	O	PRON	O
is	O	AUX	O
mainly	O	ADV	O
ascertained	O	VERB	O
by	O	ADP	O
dentists	O	NOUN	B
because	O	SCONJ	O
of	O	ADP	O
the	O	DET	O
severe	O	ADJ	B
periodontitis	B-Disease	NOUN	I
that	O	PRON	O
afflicts	O	VERB	O
patients	O	NOUN	B
.	O	PUNCT	O


Palmoplantar	B-Disease	NOUN	B
keratosis	I-Disease	NOUN	I
,	O	PUNCT	O
varying	O	VERB	O
from	O	ADP	O
mild	O	ADJ	B
psoriasiform	O	NOUN	B
scaly	O	NOUN	I
skin	O	NOUN	I
to	O	ADP	O
overt	O	ADJ	B
hyperkeratosis	B-Disease	NOUN	B
,	O	PUNCT	O
typically	O	ADV	O
develops	O	VERB	O
within	O	ADP	O
the	O	DET	O
first	O	ADJ	O
three	O	NUM	O
years	O	NOUN	B
of	O	ADP	O
life	O	NOUN	O
.	O	PUNCT	O


Most	O	ADJ	O
PLS	B-Disease	NOUN	B
patients	O	NOUN	B
display	O	VERB	B
both	O	CCONJ	O
periodontitis	B-Disease	NOUN	B
and	O	CCONJ	O
hyperkeratosis	B-Disease	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
two	O	NUM	O
of	O	ADP	O
these	O	DET	O
families	O	NOUN	B
we	O	PRON	O
used	O	VERB	O
a	O	DET	O
functional	O	ADJ	B
assay	O	NOUN	I
to	O	PART	O
demonstrate	O	VERB	O
an	O	DET	O
almost	O	ADV	O
total	O	ADJ	O
loss	O	NOUN	B
of	O	ADP	O
cathepsin	O	NOUN	B
C	O	NOUN	I
activity	O	NOUN	B
in	O	ADP	O
PLS	B-Disease	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
reduced	O	VERB	B
activity	O	NOUN	B
in	O	ADP	O
obligate	O	ADJ	B
carriers	O	NOUN	B
.	O	PUNCT	O


Van	B-Disease	NOUN	O
der	I-Disease	NOUN	O
Woude	I-Disease	NOUN	O
syndrome	I-Disease	NOUN	O
(	O	PUNCT	O
VWS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
dominant	I-Disease	ADJ	B
craniofacial	I-Disease	ADJ	B
disorder	I-Disease	NOUN	I
with	O	ADP	O
high	O	ADJ	O
penetrance	O	NOUN	B
and	O	CCONJ	O
variable	O	ADJ	B
expression	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
VWS	B-Disease	NOUN	B
families	O	NOUN	B
studied	O	VERB	O
to	O	PART	O
date	O	NOUN	B
map	O	NOUN	I
the	O	DET	O
disease	O	NOUN	B
gene	O	NOUN	I
to	O	PART	O
a	O	DET	O
<	O	NOUN	O
2	O	NUM	O
cM	O	NOUN	O
region	O	NOUN	O
of	O	ADP	O
chromosome	O	NOUN	B
1q32	O	NOUN	I
,	O	PUNCT	O
with	O	ADP	O
no	O	DET	O
evidence	O	NOUN	O
of	O	ADP	O
locus	O	NOUN	B
heterogeneity	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
analyzed	O	VERB	B
four	O	NUM	O
multiplex	O	ADJ	B
VWS	B-Disease	NOUN	B
families	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
assay	O	NOUN	B
method	O	NOUN	O
for	O	ADP	O
short	O	ADJ	B
tandem	O	ADJ	I
repeat	O	NOUN	I
(	O	PUNCT	I
STR	O	NOUN	B
)	O	PUNCT	O
markers	O	NOUN	B
provided	O	VERB	O
highly	O	ADV	O
accurate	O	ADJ	B
size	O	NOUN	B
estimation	O	NOUN	B
of	O	ADP	O
marker	O	NOUN	B
allele	O	NOUN	O
fragment	O	NOUN	O
sizes	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
therefore	O	ADV	O
enabled	O	VERB	O
us	O	PRON	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
specific	O	ADJ	O
alleles	O	NOUN	B
segregating	O	VERB	B
with	O	ADP	O
the	O	DET	O
VWS	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
each	O	DET	O
of	O	ADP	O
our	O	PRON	O
four	O	NUM	O
families	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
the	O	DET	O
possibility	O	NOUN	O
of	O	ADP	O
a	O	DET	O
unique	O	ADJ	B
origin	O	NOUN	B
for	O	ADP	O
a	O	DET	O
mutation	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
many	O	ADJ	O
or	O	CCONJ	O
most	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
VWS	B-Disease	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
cathepsin	O	NOUN	B
C	O	NOUN	I
gene	O	NOUN	I
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
Papillon	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Lefevre	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


A	O	DET	O
major	O	ADJ	O
gene	O	NOUN	B
locus	O	NOUN	I
for	O	ADP	O
PLS	B-Disease	PROPN	B
has	O	AUX	O
been	O	AUX	O
mapped	O	VERB	B
to	O	PART	O
a	O	DET	O
2	O	NUM	O
.	O	PUNCT	O


Sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
CTSC	O	NOUN	B
from	O	ADP	O
subjects	O	NOUN	B
affected	O	VERB	B
with	O	ADP	O
PLS	B-Disease	PROPN	B
from	O	ADP	O
five	O	NUM	O
consanguineous	O	ADJ	B
Turkish	O	ADJ	B
families	O	NOUN	B
identified	O	VERB	B
four	O	NUM	O
different	O	ADJ	O
mutations	O	NOUN	B
.	O	PUNCT	O


Parents	O	NOUN	B
and	O	CCONJ	O
sibs	O	NOUN	B
heterozygous	O	ADJ	B
for	O	ADP	O
cathepsin	O	NOUN	B
C	O	NOUN	I
mutations	O	NOUN	B
do	O	AUX	O
not	O	PART	O
show	O	VERB	O
either	O	CCONJ	O
the	O	DET	O
palmoplantar	B-Disease	NOUN	B
hyperkeratosis	I-Disease	NOUN	I
or	O	CCONJ	O
severe	O	ADJ	B
early	O	ADJ	O
onset	O	NOUN	O
periodontitis	B-Disease	NOUN	B
characteristic	O	NOUN	O
of	O	ADP	O
PLS	B-Disease	PROPN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
HGO	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
Finnish	O	ADJ	B
alkaptonuria	B-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


So	O	ADV	O
far	O	ADV	O
17	O	NUM	O
mutations	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
characterised	O	VERB	B
in	O	ADP	O
AKU	B-Disease	NOUN	B
patients	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
ethnic	O	ADJ	B
origin	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
three	O	NUM	O
novel	O	ADJ	O
AKU	B-Disease	NOUN	B
mutations	O	NOUN	B
are	O	AUX	O
most	O	ADV	O
likely	O	ADV	O
specific	O	ADJ	O
for	O	ADP	O
the	O	DET	O
Finnish	O	ADJ	B
population	O	NOUN	B
and	O	CCONJ	O
have	O	AUX	O
originated	O	VERB	O
recently	O	ADV	O
.	O	PUNCT	O
.	O	PUNCT	O


Inherited	O	VERB	B
mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
predispose	O	VERB	O
carriers	O	NOUN	B
to	O	PART	O
multiple	O	ADJ	O
adenomatous	B-Disease	ADJ	B
polyps	I-Disease	NOUN	I
of	I-Disease	ADP	O
the	I-Disease	DET	O
colon	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
rectum	I-Disease	NOUN	B
and	O	CCONJ	O
to	O	PART	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Many	O	ADJ	O
individuals	O	NOUN	B
with	O	ADP	O
AAPC	B-Disease	NOUN	B
develop	O	VERB	O
relatively	O	ADV	O
few	O	ADJ	O
colorectal	B-Disease	ADJ	B
polyps	I-Disease	NOUN	I
but	O	CCONJ	O
are	O	AUX	O
still	O	ADV	O
at	O	ADP	O
high	O	ADJ	B
risk	O	NOUN	I
for	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


This	O	DET	O
disease	O	NOUN	B
-	O	PUNCT	O
causing	O	VERB	B
mutation	O	NOUN	B
is	O	AUX	O
a	O	DET	O
single	O	ADJ	O
basepair	O	NOUN	O
change	O	NOUN	O
(	O	PUNCT	O
G	O	NOUN	B
to	O	PART	O
A	O	NOUN	O
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
splice	O	NOUN	B
-	O	PUNCT	O
acceptor	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
APC	B-Disease	NOUN	B
intron	O	NOUN	O
3	O	NUM	O
that	O	PRON	O
creates	O	VERB	O
a	O	DET	O
mutant	O	ADJ	B
RNA	O	NOUN	I
without	O	ADP	O
exon	O	NOUN	B
4	O	NUM	I
of	O	ADP	O
APC	O	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
this	O	DET	O
germline	O	NOUN	B
mutation	O	NOUN	I
strengthens	O	VERB	O
the	O	DET	O
correlation	O	NOUN	B
between	O	ADP	O
the	O	DET	O
5	O	NUM	O
location	O	NOUN	B
of	O	ADP	O
an	O	DET	O
APC	B-Disease	NOUN	B
disease	O	NOUN	I
-	O	PUNCT	O
causing	O	VERB	B
mutation	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
attenuated	B-Disease	VERB	B
polyposis	I-Disease	NOUN	B
phenotype	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Alstrom	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
is	O	AUX	O
a	O	DET	O
rare	O	ADJ	B
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	O
disorder	I-Disease	NOUN	O
characterized	O	VERB	B
by	O	ADP	O
retinal	B-Disease	ADJ	B
degeneration	I-Disease	NOUN	I
,	O	PUNCT	O
sensorineural	B-Disease	ADJ	B
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
,	O	PUNCT	O
early	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
obesity	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
insulin	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
dependent	I-Disease	ADJ	B
diabetes	I-Disease	NOUN	B
mellitus	I-Disease	NOUN	I
.	O	PUNCT	O


To	O	PART	O
confirm	O	VERB	O
these	O	DET	O
findings	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
large	O	ADJ	O
linkage	O	NOUN	B
study	O	NOUN	I
was	O	AUX	O
performed	O	VERB	O
in	O	ADP	O
twelve	O	NUM	O
additional	O	ADJ	O
families	O	NOUN	B
segregating	O	VERB	B
for	O	ADP	O
Alstrom	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
comprises	O	VERB	O
congenital	B-Disease	ADJ	B
sensorineural	I-Disease	ADJ	I
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
,	O	PUNCT	O
thyroid	B-Disease	NOUN	B
goiter	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
positive	O	ADJ	B
perchlorate	O	NOUN	B
discharge	O	NOUN	I
test	O	NOUN	I
.	O	PUNCT	O


Molecular	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
PDS	B-Disease	PROPN	B
gene	O	NOUN	I
was	O	AUX	O
performed	O	VERB	O
in	O	ADP	O
two	O	NUM	O
consanguineous	O	ADJ	B
large	O	ADJ	O
families	O	NOUN	B
from	O	ADP	O
Southern	O	PROPN	B
Tunisia	O	PROPN	I
comprising	O	VERB	O
a	O	DET	O
total	O	NOUN	O
of	O	ADP	O
23	O	NUM	O
individuals	O	NOUN	B
affected	O	VERB	B
with	O	ADP	O
profound	O	ADJ	O
congenital	B-Disease	ADJ	B
deafness	I-Disease	NOUN	I
;	O	PUNCT	O
the	O	DET	O
same	O	ADJ	O
missense	O	NOUN	B
mutation	O	NOUN	I
,	O	PUNCT	O
L445W	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
all	O	DET	O
affected	O	VERB	B
individuals	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
goiter	B-Disease	NOUN	B
was	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
only	O	ADV	O
11	O	NUM	O
affected	O	VERB	B
individuals	O	NOUN	B
,	O	PUNCT	O
who	O	PRON	O
interestingly	O	ADV	O
had	O	AUX	O
a	O	DET	O
normal	O	ADJ	O
result	O	NOUN	O
of	O	ADP	O
the	O	DET	O
perchlorate	O	NOUN	B
discharge	O	NOUN	I
test	O	NOUN	I
whenever	O	SCONJ	O
performed	O	VERB	O
.	O	PUNCT	O


Knobloch	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
involving	O	VERB	O
midline	B-Disease	NOUN	B
scalp	I-Disease	NOUN	O
defect	I-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
frontal	I-Disease	ADJ	B
region	I-Disease	NOUN	I
.	O	PUNCT	O


He	O	PRON	O
has	O	AUX	O
vitreoretinal	B-Disease	ADJ	B
degeneration	I-Disease	NOUN	I
,	O	PUNCT	O
high	B-Disease	ADJ	B
myopia	I-Disease	NOUN	I
,	O	PUNCT	O
cataract	B-Disease	NOUN	B
,	O	PUNCT	O
telecanthus	B-Disease	ADJ	B
,	O	PUNCT	O
hypertelorism	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
high	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
arched	I-Disease	ADJ	B
palate	I-Disease	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
patient	O	NOUN	B
illustrates	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
investigating	O	VERB	B
for	O	ADP	O
underlying	O	VERB	O
ocular	O	ADJ	B
and	O	CCONJ	O
central	O	ADJ	B
nervous	O	ADJ	I
system	O	NOUN	I
pathology	O	NOUN	B
whenever	O	SCONJ	O
midline	B-Disease	NOUN	B
scalp	I-Disease	NOUN	I
defects	I-Disease	NOUN	B
are	O	AUX	O
present	O	ADJ	O
.	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
hypomorphic	O	ADJ	B
mutations	O	NOUN	I
in	O	ADP	O
hMRE11	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
ATM	O	NOUN	B
,	O	PUNCT	O
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
certain	O	ADJ	O
individuals	O	NOUN	B
with	O	ADP	O
an	O	DET	O
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
like	I-Disease	ADJ	B
disorder	I-Disease	NOUN	I
(	O	PUNCT	O
ATLD	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
ATM	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
hMre11	O	NOUN	B
/	O	PUNCT	O
hRad50	O	ADJ	B
/	O	PUNCT	O
Nbs1	O	NOUN	B
protein	O	NOUN	I
complex	O	NOUN	I
act	O	VERB	O
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
DNA	O	NOUN	B
damage	O	NOUN	I
response	O	NOUN	I
pathway	O	NOUN	I
and	O	CCONJ	O
link	O	VERB	O
hMre11	O	VERB	B
to	O	PART	O
the	O	DET	O
complex	O	ADJ	B
pathology	O	NOUN	B
of	O	ADP	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
expansile	I-Disease	ADJ	I
osteolysis	I-Disease	NOUN	I
(	O	PUNCT	O
FEO	B-Disease	PROPN	B
,	O	PUNCT	O
MIM	O	NOUN	B
174810	O	NUM	I
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
rare	O	ADJ	B
,	O	PUNCT	O
autosomal	B-Disease	ADJ	B
dominant	I-Disease	ADJ	O
bone	I-Disease	NOUN	B
disorder	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
focal	O	ADJ	B
areas	O	NOUN	I
of	O	ADP	O
increased	B-Disease	VERB	B
bone	I-Disease	NOUN	B
remodelling	I-Disease	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
previous	O	ADJ	O
linkage	O	NOUN	B
studies	O	NOUN	I
mapped	O	VERB	B
the	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
FEO	B-Disease	PROPN	B
to	O	ADP	O
an	O	DET	O
interval	O	NOUN	B
of	O	ADP	O
less	O	ADJ	O
than	O	ADP	O
5	O	NUM	O
cM	O	NOUN	O
between	O	ADP	O
D18S64	O	NOUN	B
and	O	CCONJ	O
D18S51	O	NOUN	O
on	O	ADP	O
chromosome	O	NOUN	O
18q21	O	NOUN	O
.	O	PUNCT	O


Cardiac	O	PROPN	B
Na	O	PROPN	I
(	O	PUNCT	O
+	O	CCONJ	O
)	O	PUNCT	O
channel	O	NOUN	O
dysfunction	O	NOUN	O
in	O	ADP	O
Brugada	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
is	O	AUX	O
aggravated	O	VERB	B
by	O	ADP	O
beta	O	NOUN	B
(	O	PUNCT	I
1	O	NUM	I
)	O	PUNCT	I
-	O	PUNCT	O
subunit	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
characterize	O	VERB	O
the	O	DET	O
altered	O	ADJ	O
effects	O	NOUN	B
of	O	ADP	O
a	O	DET	O
human	O	ADJ	B
beta	O	NOUN	I
(	O	PUNCT	I
1	O	NUM	I
)	O	PUNCT	O
-	O	PUNCT	O
subunit	O	NOUN	B
(	O	PUNCT	O
hbeta	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
heterologously	O	ADV	B
expressed	O	VERB	B
hH1	O	NOUN	B
mutation	O	NOUN	B
(	O	PUNCT	O
T1620M	O	NOUN	B
)	O	PUNCT	O
previously	O	ADV	O
associated	O	VERB	B
with	O	ADP	I
IVF	B-Disease	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
It	O	PRON	O
is	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
coexpression	O	NOUN	B
of	O	ADP	O
hbeta	O	NOUN	B
(	O	PUNCT	O
1	O	NUM	O
)	O	PUNCT	O
exposes	O	VERB	O
a	O	DET	O
more	O	ADV	O
severe	O	ADJ	B
functional	O	ADJ	B
defect	O	NOUN	I
that	O	PRON	O
results	O	VERB	B
in	O	ADP	O
a	O	DET	O
greater	O	ADJ	O
overlap	O	NOUN	B
in	O	ADP	O
the	O	DET	O
relationship	O	NOUN	B
between	O	ADP	O
channel	O	NOUN	B
inactivation	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
(	O	PUNCT	O
window	O	NOUN	B
current	O	ADJ	I
)	O	PUNCT	O
in	O	ADP	O
T1620M	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
proposed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
potential	O	ADJ	B
pathophysiological	O	ADJ	B
mechanism	O	NOUN	B
of	O	ADP	O
IVF	B-Disease	NOUN	B
in	O	X	B
vivo	O	X	I
.	O	PUNCT	O


In	O	ADP	O
hereditary	B-Disease	ADJ	B
retinoblastoma	I-Disease	NOUN	I
,	O	PUNCT	O
different	O	ADJ	O
epidemiological	O	ADJ	B
studies	O	NOUN	I
have	O	AUX	O
indicated	O	VERB	O
a	O	DET	O
preferential	O	ADJ	O
paternal	O	ADJ	B
transmission	O	NOUN	I
of	O	ADP	O
mutant	O	ADJ	B
retinoblastoma	B-Disease	NOUN	I
alleles	O	NOUN	I
to	O	ADP	O
offspring	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
the	O	DET	O
occurrence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
meiotic	O	ADJ	B
drive	O	NOUN	O
.	O	PUNCT	O


Single	O	ADJ	B
-	O	PUNCT	O
sperm	O	NOUN	B
typing	O	NOUN	O
techniques	O	NOUN	B
were	O	AUX	O
performed	O	VERB	O
for	O	ADP	O
each	O	DET	O
sample	O	NOUN	B
by	O	ADP	O
study	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
informative	O	ADJ	O
short	O	ADJ	B
tandem	O	ADJ	I
repeats	O	NOUN	I
located	O	ADJ	O
either	O	CCONJ	O
in	O	ADP	O
or	O	CCONJ	O
close	O	ADV	O
to	O	PART	O
the	O	DET	O
retinoblastoma	B-Disease	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
RB1	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Friedreich	B-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
,	O	PUNCT	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
neurodegenerative	I-Disease	ADJ	B
disease	I-Disease	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
of	O	ADP	O
the	O	DET	O
inherited	B-Disease	VERB	B
ataxias	I-Disease	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
is	O	AUX	O
mounting	O	VERB	B
evidence	O	NOUN	B
to	O	PART	O
suggest	O	VERB	O
that	O	SCONJ	O
Friedreich	B-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
is	O	AUX	O
the	O	DET	O
result	O	NOUN	O
of	O	ADP	O
accumulation	O	NOUN	B
of	O	ADP	O
iron	O	NOUN	B
in	O	ADP	O
mitochondria	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
excess	O	ADJ	B
production	O	NOUN	B
of	O	ADP	O
free	O	ADJ	B
radicals	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
then	O	ADV	O
results	O	VERB	B
in	O	ADP	O
cellular	O	ADJ	B
damage	O	NOUN	I
and	O	CCONJ	O
death	O	NOUN	B
.	O	PUNCT	O


X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
retinoschisis	I-Disease	NOUN	B
with	O	ADP	O
point	O	NOUN	O
mutations	O	NOUN	O
in	O	ADP	O
the	O	DET	O
XLRS1	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
To	O	PART	O
analyze	O	VERB	O
Japanese	O	ADJ	B
patients	O	NOUN	B
clinically	O	ADV	B
diagnosed	O	VERB	I
as	O	ADP	O
having	O	VERB	O
XLRS	B-Disease	NOUN	B
formutational	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
XLRS1	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
The	O	DET	O
discovery	O	NOUN	B
of	O	ADP	O
new	O	ADJ	O
point	O	NOUN	O
mutations	O	NOUN	B
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
increases	O	VERB	B
the	O	DET	O
available	O	ADJ	O
information	O	NOUN	B
regarding	O	VERB	O
the	O	DET	O
spectrum	O	NOUN	B
of	O	ADP	O
genetic	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
and	O	CCONJ	O
clinical	O	ADJ	B
manifestations	O	NOUN	I
of	O	ADP	O
XLRS	B-Disease	NOUN	B
.	O	PUNCT	O


Ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
is	O	AUX	O
a	O	DET	O
hereditary	B-Disease	ADJ	B
multisystemic	I-Disease	ADJ	I
disease	I-Disease	NOUN	I
resulting	O	VERB	O
from	O	ADP	O
mutations	O	NOUN	B
of	O	ADP	O
ataxia	B-Disease	NOUN	B
telangiectasia	I-Disease	NOUN	I
,	O	PUNCT	O
mutated	O	VERB	B
(	O	PUNCT	O
ATM	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
neurodegeneration	B-Disease	NOUN	B
,	O	PUNCT	O
cancer	B-Disease	NOUN	B
,	O	PUNCT	O
immune	B-Disease	ADJ	B
defects	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
hypersensitivity	B-Disease	NOUN	B
to	I-Disease	PART	O
ionizing	I-Disease	VERB	B
radiation	I-Disease	NOUN	I
.	O	PUNCT	O


Haim	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Munk	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
and	O	CCONJ	O
Papillon	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Lefevre	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
are	O	AUX	O
allelic	O	ADJ	B
mutations	O	NOUN	I
in	O	ADP	O
cathepsin	O	NOUN	B
C	O	NOUN	I
.	O	PUNCT	O


Although	O	SCONJ	O
both	O	DET	O
PLS	B-Disease	PROPN	B
and	O	CCONJ	O
HMS	B-Disease	PROPN	B
share	O	VERB	O
the	O	DET	O
cardinal	O	ADJ	O
features	O	NOUN	B
of	O	ADP	O
PPK	B-Disease	NOUN	B
and	O	CCONJ	O
severe	O	ADJ	B
periodontitis	B-Disease	NOUN	I
,	O	PUNCT	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
additional	O	ADJ	O
findings	O	NOUN	B
are	O	AUX	O
reported	O	VERB	O
in	O	ADP	O
HMS	B-Disease	NOUN	B
including	O	VERB	O
arachnodactyly	B-Disease	ADJ	B
,	O	PUNCT	O
acro	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
osteolysis	I-Disease	NOUN	B
,	O	PUNCT	O
atrophic	B-Disease	ADJ	B
changes	I-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
nails	I-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
radiographic	B-Disease	ADJ	B
deformity	I-Disease	NOUN	O
of	I-Disease	ADP	O
the	I-Disease	DET	O
fingers	I-Disease	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
autosomal	O	ADJ	B
recessive	O	ADJ	B
transmission	O	NOUN	I
of	O	ADP	O
PLS	B-Disease	PROPN	B
is	O	AUX	O
evident	O	ADJ	O
,	O	PUNCT	O
a	O	DET	O
more	O	ADJ	O
"	O	PUNCT	O
complex	O	ADJ	B
"	O	PUNCT	O
autosomal	O	ADJ	B
recessive	O	ADJ	O
pattern	O	NOUN	O
of	O	ADP	O
inheritance	O	NOUN	B
with	O	ADP	O
phenotypic	O	ADJ	B
influences	O	NOUN	B
from	O	ADP	O
a	O	DET	O
closely	O	ADV	O
linked	O	VERB	O
modifying	O	VERB	O
locus	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
hypothesised	O	VERB	O
for	O	ADP	O
HMS	B-Disease	PROPN	B
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
if	O	SCONJ	O
a	O	DET	O
cathepsin	O	NOUN	B
C	O	NOUN	I
mutation	O	NOUN	B
is	O	AUX	O
also	O	ADV	O
responsible	O	ADJ	O
for	O	ADP	O
HMS	B-Disease	PROPN	B
,	O	PUNCT	O
we	O	PRON	O
sequenced	O	VERB	B
the	O	DET	O
gene	O	NOUN	B
in	O	ADP	O
affected	O	VERB	B
and	O	CCONJ	O
unaffected	O	ADJ	O
subjects	O	NOUN	B
from	O	ADP	O
the	O	DET	O
Cochin	O	PROPN	B
isolate	O	NOUN	B
in	O	ADP	O
which	O	DET	O
both	O	CCONJ	O
the	O	DET	O
PLS	B-Disease	PROPN	B
and	O	CCONJ	O
HMS	B-Disease	PROPN	B
phenotypes	O	NOUN	B
appear	O	VERB	O
.	O	PUNCT	O


This	O	DET	O
finding	O	NOUN	B
supports	O	VERB	O
simple	O	ADJ	O
autosomal	O	ADJ	B
recessive	O	ADJ	O
inheritance	O	NOUN	B
for	O	ADP	O
HMS	B-Disease	NOUN	B
in	O	ADP	O
these	O	DET	O
families	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
PLS	B-Disease	PROPN	B
and	O	CCONJ	O
HMS	B-Disease	PROPN	B
are	O	AUX	O
allelic	O	ADJ	B
variants	O	NOUN	B
of	O	ADP	O
cathepsin	O	NOUN	B
C	O	NOUN	I
gene	O	NOUN	I
mutations	O	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ATM	O	NOUN	B
gene	O	NOUN	I
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
disorder	I-Disease	NOUN	I
ataxia	B-Disease	NOUN	I
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
(	O	PUNCT	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
MIM	O	NOUN	B
208900	O	NUM	I
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
view	O	NOUN	O
of	O	ADP	O
this	O	DET	O
discrepancy	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
the	O	DET	O
frequency	O	NOUN	B
of	O	ADP	O
ATM	O	NOUN	B
germline	O	NOUN	B
mutations	O	NOUN	I
in	O	ADP	O
a	O	DET	O
selected	O	VERB	O
group	O	NOUN	B
of	O	ADP	O
Dutch	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
breast	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
82	O	NUM	O
patients	O	NOUN	B
included	O	VERB	O
in	O	ADP	O
this	O	DET	O
study	O	NOUN	B
had	O	AUX	O
developed	O	VERB	O
breast	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
at	O	ADP	O
age	O	NOUN	B
<	O	X	O
45	O	NUM	O
and	O	CCONJ	O
had	O	AUX	O
survived	O	VERB	O
>	O	X	O
/	O	PUNCT	O
=	O	ADJ	O
5	O	NUM	O
years	O	NOUN	B
(	O	PUNCT	O
mean	O	VERB	O
15	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
33	O	NUM	O
(	O	PUNCT	O
40	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
a	O	DET	O
contralateral	O	ADJ	B
breast	O	NOUN	B
tumor	O	NOUN	I
had	O	AUX	O
been	O	AUX	O
diagnosed	O	VERB	B
.	O	PUNCT	O


From	O	ADP	O
the	O	DET	O
alignment	O	NOUN	B
of	O	ADP	O
the	O	DET	O
amino	O	NOUN	B
acid	O	NOUN	I
(	O	PUNCT	O
aa	O	NOUN	O
)	O	PUNCT	O
sequence	O	NOUN	O
of	O	ADP	O
52	O	NUM	O
glucose	O	NOUN	B
6	O	NUM	O
-	O	PUNCT	O
phosphate	O	NOUN	B
dehydrogenase	O	NOUN	I
(	O	PUNCT	O
G6PD	O	NOUN	B
)	O	PUNCT	O
species	O	NOUN	B
from	O	ADP	O
42	O	NUM	O
different	O	ADJ	O
organisms	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
found	O	VERB	O
a	O	DET	O
striking	O	ADJ	O
correlation	O	NOUN	B
between	O	ADP	O
the	O	DET	O
aa	O	NOUN	B
replacements	O	NOUN	I
that	O	PRON	O
cause	O	VERB	O
G6PD	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	O
in	O	ADP	O
humans	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
sequence	O	NOUN	B
conservation	O	NOUN	B
of	O	ADP	O
G6PD	O	NOUN	B
two	O	NUM	O
-	O	PUNCT	O
thirds	O	NOUN	B
of	O	ADP	O
such	O	ADJ	O
replacements	O	NOUN	B
are	O	AUX	O
in	O	ADP	O
highly	O	ADV	B
and	O	CCONJ	O
moderately	O	ADV	O
conserved	O	VERB	O
(	O	PUNCT	O
50	O	NUM	O
-	O	SYM	O
99	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
aa	O	NOUN	B
;	O	PUNCT	O
relatively	O	ADV	O
few	O	ADJ	O
are	O	AUX	O
in	O	ADP	O
fully	O	ADV	O
conserved	O	VERB	B
aa	O	NOUN	I
(	O	PUNCT	O
where	O	SCONJ	O
they	O	PRON	O
might	O	AUX	O
be	O	AUX	O
lethal	O	ADJ	B
)	O	PUNCT	O
or	O	CCONJ	O
in	O	ADP	O
poorly	O	ADV	O
conserved	O	VERB	B
aa	O	NOUN	I
,	O	PUNCT	O
where	O	SCONJ	O
presumably	O	ADV	O
they	O	PRON	O
simply	O	ADV	O
would	O	AUX	O
not	O	PART	O
cause	O	VERB	O
G6PD	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	B
.	O	PUNCT	O


Myotonic	B-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
(	O	PUNCT	O
DM	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
prevalent	O	ADJ	O
inherited	B-Disease	VERB	B
neuromuscular	I-Disease	ADJ	B
disease	I-Disease	NOUN	I
in	O	ADP	O
adults	O	NOUN	B
.	O	PUNCT	O


Information	O	NOUN	B
on	O	ADP	O
DMPK	O	NOUN	B
mRNA	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
isoform	O	NOUN	I
expression	O	NOUN	B
patterns	O	NOUN	I
will	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
for	O	ADP	O
recognizing	O	VERB	O
differential	O	ADJ	B
effects	O	NOUN	O
of	O	ADP	O
(	O	PUNCT	O
CTG	O	NOUN	B
)	O	PUNCT	O
(	O	PUNCT	O
n	O	NOUN	O
)	O	PUNCT	O
expansion	O	NOUN	B
in	O	ADP	O
DM	B-Disease	NOUN	B
manifestation	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Protein	B-Disease	NOUN	B
S	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
is	O	AUX	O
a	O	DET	O
recognized	O	VERB	O
risk	O	NOUN	B
factor	O	NOUN	I
for	O	ADP	O
venous	B-Disease	ADJ	B
thrombosis	I-Disease	NOUN	I
.	O	PUNCT	O


Twenty	O	NUM	B
-	O	PUNCT	O
eight	O	NUM	O
index	O	NOUN	O
patients	O	NOUN	B
with	O	ADP	O
protein	B-Disease	NOUN	B
S	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
and	O	CCONJ	O
a	O	DET	O
PROS1	B-Disease	NOUN	B
gene	I-Disease	NOUN	I
defect	I-Disease	NOUN	I
were	O	AUX	O
studied	O	VERB	O
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
109	O	NUM	O
first	O	ADJ	B
-	O	PUNCT	O
degree	O	NOUN	B
relatives	O	NOUN	O
.	O	PUNCT	O


First	O	ADJ	B
-	O	PUNCT	O
degree	O	NOUN	B
relatives	O	NOUN	B
with	O	ADP	O
a	O	DET	O
PROS1	B-Disease	NOUN	B
gene	I-Disease	NOUN	I
defect	I-Disease	NOUN	I
had	O	AUX	O
a	O	DET	O
5	O	NUM	O
.	O	PUNCT	O


Although	O	SCONJ	O
pregnancy	O	NOUN	B
/	O	SYM	O
puerperium	O	NOUN	B
and	O	CCONJ	O
immobility	O	NOUN	B
/	O	PUNCT	O
trauma	B-Disease	NOUN	B
were	O	AUX	O
important	O	ADJ	O
precipitating	O	NOUN	B
factors	O	NOUN	I
for	O	ADP	O
thrombosis	B-Disease	NOUN	B
,	O	PUNCT	O
almost	O	ADV	O
half	O	NOUN	O
of	O	ADP	O
the	O	DET	O
events	O	NOUN	B
were	O	AUX	O
spontaneous	O	ADJ	B
.	O	PUNCT	O


We	O	PRON	O
conclude	O	VERB	O
that	O	SCONJ	O
persons	O	NOUN	B
with	O	ADP	O
PROS1	B-Disease	NOUN	B
gene	I-Disease	NOUN	I
defects	I-Disease	NOUN	B
and	O	CCONJ	O
protein	B-Disease	NOUN	B
S	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
are	O	AUX	O
at	O	ADP	O
increased	O	VERB	B
risk	O	NOUN	B
of	O	ADP	O
thrombosis	B-Disease	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
free	O	ADJ	B
protein	O	NOUN	I
S	O	NOUN	I
estimation	O	NOUN	B
offers	O	VERB	O
the	O	DET	O
most	O	ADV	O
reliable	O	ADJ	O
way	O	NOUN	O
of	O	ADP	O
diagnosing	O	VERB	B
the	O	DET	O
deficiency	O	NOUN	B
.	O	PUNCT	O


Autoimmune	B-Disease	ADJ	B
lymphoproliferative	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
ALPS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
autoimmune	O	ADJ	B
features	O	NOUN	I
and	O	CCONJ	O
lymphoproliferations	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
generally	O	ADV	O
caused	O	VERB	O
by	O	ADP	O
defective	O	ADJ	B
Fas	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
apoptosis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
patient	O	NOUN	B
reported	O	VERB	O
here	O	ADV	O
is	O	AUX	O
a	O	DET	O
human	O	ADJ	B
homologue	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Fas	O	NOUN	B
-	O	PUNCT	O
null	O	ADJ	B
mouse	O	NOUN	B
,	O	PUNCT	O
inasmuch	O	ADV	O
as	O	ADP	O
she	O	PRON	O
carries	O	VERB	O
an	O	DET	O
autosomal	O	ADJ	B
homozygous	O	ADJ	B
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
FAS	O	NOUN	B
gene	O	NOUN	I
and	O	CCONJ	O
she	O	PRON	O
shows	O	VERB	O
the	O	DET	O
severe	O	ADJ	B
and	O	CCONJ	O
accelerated	O	VERB	B
ALPS	B-Disease	NOUN	B
phenotype	O	NOUN	B
.	O	PUNCT	O


Identification	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	B
imprinted	O	ADJ	B
transcripts	O	NOUN	O
in	O	ADP	O
the	O	DET	O
Prader	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
and	O	CCONJ	O
Angelman	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
deletion	O	NOUN	B
region	O	NOUN	I
:	O	PUNCT	O
further	O	ADJ	O
evidence	O	NOUN	B
for	O	ADP	O
regional	O	ADJ	B
imprinting	O	NOUN	I
control	O	NOUN	I
.	O	PUNCT	O


Loss	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
imprinted	O	ADJ	B
,	O	PUNCT	O
paternally	O	ADV	B
expressed	O	VERB	I
genes	O	NOUN	I
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
PWS	B-Disease	NOUN	B
.	O	PUNCT	O


To	O	PART	O
identify	O	VERB	O
additional	O	ADJ	O
imprinted	O	ADJ	B
genes	O	NOUN	I
that	O	PRON	O
could	O	AUX	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
PWS	B-Disease	NOUN	B
phenotype	O	NOUN	B
and	O	CCONJ	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
regional	O	ADJ	B
control	O	NOUN	I
of	O	ADP	O
imprinting	O	NOUN	B
in	O	ADP	O
15q11	O	NOUN	B
-	O	PUNCT	O
q13	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
constructed	O	VERB	O
an	O	DET	O
imprinted	O	ADJ	B
transcript	O	NOUN	I
map	O	NOUN	I
of	O	ADP	O
the	O	DET	O
PWS	O	PROPN	B
-	O	PUNCT	O
AS	O	ADJ	B
deletion	O	NOUN	B
interval	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
previous	O	ADJ	O
linkage	O	NOUN	B
study	O	NOUN	I
provided	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
-	O	PUNCT	O
susceptibility	O	NOUN	B
locus	O	NOUN	O
at	O	ADP	O
1q24	O	NOUN	B
-	O	PUNCT	O
25	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
describes	O	VERB	O
a	O	DET	O
combined	O	ADJ	B
analysis	O	NOUN	I
for	O	ADP	O
six	O	NUM	O
markers	O	NOUN	B
in	O	ADP	O
the	O	DET	O
1q24	O	NOUN	B
-	O	PUNCT	O
25	O	NUM	O
region	O	NOUN	B
in	O	ADP	O
772	O	NUM	O
families	O	NOUN	B
affected	O	VERB	B
by	O	ADP	O
hereditary	B-Disease	ADJ	B
prostate	I-Disease	NOUN	I
cancer	I-Disease	NOUN	I
and	O	CCONJ	O
ascertained	O	VERB	O
by	O	ADP	O
the	O	DET	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
International	O	PROPN	B
Consortium	O	PROPN	I
for	O	ADP	I
Prostate	B-Disease	PROPN	I
Cancer	I-Disease	PROPN	I
Genetics	O	PROPN	I
(	O	PUNCT	O
ICPCG	O	PROPN	B
)	O	PUNCT	O
from	O	ADP	O
North	O	PROPN	B
America	O	PROPN	I
,	O	PUNCT	O
Australia	O	PROPN	B
,	O	PUNCT	O
Finland	O	PROPN	B
,	O	PUNCT	O
Norway	O	PROPN	B
,	O	PUNCT	O
Sweden	O	PROPN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
United	O	PROPN	B
Kingdom	O	PROPN	I
.	O	PUNCT	O


Although	O	SCONJ	O
HPC1	O	NOUN	B
accounts	O	VERB	O
for	O	ADP	O
only	O	ADV	O
a	O	DET	O
small	O	ADJ	O
proportion	O	NOUN	B
of	O	ADP	O
all	O	DET	O
families	O	NOUN	B
affected	O	VERB	B
by	O	ADP	O
hereditary	B-Disease	ADJ	B
prostate	I-Disease	NOUN	I
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
it	O	PRON	O
appears	O	VERB	O
to	O	PART	O
play	O	VERB	O
a	O	DET	O
more	O	ADV	O
prominent	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
subset	O	NOUN	O
of	O	ADP	O
families	O	NOUN	B
with	O	ADP	O
several	O	ADJ	O
members	O	NOUN	B
affected	O	VERB	B
at	O	ADP	O
an	O	DET	O
early	O	ADJ	B
age	O	NOUN	B
and	O	CCONJ	O
with	O	ADP	O
male	O	NOUN	B
-	O	PUNCT	O
to	O	ADP	O
-	O	PUNCT	O
male	O	NOUN	B
disease	O	NOUN	B
transmission	O	NOUN	I
.	O	PUNCT	O


Large	O	ADJ	O
intergenerational	O	ADJ	B
repeat	O	NOUN	I
expansions	O	NOUN	I
of	O	ADP	O
the	O	DET	O
CAG	O	NOUN	B
trinucleotide	O	NOUN	I
repeat	O	NOUN	I
in	O	ADP	O
the	O	DET	O
HD	B-Disease	NOUN	B
gene	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
well	O	ADV	O
documented	O	VERB	B
for	O	ADP	O
the	O	DET	O
male	O	NOUN	B
germline	O	NOUN	B
.	O	PUNCT	O


Motor	B-Disease	NOUN	B
incoordination	I-Disease	NOUN	I
,	O	PUNCT	O
immune	B-Disease	ADJ	B
deficiencies	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
increased	O	VERB	B
risk	O	NOUN	B
of	O	ADP	O
cancer	B-Disease	NOUN	B
are	O	AUX	O
the	O	DET	O
characteristic	O	ADJ	O
features	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hereditary	B-Disease	ADJ	B
disease	I-Disease	NOUN	I
ataxia	B-Disease	NOUN	I
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
(	O	PUNCT	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ATM	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Atm	O	NOUN	B
(	O	PUNCT	O
y	O	NOUN	O
/	O	SYM	O
y	O	NOUN	O
)	O	PUNCT	O
mice	O	NOUN	B
exhibit	O	VERB	O
deficits	O	NOUN	B
in	O	ADP	O
motor	O	NOUN	B
learning	O	NOUN	I
indicative	O	ADJ	B
of	O	ADP	O
cerebellar	B-Disease	ADJ	B
dysfunction	I-Disease	NOUN	I
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
establish	O	VERB	O
that	O	SCONJ	O
some	O	DET	O
neuropathological	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
seen	O	VERB	O
in	O	ADP	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
patients	O	NOUN	B
also	O	ADV	O
are	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
Atm	O	NOUN	B
mutant	O	ADJ	I
mice	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
discuss	O	VERB	O
these	O	DET	O
findings	O	NOUN	B
in	O	ADP	O
the	O	DET	O
context	O	NOUN	B
of	O	ADP	O
the	O	DET	O
hypothesis	O	NOUN	B
that	O	SCONJ	O
abnormal	O	ADJ	B
development	O	NOUN	I
of	O	ADP	O
Purkinje	O	NOUN	B
cells	O	NOUN	I
and	O	CCONJ	O
lymphocytes	O	NOUN	B
contributes	O	VERB	O
to	O	PART	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Wilson	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
WD	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
disorder	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
copper	O	NOUN	B
accumulation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
,	O	PUNCT	O
brain	O	NOUN	B
,	O	PUNCT	O
kidneys	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
corneas	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
culminating	O	VERB	O
in	O	ADP	O
copper	O	NOUN	B
toxication	O	NOUN	B
in	O	ADP	O
these	O	DET	O
organs	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
accumulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
types	O	NOUN	O
of	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
Japanese	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
WD	B-Disease	NOUN	B
will	O	AUX	O
facilitate	O	VERB	O
the	O	DET	O
fast	O	ADJ	B
and	O	CCONJ	O
effective	O	ADJ	B
genetic	O	ADJ	B
diagnosis	O	NOUN	I
of	O	ADP	O
WD	B-Disease	NOUN	B
in	O	ADP	O
Japanese	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
Rho	O	NOUN	B
-	O	PUNCT	O
family	O	NOUN	B
GTPase	O	NOUN	B
,	O	PUNCT	O
Cdc42	O	NOUN	B
,	O	PUNCT	O
can	O	AUX	O
regulate	O	VERB	B
the	O	DET	O
actin	O	NOUN	B
cytoskeleton	O	NOUN	I
through	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
Wiskott	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Aldrich	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
protein	O	NOUN	I
(	O	PUNCT	O
WASP	O	NOUN	B
)	O	PUNCT	O
family	O	NOUN	B
members	O	NOUN	I
.	O	PUNCT	O


Machado	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Joseph	I-Disease	PROPN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
MJD	B-Disease	NOUN	B
)	O	PUNCT	O
belongs	O	VERB	O
to	O	PART	O
a	O	DET	O
group	O	NOUN	B
of	O	ADP	O
clinically	O	ADV	B
and	O	CCONJ	O
genetically	O	ADV	B
heterogeneous	O	ADJ	O
neurodegenerative	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
progressive	B-Disease	ADJ	B
cerebellar	I-Disease	ADJ	B
ataxia	I-Disease	NOUN	I
.	O	PUNCT	O


Analyzing	O	VERB	O
the	O	DET	O
expression	O	NOUN	B
level	O	NOUN	B
of	O	ADP	O
the	O	DET	O
SCA3	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
several	O	ADJ	O
human	O	ADJ	B
brain	O	NOUN	B
sections	O	NOUN	I
revealed	O	VERB	O
no	O	DET	O
significant	O	ADJ	O
higher	O	ADJ	O
mRNA	O	NOUN	B
level	O	NOUN	O
in	O	ADP	O
regions	O	NOUN	B
predominantly	O	ADV	O
affected	O	VERB	B
in	O	ADP	O
MJD	B-Disease	NOUN	B
.	O	PUNCT	O


Emerin	B-Disease	NOUN	B
,	I-Disease	PUNCT	O
deficiency	I-Disease	NOUN	B
of	O	ADP	O
which	O	DET	O
causes	O	VERB	O
Emery	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
,	O	PUNCT	O
is	O	AUX	O
localized	O	ADJ	B
at	O	ADP	O
the	O	DET	O
inner	O	ADJ	B
nuclear	O	ADJ	I
membrane	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
for	O	ADP	O
EDMD	B-Disease	NOUN	B
on	O	ADP	O
Xq28	O	NOUN	B
encodes	O	VERB	I
a	O	DET	O
novel	O	ADJ	O
protein	O	NOUN	B
named	O	VERB	O
emerin	O	NOUN	B
that	O	PRON	O
localizes	O	VERB	B
at	O	ADP	O
the	O	DET	O
nuclear	O	ADJ	B
membrane	O	NOUN	I
of	O	ADP	O
skeletal	O	ADJ	B
,	O	PUNCT	O
cardiac	O	ADJ	B
and	O	CCONJ	O
smooth	O	ADJ	B
muscles	O	NOUN	I
and	O	CCONJ	O
some	O	DET	O
other	O	ADJ	O
non	O	ADJ	B
-	O	PUNCT	O
muscle	O	NOUN	B
tissues	O	NOUN	B
.	O	PUNCT	O


Friedreich	B-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
(	O	PUNCT	O
FRDA	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	O
ataxia	I-Disease	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
now	O	ADV	O
provide	O	VERB	O
strong	O	ADJ	O
evidence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
second	O	ADJ	O
FRDA	B-Disease	NOUN	B
locus	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
the	O	DET	O
patients	O	NOUN	B
studied	O	VERB	O
had	O	AUX	O
typical	O	ADJ	O
FRDA	B-Disease	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
sibpair	O	NOUN	B
had	O	AUX	O
the	O	DET	O
uncommon	O	ADJ	O
symptom	O	NOUN	B
of	O	ADP	O
retained	O	VERB	B
tendon	O	NOUN	B
reflexes	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
observation	O	NOUN	B
of	O	ADP	O
typical	O	ADJ	O
mutations	O	NOUN	B
in	O	ADP	O
STM7	O	NOUN	B
/	O	SYM	O
X25	O	NOUN	B
(	O	PUNCT	O
GAA	O	NOUN	B
expansions	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
this	O	DET	O
patient	O	NOUN	B
demonstrates	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
genetically	O	ADV	B
different	O	ADJ	O
forms	O	NOUN	O
of	O	ADP	O
FRDA	B-Disease	NOUN	B
cannot	O	AUX	O
be	O	AUX	O
distinguished	O	VERB	O
clinically	O	ADV	B
.	O	PUNCT	O
.	O	PUNCT	O


Impaired	B-Disease	ADJ	B
glucose	I-Disease	NOUN	I
tolerance	I-Disease	NOUN	I
(	O	PUNCT	O
IGT	B-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
hypertriglyceridemia	B-Disease	NOUN	B
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
an	O	DET	O
increased	O	VERB	B
risk	O	NOUN	B
of	O	ADP	O
diabetes	B-Disease	NOUN	B
mellitus	I-Disease	NOUN	I
and	O	CCONJ	O
cardiovascular	B-Disease	ADJ	B
disease	I-Disease	NOUN	I
.	O	PUNCT	O


Family	O	NOUN	B
screening	O	NOUN	I
in	O	ADP	O
the	O	DET	O
initial	O	ADJ	O
cohort	O	NOUN	B
identified	O	VERB	B
18	O	NUM	O
men	O	NOUN	B
from	O	ADP	O
five	O	NUM	O
families	O	NOUN	B
with	O	ADP	O
severe	O	ADJ	B
hyperglycerolemia	B-Disease	NOUN	B
(	O	PUNCT	O
values	O	NOUN	B
above	O	ADP	O
2	O	NUM	O
.	O	PUNCT	O
0	O	NUM	O
mmol	O	NOUN	O
/	O	SYM	O
liter	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
demonstrated	O	VERB	O
an	O	DET	O
X	O	NOUN	B
-	O	PUNCT	O
linked	O	VERB	B
pattern	O	NOUN	B
of	O	ADP	O
inheritance	O	NOUN	B
.	O	PUNCT	O


Primary	B-Disease	ADJ	B
dystonias	I-Disease	NOUN	I
are	O	AUX	O
movement	B-Disease	NOUN	B
disorders	I-Disease	NOUN	I
with	O	ADP	O
dystonia	B-Disease	NOUN	B
as	O	ADP	O
a	O	DET	O
major	O	ADJ	O
symptom	O	NOUN	B
.	O	PUNCT	O


1	O	NUM	O
in	O	ADP	O
the	O	DET	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
dystonia	I-Disease	NOUN	B
parkinsonism	I-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
and	O	CCONJ	O
to	O	PART	O
Xq22	O	NOUN	B
in	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
sensorineural	I-Disease	ADJ	B
deafness	I-Disease	NOUN	I
,	O	PUNCT	O
dystonia	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
sensorineural	B-Disease	ADJ	B
deafness	I-Disease	NOUN	I
,	O	PUNCT	O
dystonia	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
,	O	PUNCT	O
mutations	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
DDP	O	NOUN	B
coding	O	VERB	B
for	O	ADP	O
a	O	DET	O
polypeptide	O	NOUN	B
of	O	ADP	O
unknown	O	ADJ	B
function	O	NOUN	I
.	O	PUNCT	O


Determination	O	NOUN	B
of	O	ADP	O
30	O	NUM	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
adrenoleukodystrophy	I-Disease	NOUN	B
mutations	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
15	O	NUM	O
not	O	PART	O
previously	O	ADV	O
described	O	VERB	O
.	O	PUNCT	O


Of	O	ADP	O
particular	O	ADJ	O
concern	O	NOUN	O
are	O	AUX	O
female	O	ADJ	B
members	O	NOUN	I
of	O	ADP	O
kindreds	O	NOUN	B
segregating	O	VERB	B
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	NOUN	B
mutations	O	NOUN	B
,	O	PUNCT	O
because	O	SCONJ	O
normal	O	ADJ	O
VLCFA	O	NOUN	B
levels	O	NOUN	B
do	O	AUX	O
not	O	PART	O
guarantee	O	VERB	O
lack	O	NOUN	O
of	O	ADP	O
carrier	O	NOUN	B
status	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
this	O	DET	O
methodology	O	NOUN	B
we	O	PRON	O
have	O	AUX	O
found	O	VERB	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
30	O	NUM	O
kindreds	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
15	O	NUM	O
not	O	PART	O
previously	O	ADV	O
reported	O	VERB	O
.	O	PUNCT	O


GM1	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
gangliosidosis	I-Disease	NOUN	B
is	O	AUX	O
a	O	DET	O
lysosomal	B-Disease	ADJ	B
storage	I-Disease	NOUN	I
disorder	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
acid	I-Disease	NOUN	B
beta	I-Disease	NOUN	I
-	I-Disease	PUNCT	O
galactosidase	I-Disease	NOUN	B
(	O	PUNCT	O
GLB1	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
all	O	DET	O
patients	O	NOUN	B
with	O	ADP	O
cardiac	B-Disease	ADJ	B
involvement	I-Disease	NOUN	O
were	O	AUX	O
homozygous	O	ADJ	B
for	O	ADP	O
one	O	NUM	O
of	O	ADP	O
these	O	DET	O
mutations	O	NOUN	B
R59H	O	NOUN	O
,	O	PUNCT	O
Y591C	O	NOUN	B
,	O	PUNCT	O
Y591N	O	NOUN	O
,	O	PUNCT	O
or	O	CCONJ	O
IVS14	O	NOUN	B
-	O	PUNCT	O
2A	O	NOUN	B
>	O	X	O
G	O	NOUN	B
.	O	PUNCT	O


In	O	X	B
vivo	O	X	I
modulation	O	NOUN	B
of	O	ADP	O
Hmgic	O	NOUN	B
reduces	O	VERB	B
obesity	B-Disease	NOUN	B
.	O	PUNCT	O


To	O	PART	O
study	O	VERB	B
its	O	PRON	O
role	O	NOUN	O
in	O	ADP	O
adipogenesis	O	NOUN	B
and	O	CCONJ	O
obesity	B-Disease	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
examined	O	VERB	O
Hmgic	O	ADJ	B
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
adipose	O	NOUN	B
tissue	O	NOUN	I
of	O	ADP	O
adult	O	ADJ	B
,	O	PUNCT	O
obese	B-Disease	ADJ	B
mice	O	NOUN	B
.	O	PUNCT	O


Disruption	O	NOUN	B
of	O	ADP	O
Hmgic	O	NOUN	B
caused	O	VERB	O
a	O	DET	O
reduction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
obesity	B-Disease	NOUN	B
induced	O	VERB	B
by	O	ADP	O
leptin	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
(	O	PUNCT	O
Lepob	O	PROPN	B
/	O	SYM	O
Lepob	O	PROPN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
-	O	PUNCT	O
dose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


Molecular	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
relationship	O	NOUN	B
in	O	ADP	O
factor	B-Disease	NOUN	B
X	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
factor	O	NOUN	B
X	O	NOUN	I
(	O	PUNCT	O
F10	O	NOUN	O
)	O	PUNCT	O
genes	O	NOUN	O
of	O	ADP	O
14	O	NUM	O
unrelated	O	ADJ	O
individuals	O	NOUN	B
with	O	ADP	O
factor	B-Disease	NOUN	B
X	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
(	O	PUNCT	O
12	O	NUM	O
familial	O	ADJ	B
and	O	CCONJ	O
two	O	NUM	O
sporadic	O	ADJ	B
cases	O	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
sequenced	O	VERB	B
yielding	O	VERB	O
a	O	DET	O
total	O	NOUN	O
of	O	ADP	O
13	O	NUM	O
novel	O	ADJ	B
mutations	O	NOUN	B
.	O	PUNCT	O


Chromosomal	O	ADJ	B
translocations	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
lipomas	B-Disease	NOUN	I
frequently	O	ADV	O
create	O	VERB	O
fusion	O	NOUN	B
transcripts	O	NOUN	B
encoding	O	VERB	B
high	O	ADJ	O
mobility	O	NOUN	B
group	O	NOUN	I
(	O	PUNCT	O
HMG	O	NOUN	B
)	O	PUNCT	O
I	O	NUM	O
-	O	PUNCT	O
C	O	NOUN	B
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domains	O	NOUN	I
and	O	CCONJ	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
sequences	O	NOUN	B
from	O	ADP	O
different	O	ADJ	O
presumed	O	VERB	O
transcription	O	NOUN	B
factors	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
a	O	DET	O
potential	O	ADJ	O
role	O	NOUN	O
for	O	ADP	O
HMG	O	NOUN	B
I	O	NUM	I
-	O	PUNCT	O
C	O	NOUN	B
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
lipomas	B-Disease	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domains	O	NOUN	O
of	O	ADP	O
HMG	O	NOUN	B
I	O	NUM	I
-	O	PUNCT	O
C	O	PROPN	B
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
C	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
fusion	O	NOUN	B
partner	O	NOUN	O
,	O	PUNCT	O
are	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
perturb	O	VERB	B
adipogenesis	O	NOUN	B
and	O	CCONJ	O
predispose	O	VERB	O
to	O	PART	O
lipomas	B-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
rare	B-Disease	ADJ	B
diseases	I-Disease	NOUN	B
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
(	O	PUNCT	O
AT	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ATM	O	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
Nijmegen	B-Disease	NOUN	B
breakage	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
NBS	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
p95	O	NOUN	B
/	O	SYM	O
nbs1	O	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
share	O	VERB	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
phenotypic	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
such	O	ADJ	O
as	O	ADP	O
chromosomal	B-Disease	ADJ	B
instability	I-Disease	NOUN	I
,	O	PUNCT	O
radiation	O	NOUN	B
sensitivity	O	NOUN	I
and	O	CCONJ	O
defects	O	NOUN	B
in	O	ADP	O
cell	O	NOUN	B
-	O	PUNCT	O
cycle	O	NOUN	B
checkpoints	O	NOUN	I
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
ionizing	O	VERB	B
radiation	O	NOUN	I
.	O	PUNCT	O


Activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ATM	O	NOUN	B
kinase	O	NOUN	I
by	O	ADP	O
ionizing	O	VERB	B
radiation	O	NOUN	I
and	O	CCONJ	O
induction	O	NOUN	B
of	O	ADP	O
ATM	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
responses	O	NOUN	B
in	O	ADP	O
NBS	B-Disease	NOUN	B
cells	O	NOUN	B
indicated	O	VERB	O
that	O	SCONJ	O
p95	O	NOUN	B
/	O	SYM	O
nbs1	O	PROPN	B
may	O	AUX	O
not	O	PART	O
be	O	AUX	O
required	O	VERB	O
for	O	ADP	O
signalling	O	NOUN	B
to	O	PART	O
ATM	O	NOUN	B
after	O	ADP	O
ionizing	O	VERB	B
radiation	O	NOUN	I
.	O	PUNCT	O


Understanding	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
basis	O	NOUN	I
of	O	ADP	O
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
the	O	DET	O
expanded	O	VERB	O
CGG	O	NOUN	B
triplet	O	NOUN	I
repeats	O	NOUN	I
are	O	AUX	O
hypermethylated	O	VERB	B
and	O	CCONJ	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
FMR1	O	NOUN	B
gene	O	NOUN	I
is	O	AUX	O
repressed	O	VERB	B
,	O	PUNCT	O
which	O	DET	O
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
FMR1	O	NOUN	B
protein	O	NOUN	I
(	O	PUNCT	O
FMRP	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
subsequent	O	ADJ	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
.	O	PUNCT	O


Anterior	B-Disease	ADJ	B
segment	I-Disease	NOUN	I
developmental	I-Disease	ADJ	I
disorders	I-Disease	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
Axenfeld	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Rieger	I-Disease	PROPN	B
anomaly	I-Disease	NOUN	I
(	O	PUNCT	O
ARA	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
variably	O	ADV	O
associate	O	VERB	B
with	O	ADP	I
harmfully	O	ADV	B
elevated	O	ADJ	I
intraocular	O	ADJ	I
pressure	O	NOUN	I
(	O	PUNCT	O
IOP	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
causes	O	VERB	O
glaucoma	B-Disease	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
homolog	O	NOUN	B
of	O	ADP	O
Foxc1	O	NOUN	B
,	O	PUNCT	O
FKHL7	O	NOUN	B
,	O	PUNCT	O
cause	O	VERB	O
dominant	O	ADJ	B
anterior	B-Disease	ADJ	B
segment	I-Disease	NOUN	O
defects	I-Disease	NOUN	B
and	O	CCONJ	O
glaucoma	B-Disease	NOUN	B
in	O	ADP	O
various	O	ADJ	O
families	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
abnormalities	O	NOUN	B
include	O	VERB	O
small	O	ADJ	B
or	O	CCONJ	O
absent	O	ADJ	B
Schlemms	O	ADJ	B
canal	O	NOUN	I
,	O	PUNCT	O
aberrantly	O	ADV	B
developed	O	VERB	O
trabecular	O	NOUN	B
meshwork	O	NOUN	I
,	O	PUNCT	O
iris	B-Disease	ADJ	B
hypoplasia	I-Disease	NOUN	I
,	O	PUNCT	O
severely	O	ADV	B
eccentric	O	ADJ	B
pupils	O	NOUN	I
and	O	CCONJ	O
displaced	O	VERB	B
Schwalbes	O	PROPN	I
line	O	NOUN	I
.	O	PUNCT	O


Foxc1	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
)	O	PUNCT	O
and	O	CCONJ	O
Foxc2	O	NOUN	B
(	O	PUNCT	O
+	O	CCONJ	O
/	O	SYM	O
-	O	PUNCT	O
)	O	PUNCT	O
mice	O	NOUN	B
are	O	AUX	O
useful	O	ADJ	O
models	O	NOUN	B
for	O	ADP	O
studying	O	VERB	O
anterior	O	ADJ	B
segment	O	NOUN	O
development	O	NOUN	O
and	O	CCONJ	O
its	O	PRON	O
anomalies	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
allow	O	VERB	O
identification	O	NOUN	B
of	O	ADP	O
genes	O	NOUN	B
that	O	PRON	O
interact	O	VERB	B
with	O	ADP	O
Foxc1	O	NOUN	B
and	O	CCONJ	O
Foxc2	O	NOUN	B
(	O	PUNCT	O
or	O	CCONJ	O
FKHL7	O	NOUN	B
and	O	CCONJ	O
FKHL14	O	NOUN	B
)	O	PUNCT	O
to	O	PART	O
produce	O	VERB	O
a	O	DET	O
phenotype	O	NOUN	B
with	O	ADP	O
elevated	O	ADJ	B
IOP	O	NOUN	B
and	O	CCONJ	O
glaucoma	B-Disease	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Fragile	B-Disease	NOUN	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
is	O	AUX	O
a	O	DET	O
common	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
involving	O	VERB	O
loss	O	NOUN	B
of	O	ADP	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
FMR1	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


As	O	ADP	O
a	O	DET	O
step	O	NOUN	O
toward	O	ADP	O
understanding	O	VERB	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
FMR1	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
determination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
potential	O	NOUN	B
for	O	ADP	O
therapeutic	O	ADJ	B
approaches	O	NOUN	I
to	O	PART	O
fragile	B-Disease	VERB	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
yeast	O	NOUN	B
artificial	O	ADJ	O
chromosome	O	NOUN	O
(	O	PUNCT	O
YAC	O	NOUN	B
)	O	PUNCT	O
transgenic	O	ADJ	B
mice	O	NOUN	I
were	O	AUX	O
generated	O	VERB	O
in	O	ADP	O
order	O	NOUN	O
to	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
the	O	DET	O
Fmr1	O	NOUN	B
knockout	O	ADJ	B
mouse	O	NOUN	I
phenotype	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
rescued	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
mouse	O	NOUN	B
displayed	O	VERB	O
reduced	O	VERB	B
anxiety	B-Disease	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
responses	O	NOUN	B
with	O	ADP	O
increased	O	VERB	B
exploratory	O	ADJ	B
behavior	O	NOUN	I
.	O	PUNCT	O


Transgenic	O	ADJ	B
mice	O	NOUN	I
carrying	O	VERB	O
large	O	ADJ	O
human	O	ADJ	B
genomic	O	ADJ	B
sequences	O	NOUN	I
with	O	ADP	O
expanded	O	VERB	O
CTG	O	NOUN	B
repeat	O	NOUN	I
mimic	O	VERB	O
closely	O	ADV	O
the	O	DET	O
DM	B-Disease	NOUN	B
CTG	O	NOUN	O
repeat	O	NOUN	O
intergenerational	O	ADJ	B
and	O	CCONJ	O
somatic	O	ADJ	B
instability	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
tissues	O	NOUN	B
from	O	ADP	O
DM	B-Disease	NOUN	B
patients	O	NOUN	B
exhibit	O	VERB	O
somatic	O	ADJ	B
mosaicism	O	NOUN	B
that	O	PRON	O
increases	O	VERB	B
with	O	ADP	O
age	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
we	O	PRON	O
did	O	AUX	O
not	O	PART	O
observe	O	VERB	O
dramatic	O	ADJ	O
expansions	O	NOUN	O
(	O	PUNCT	O
or	O	CCONJ	O
big	O	ADJ	B
jumps	O	NOUN	I
over	O	ADP	O
several	O	ADJ	O
hundred	O	NUM	O
CTG	O	NOUN	B
repeats	O	NOUN	I
)	O	PUNCT	O
as	O	ADP	O
in	O	ADP	O
congenital	O	ADJ	B
forms	O	NOUN	I
of	O	ADP	O
DM	B-Disease	NOUN	B
,	O	PUNCT	O
our	O	PRON	O
model	O	NOUN	B
carrying	O	VERB	O
>	O	X	O
300	O	NUM	O
CTG	O	NOUN	B
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
to	O	PART	O
show	O	VERB	O
instability	O	NOUN	B
so	O	ADV	O
close	O	ADV	O
to	O	PART	O
the	O	DET	O
human	O	ADJ	B
DM	B-Disease	NOUN	B
situation	O	NOUN	O
.	O	PUNCT	O


Friedreich	B-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
(	O	PUNCT	O
FRDA	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	O
ataxia	I-Disease	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
caused	O	VERB	O
in	O	ADP	O
almost	O	ADV	O
all	O	DET	O
cases	O	NOUN	B
by	O	ADP	O
homozygous	O	ADJ	B
intronic	O	ADJ	B
expansions	O	NOUN	I
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
frataxin	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
mitochondrial	O	ADJ	B
protein	O	NOUN	I
conserved	O	VERB	O
through	O	ADP	O
evolution	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
involved	O	VERB	O
in	O	ADP	O
mitochondrial	O	ADJ	B
iron	O	NOUN	B
homeostasis	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
study	O	VERB	B
the	O	DET	O
mechanism	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
generated	O	VERB	O
a	O	DET	O
mouse	O	NOUN	B
model	O	NOUN	I
by	O	ADP	O
deletion	O	NOUN	B
of	O	ADP	O
exon	O	NOUN	B
4	O	NUM	I
leading	O	VERB	O
to	O	PART	O
inactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Frda	B-Disease	NOUN	B
gene	O	NOUN	I
product	O	NOUN	O
.	O	PUNCT	O


Gaucher	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
:	O	PUNCT	O
the	O	DET	O
origins	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ashkenazi	O	PROPN	B
Jewish	O	ADJ	I
N370S	O	NOUN	I
and	O	CCONJ	O
84GG	O	ADJ	O
acid	O	NOUN	B
beta	O	NOUN	I
-	O	PUNCT	O
glucosidase	O	NOUN	B
mutations	O	NOUN	B
.	O	PUNCT	O


HLA	O	NOUN	B
B27	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
genetics	O	NOUN	B
of	O	ADP	O
ankylosing	B-Disease	ADJ	B
spondylitis	I-Disease	NOUN	I
.	O	PUNCT	O


Five	O	NUM	O
patients	O	NOUN	B
had	O	AUX	O
evidence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
sero	O	NOUN	B
-	O	PUNCT	O
negative	O	ADJ	B
peripheral	B-Disease	ADJ	B
arthritis	I-Disease	NOUN	I
resembling	O	VERB	O
peripheral	B-Disease	ADJ	B
psoriatic	I-Disease	ADJ	I
arthritis	I-Disease	NOUN	I
and	O	CCONJ	O
3	O	NUM	O
of	O	ADP	O
these	O	DET	O
were	O	AUX	O
B27	O	NOUN	O
negative	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
are	O	AUX	O
interpreted	O	VERB	O
as	O	ADP	O
suggesting	O	VERB	O
some	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
clinical	O	ADJ	B
and	O	CCONJ	O
genetic	O	ADJ	B
heterogeneity	O	NOUN	I
in	O	ADP	O
ankylosing	B-Disease	ADJ	B
spondylitis	I-Disease	NOUN	I
with	O	ADP	O
genes	O	NOUN	B
for	O	ADP	O
psoriasis	B-Disease	NOUN	B
and	O	CCONJ	O
inflammatory	B-Disease	ADJ	B
bowel	I-Disease	NOUN	I
disease	I-Disease	NOUN	I
being	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
some	O	DET	O
individuals	O	NOUN	B
,	O	PUNCT	O
particularly	O	ADV	O
those	O	DET	O
who	O	PRON	O
are	O	AUX	O
B27	O	NOUN	O
negative	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
only	O	ADJ	O
instance	O	NOUN	O
of	O	ADP	O
disassociation	O	NOUN	B
of	O	ADP	O
B27	O	NOUN	B
and	O	CCONJ	O
spondylitis	B-Disease	NOUN	B
in	O	ADP	O
a	O	DET	O
family	O	NOUN	B
was	O	AUX	O
where	O	SCONJ	O
the	O	DET	O
proband	O	NOUN	B
had	O	AUX	O
ulcerative	B-Disease	ADJ	B
colitis	I-Disease	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
spondylitis	B-Disease	NOUN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
are	O	AUX	O
thought	O	VERB	O
to	O	PART	O
provide	O	VERB	O
evidence	O	NOUN	B
against	O	ADP	O
the	O	DET	O
concept	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
gene	O	NOUN	B
for	O	ADP	O
ankylosing	B-Disease	ADJ	B
spondylitis	I-Disease	NOUN	I
is	O	AUX	O
not	O	PART	O
B27	O	NOUN	B
but	O	CCONJ	O
a	O	DET	O
closely	O	ADV	O
linked	O	VERB	O
gene	O	NOUN	B
and	O	CCONJ	O
favour	O	VERB	O
the	O	DET	O
occurrence	O	NOUN	B
of	O	ADP	O
an	O	DET	O
environmental	O	ADJ	B
event	O	NOUN	I
affecting	O	VERB	B
approximately	O	ADV	O
one	O	NUM	O
-	O	PUNCT	O
fifth	O	NOUN	B
of	O	ADP	O
B27	O	NOUN	O
positive	O	ADJ	B
males	O	NOUN	B
to	O	PART	O
result	O	VERB	O
in	O	ADP	O
disease	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
study	O	NOUN	B
group	O	NOUN	I
consisted	O	VERB	O
of	O	ADP	O
66	O	NUM	O
Polish	O	ADJ	B
families	O	NOUN	B
with	O	ADP	O
cancer	B-Disease	NOUN	B
who	O	PRON	O
have	O	AUX	O
at	O	ADV	O
least	O	ADJ	O
three	O	NUM	O
related	O	ADJ	O
females	O	NOUN	B
affected	O	VERB	B
with	O	ADP	O
breast	B-Disease	NOUN	B
or	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
and	O	CCONJ	O
who	O	PRON	O
had	O	AUX	O
cancer	B-Disease	NOUN	B
diagnosed	O	VERB	B
,	O	PUNCT	O
in	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
one	O	NUM	O
of	O	ADP	O
the	O	DET	O
three	O	NUM	O
affected	O	VERB	B
females	O	NOUN	B
,	O	PUNCT	O
at	O	ADP	O
age	O	NOUN	B
<	O	X	O
50	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


BRCA1	B-Disease	NOUN	B
abnormalities	I-Disease	NOUN	B
were	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
all	O	DET	O
four	O	NUM	O
families	O	NOUN	B
with	O	ADP	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
only	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
67	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
27	O	NUM	O
families	O	NOUN	B
with	O	ADP	O
both	O	CCONJ	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
34	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
35	O	NUM	O
families	O	NOUN	B
with	O	ADP	O
breast	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
only	O	ADV	O
.	O	PUNCT	O


Three	O	NUM	O
BRCA1	B-Disease	NOUN	B
abnormalities	I-Disease	NOUN	B
-	O	PUNCT	O
5382insC	O	PROPN	B
,	O	PUNCT	O
C61G	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
4153delA	O	NOUN	B
-	O	PUNCT	O
accounted	O	VERB	B
for	O	ADP	O
51	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
20	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
11	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
identified	O	VERB	B
mutations	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O
.	O	PUNCT	O


Very	B-Disease	ADV	O
long	I-Disease	ADJ	O
chain	I-Disease	NOUN	B
acyl	I-Disease	NOUN	I
-	I-Disease	PUNCT	O
CoA	I-Disease	NOUN	B
dehydrogenase	I-Disease	NOUN	I
(	I-Disease	PUNCT	O
VLCAD	I-Disease	NOUN	B
)	I-Disease	PUNCT	O
deficiency	I-Disease	NOUN	B
is	O	AUX	O
a	O	DET	O
life	O	NOUN	B
-	O	PUNCT	O
threatening	O	VERB	B
disorder	O	NOUN	B
of	O	ADP	O
mitochondrial	O	ADJ	B
fatty	O	ADJ	I
acid	O	NOUN	I
beta	O	NOUN	I
-	O	PUNCT	O
oxidation	O	NOUN	B
.	O	PUNCT	O


Submicroscopic	O	ADJ	B
deletion	O	NOUN	I
in	O	ADP	O
cousins	O	NOUN	B
with	O	ADP	O
Prader	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
causes	O	VERB	O
a	O	DET	O
grandmatrilineal	O	NOUN	B
inheritance	O	NOUN	I
pattern	O	NOUN	B
:	O	PUNCT	O
effects	O	NOUN	B
of	O	ADP	I
imprinting	O	NOUN	B
.	O	PUNCT	O


PWS	B-Disease	PROPN	B
becomes	O	VERB	O
apparent	O	ADJ	B
when	O	SCONJ	O
genes	O	NOUN	B
on	O	ADP	O
the	O	DET	O
paternally	O	ADV	B
inherited	O	VERB	I
chromosome	O	NOUN	I
are	O	AUX	O
not	O	PART	O
expressed	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
on	O	ADP	O
a	O	DET	O
family	O	NOUN	B
in	O	ADP	O
which	O	DET	O
a	O	DET	O
male	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
female	O	ADJ	B
paternal	O	NOUN	O
first	O	ADJ	O
cousin	O	NOUN	O
both	O	DET	O
have	O	AUX	O
PWS	B-Disease	NOUN	B
with	O	ADP	O
cytogenetically	O	ADV	B
normal	O	ADJ	I
karyotypes	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
case	O	NOUN	B
,	O	PUNCT	O
PWS	B-Disease	NOUN	B
does	O	AUX	O
not	O	PART	O
become	O	VERB	O
evident	O	ADJ	O
as	O	ADV	O
long	O	ADV	O
as	O	ADP	O
the	O	DET	O
deletion	O	NOUN	B
is	O	AUX	O
passed	O	VERB	O
through	O	ADP	O
the	O	DET	O
matrilineal	O	ADJ	B
line	O	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
glycine	O	NOUN	B
decarboxylase	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
GLDC	O	NOUN	B
)	O	PUNCT	O
cause	O	VERB	O
nonketotic	B-Disease	ADJ	B
hyperglycinemia	I-Disease	NOUN	I
(	O	PUNCT	O
NKH	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
in	B-Disease	ADV	O
-	I-Disease	PUNCT	O
born	I-Disease	VERB	B
error	I-Disease	NOUN	O
of	I-Disease	ADP	O
metabolism	I-Disease	NOUN	B
characterized	O	VERB	B
by	O	ADP	O
severe	O	ADJ	B
neurological	B-Disease	ADJ	B
disturbance	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
also	O	ADV	O
examined	O	VERB	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
NKH	B-Disease	NOUN	B
with	O	ADP	O
no	O	DET	O
detectable	O	ADJ	B
GLDC	O	NOUN	B
mRNA	O	NOUN	B
in	O	ADP	O
his	O	PRON	O
lymphoblasts	O	NOUN	B
.	O	PUNCT	O


Prader	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
PWS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
neurogenetic	B-Disease	ADJ	B
disease	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
infantile	B-Disease	ADJ	B
hypotonia	I-Disease	NOUN	I
,	O	PUNCT	O
gonadal	B-Disease	ADJ	B
hypoplasia	I-Disease	NOUN	I
,	O	PUNCT	O
obsessive	O	ADJ	B
behaviour	O	NOUN	I
and	O	CCONJ	O
neonatal	O	ADJ	B
feeding	O	NOUN	B
difficulties	O	NOUN	I
followed	O	VERB	O
by	O	ADP	O
hyperphagia	B-Disease	NOUN	B
,	O	PUNCT	O
leading	O	VERB	O
to	O	PART	O
profound	O	ADJ	O
obesity	B-Disease	NOUN	B
.	O	PUNCT	O


Five	O	NUM	O
imprinted	O	ADJ	B
,	O	PUNCT	O
paternally	O	ADV	B
expressed	O	VERB	I
genes	O	NOUN	I
map	O	VERB	O
to	O	PART	O
the	O	DET	O
PWS	B-Disease	NOUN	B
region	O	NOUN	O
,	O	PUNCT	O
MKRN3	O	NOUN	B
(	O	PUNCT	O
ref	O	NOUN	O
.	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
,	O	PUNCT	O
NDN	O	NOUN	B
(	O	PUNCT	O
ref	O	NOUN	O
.	O	PUNCT	O
4	O	X	O
)	O	PUNCT	O
,	O	PUNCT	O
NDNL1	O	NOUN	B
(	O	PUNCT	O
ref	O	NOUN	O
.	O	PUNCT	O
5	O	X	O
)	O	PUNCT	O
,	O	PUNCT	O
SNRPN	O	NOUN	B
(	O	PUNCT	O
refs	O	NOUN	O
6	O	NUM	O
-	O	SYM	O
8	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
IPW	O	PROPN	B
(	O	PUNCT	O
ref	O	NOUN	O
.	O	PUNCT	O
9	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
two	O	NUM	O
poorly	O	ADV	O
characterized	O	VERB	B
framents	O	NOUN	B
designated	O	VERB	O
PAR	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	B
and	O	CCONJ	O
PAR	O	PROPN	B
-	O	PUNCT	O
5	O	NUM	O
(	O	PUNCT	O
ref	O	NOUN	O
.	O	PUNCT	O
10	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
report	O	VERB	O
a	O	DET	O
PWS	B-Disease	NOUN	B
family	O	NOUN	B
in	O	ADP	O
which	O	DET	O
the	O	DET	O
father	O	NOUN	B
is	O	AUX	O
mosaic	O	ADJ	B
for	O	ADP	O
an	O	DET	O
IC	O	NOUN	B
deletion	O	NOUN	B
on	O	ADP	O
his	O	PRON	O
paternal	O	ADJ	B
chromosome	O	NOUN	I
.	O	PUNCT	O


Mice	O	NOUN	B
deficient	B-Disease	ADJ	B
in	I-Disease	ADP	O
Six5	I-Disease	NOUN	B
develop	O	VERB	O
cataracts	B-Disease	NOUN	B
:	O	PUNCT	O
implications	O	NOUN	O
for	O	ADP	O
myotonic	B-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
.	O	PUNCT	O


Targeted	O	VERB	B
deletion	O	NOUN	I
of	O	ADP	O
Dm15	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
mouse	O	NOUN	B
orthologue	O	NOUN	I
of	O	ADP	O
human	O	ADJ	B
DMPK	O	NOUN	B
,	O	PUNCT	O
produced	O	VERB	O
mice	O	NOUN	B
with	O	ADP	O
a	O	DET	O
mild	O	ADJ	B
myopathy	B-Disease	ADJ	I
and	O	CCONJ	O
cardiac	B-Disease	ADJ	B
conduction	I-Disease	NOUN	I
abnormalities	I-Disease	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
without	O	ADP	O
other	O	ADJ	O
features	O	NOUN	B
of	O	ADP	O
myotonic	B-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
myotonia	B-Disease	NOUN	B
and	O	CCONJ	O
cataracts	B-Disease	NOUN	B
.	O	PUNCT	O


Homozygous	O	ADJ	B
mutant	O	ADJ	O
mice	O	NOUN	O
had	O	AUX	O
no	O	DET	O
apparent	O	ADJ	O
abnormalities	B-Disease	NOUN	B
of	I-Disease	ADP	O
skeletal	I-Disease	ADJ	B
muscle	I-Disease	NOUN	I
function	I-Disease	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
developed	O	VERB	O
lenticular	B-Disease	ADJ	B
opacities	I-Disease	NOUN	I
at	O	ADP	O
a	O	DET	O
higher	O	ADJ	O
rate	O	NOUN	B
than	O	ADP	O
controls	O	NOUN	B
.	O	PUNCT	O


Heterozygous	O	ADJ	B
loss	O	NOUN	O
of	O	ADP	O
Six5	O	NOUN	B
in	O	ADP	O
mice	O	NOUN	B
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
cause	O	VERB	O
ocular	O	ADJ	B
cataracts	B-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
genetic	B-Disease	ADJ	B
defect	I-Disease	NOUN	I
in	O	ADP	O
DM	B-Disease	NOUN	B
is	O	AUX	O
a	O	DET	O
CTG	O	NOUN	B
repeat	O	NOUN	I
expansion	O	NOUN	B
located	O	ADJ	O
in	O	ADP	O
the	O	DET	O
3	O	NUM	O
untranslated	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
DMPK	O	NOUN	B
and	O	CCONJ	O
5	O	NUM	O
of	O	ADP	O
a	O	DET	O
homeodomain	O	NOUN	B
-	O	PUNCT	O
encoding	O	VERB	B
gene	O	NOUN	B
,	O	PUNCT	O
SIX5	O	NOUN	B
(	O	PUNCT	O
formerly	O	ADV	O
DMAHP	O	NOUN	B
;	O	PUNCT	O
refs	O	NOUN	O
2	O	NUM	O
-	O	SYM	O
5	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Previous	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
demonstrated	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
dose	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
loss	O	NOUN	B
of	O	ADP	O
Dm15	O	NOUN	B
(	O	PUNCT	O
the	O	DET	O
mouse	O	NOUN	B
DMPK	O	NOUN	B
homologue	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
mice	O	NOUN	B
produces	O	VERB	O
a	O	DET	O
partial	O	ADJ	B
DM	B-Disease	NOUN	B
phenotype	O	NOUN	B
characterized	O	VERB	B
by	O	ADP	O
decreased	O	VERB	B
development	O	NOUN	B
of	O	ADP	O
skeletal	O	ADJ	B
muscle	O	NOUN	I
force	O	NOUN	O
and	O	CCONJ	O
cardiac	B-Disease	ADJ	B
conduction	I-Disease	NOUN	I
disorders	I-Disease	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
rate	O	NOUN	B
and	O	CCONJ	O
severity	O	NOUN	B
of	O	ADP	O
cataract	B-Disease	NOUN	B
formation	O	NOUN	I
is	O	AUX	O
inversely	O	ADV	O
related	O	ADJ	O
to	O	PART	O
Six5	O	NOUN	B
dosage	O	NOUN	B
and	O	CCONJ	O
is	O	AUX	O
temporally	O	ADV	O
progressive	O	ADJ	B
.	O	PUNCT	O


As	O	ADP	O
ocular	O	ADJ	B
cataracts	B-Disease	NOUN	I
are	O	AUX	O
a	O	DET	O
characteristic	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
DM	B-Disease	NOUN	B
,	O	PUNCT	O
these	O	DET	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
decreased	O	VERB	B
SIX5	O	NOUN	B
transcription	O	NOUN	B
is	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
the	O	DET	O
aetiology	O	NOUN	B
of	O	ADP	O
DM	B-Disease	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
ATM	O	NOUN	I
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
genetic	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
(	O	PUNCT	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
cerebellar	B-Disease	ADJ	B
dysfunction	I-Disease	NOUN	I
,	O	PUNCT	O
radiosensitivity	O	NOUN	B
,	O	PUNCT	O
chromosomal	O	ADJ	B
instability	O	NOUN	I
and	O	CCONJ	O
cancer	B-Disease	NOUN	B
predisposition	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
strong	O	ADJ	O
parallels	O	NOUN	O
between	O	ADP	O
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
radiosensitivity	O	NOUN	B
,	O	PUNCT	O
chromosomal	O	ADJ	B
instability	O	NOUN	I
and	O	CCONJ	O
cancer	B-Disease	NOUN	B
predisposition	O	NOUN	I
in	O	ADP	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
Nijmegen	B-Disease	NOUN	B
breakage	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
NBS	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
overlap	O	NOUN	B
between	O	ADP	O
clinical	O	ADJ	B
and	O	CCONJ	O
cellular	O	ADJ	B
phenotypes	O	NOUN	B
in	O	ADP	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
and	O	CCONJ	O
NBS	B-Disease	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
ATM	O	NOUN	B
and	O	CCONJ	O
nibrin	O	NOUN	B
may	O	AUX	O
function	O	VERB	B
in	O	ADP	O
the	O	DET	O
same	O	ADJ	O
biochemical	O	ADJ	B
pathway	O	NOUN	I
.	O	PUNCT	O


Phosphorylation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
site	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
functionally	O	ADV	O
important	O	ADJ	O
because	O	SCONJ	O
mutated	O	VERB	B
nibrin	O	NOUN	O
(	O	PUNCT	O
S343A	O	NOUN	B
)	O	PUNCT	O
does	O	AUX	O
not	O	PART	O
completely	O	ADV	O
complement	O	NOUN	B
radiosensitivity	O	NOUN	B
in	O	ADP	O
NBS	B-Disease	NOUN	B
cells	O	NOUN	B
.	O	PUNCT	O


Clinicopathologic	O	ADJ	B
features	O	NOUN	B
of	O	ADP	O
BRCA	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
and	I-Disease	CCONJ	O
sporadic	I-Disease	ADJ	B
ovarian	I-Disease	ADJ	O
cancer	I-Disease	NOUN	O
.	O	PUNCT	O


Attempts	O	VERB	O
to	O	PART	O
define	O	VERB	O
the	O	DET	O
clinical	O	ADJ	B
significance	O	NOUN	I
of	O	ADP	O
BRCA	O	NOUN	B
mutation	O	NOUN	B
status	O	NOUN	I
in	O	ADP	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
have	O	AUX	O
produced	O	VERB	O
conflicting	O	ADJ	O
results	O	NOUN	B
,	O	PUNCT	O
especially	O	ADV	O
regarding	O	VERB	O
survival	O	NOUN	B
.	O	PUNCT	O


DESIGN	O	NOUN	O
AND	O	CCONJ	O
SETTING	O	VERB	O
Retrospective	O	ADJ	B
cohort	O	NOUN	O
study	O	NOUN	O
of	O	ADP	O
a	O	DET	O
consecutive	O	ADJ	B
series	O	NOUN	B
of	O	ADP	O
933	O	NUM	O
ovarian	B-Disease	ADJ	B
cancers	I-Disease	NOUN	I
diagnosed	O	VERB	B
and	O	CCONJ	O
treated	O	VERB	B
at	O	ADP	O
our	O	PRON	O
institution	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
a	O	DET	O
comprehensive	O	ADJ	B
cancer	B-Disease	NOUN	B
center	O	NOUN	I
as	O	ADP	O
designated	O	VERB	O
by	O	ADP	O
the	O	DET	O
National	O	PROPN	B
Cancer	B-Disease	PROPN	I
Institute	O	PROPN	I
,	O	PUNCT	O
over	O	ADP	O
a	O	DET	O
12	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
period	O	NOUN	B
(	O	PUNCT	O
December	O	PROPN	O
1986	O	NUM	O
to	O	ADP	O
August	O	PROPN	O
1998	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


RESULTS	O	VERB	O
Hereditary	B-Disease	ADJ	B
cancers	I-Disease	NOUN	I
were	O	AUX	O
rarely	O	ADV	O
diagnosed	O	VERB	B
before	O	ADP	O
age	O	NOUN	B
40	O	NUM	O
years	O	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
common	O	ADJ	O
after	O	ADP	O
age	O	NOUN	B
60	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
mean	O	ADJ	O
age	O	NOUN	B
at	O	ADP	O
diagnosis	O	NOUN	B
being	O	AUX	O
significantly	O	ADV	O
younger	O	ADJ	O
for	O	ADP	O
BRCA1	O	NOUN	B
-	O	PUNCT	O
vs	O	CCONJ	O
BRCA2	O	NOUN	B
-	O	PUNCT	O
linked	O	VERB	B
patients	O	NOUN	B
(	O	PUNCT	O
54	O	NUM	O
vs	O	CCONJ	O
62	O	NUM	O
years	O	NOUN	B
;	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
04	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


For	O	ADP	O
stage	B-Disease	NOUN	B
III	I-Disease	NUM	I
cancers	I-Disease	NOUN	I
,	O	PUNCT	O
BRCA	O	NOUN	B
mutation	O	NOUN	B
status	O	NOUN	I
was	O	AUX	O
an	O	DET	O
independent	O	ADJ	O
prognostic	O	ADJ	B
variable	O	NOUN	O
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
03	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Age	O	NOUN	B
penetrance	O	NOUN	B
is	O	AUX	O
greater	O	ADJ	O
for	O	ADP	O
BRCA1	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
than	I-Disease	ADP	O
for	I-Disease	ADP	O
BRCA2	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
cancers	I-Disease	NOUN	B
in	O	ADP	O
this	O	DET	O
population	O	NOUN	B
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	I
fever	I-Disease	NOUN	I
(	O	PUNCT	O
FMF	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recessive	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
episodes	O	NOUN	B
of	O	ADP	O
fever	B-Disease	NOUN	B
and	O	CCONJ	O
neutrophil	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
mediated	I-Disease	VERB	B
serosal	I-Disease	ADJ	B
inflammation	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	X	B
vitro	O	X	I
stimulation	O	NOUN	B
of	O	ADP	O
monocytes	O	NOUN	B
with	O	ADP	O
the	O	DET	O
proinflammatory	O	ADJ	B
agents	O	NOUN	I
interferon	O	NOUN	B
(	O	PUNCT	O
IFN	O	NOUN	B
)	O	PUNCT	O
gamma	O	NOUN	B
,	O	PUNCT	O
tumor	B-Disease	NOUN	B
necrosis	O	NOUN	I
factor	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
lipopolysaccharide	O	NOUN	B
induced	O	VERB	B
MEFV	O	NOUN	B
expression	O	NOUN	B
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
antiinflammatory	O	ADJ	B
cytokines	O	NOUN	I
interleukin	O	NOUN	I
(	O	PUNCT	O
IL	O	NOUN	B
)	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
IL	O	NOUN	B
-	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
transforming	O	VERB	B
growth	O	NOUN	I
factor	O	NOUN	I
beta	O	NOUN	I
inhibited	O	VERB	B
such	O	ADJ	O
expression	O	NOUN	B
.	O	PUNCT	O


Mucopolysaccharidosis	B-Disease	NOUN	B
IVA	I-Disease	NOUN	I
(	O	PUNCT	O
MPS	B-Disease	PROPN	B
IVA	I-Disease	PROPN	B
;	O	PUNCT	O
OMIM	O	NOUN	B
#	O	NOUN	O
253000	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
a	O	DET	O
lysosomal	B-Disease	ADJ	B
storage	I-Disease	NOUN	I
disorder	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
a	O	DET	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
N	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
acetylgalactosamine	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
6	I-Disease	NUM	O
-	I-Disease	PUNCT	O
sulfate	I-Disease	NOUN	B
sulfatase	I-Disease	NOUN	I
(	O	PUNCT	O
GALNS	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
has	O	AUX	O
variable	O	ADJ	B
clinical	O	ADJ	B
phenotypes	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
shed	O	VERB	O
further	O	ADJ	O
light	O	NOUN	O
on	O	ADP	O
the	O	DET	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlation	O	NOUN	B
of	O	ADP	O
MPS	B-Disease	NOUN	B
IVA	I-Disease	PROPN	B
and	O	CCONJ	O
structure	O	NOUN	B
-	O	PUNCT	O
function	O	NOUN	B
relationship	O	NOUN	B
in	O	ADP	O
the	O	DET	O
sulfatase	O	NOUN	B
family	O	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
at	O	ADP	O
the	O	DET	O
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
(	O	PUNCT	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
)	O	PUNCT	O
locus	O	NOUN	O
on	O	ADP	O
chromosome	O	NOUN	B
band	O	NOUN	I
11q22	O	NOUN	I
cause	O	VERB	O
a	O	DET	O
distinctive	O	ADJ	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
in	O	ADP	O
homozygotes	O	NOUN	B
and	O	CCONJ	O
predispose	O	VERB	O
heterozygotes	O	NOUN	B
to	O	PART	O
cancer	B-Disease	NOUN	B
,	O	PUNCT	O
ischemic	B-Disease	ADJ	B
heart	I-Disease	NOUN	I
disease	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
early	O	ADJ	B
mortality	O	NOUN	B
.	O	PUNCT	O


Heteroduplex	O	NOUN	B
analysis	O	NOUN	I
detected	O	VERB	B
another	O	DET	O
42	O	NUM	O
mutations	O	NOUN	B
at	O	ADP	O
the	O	DET	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
locus	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
mean	O	ADJ	B
survival	O	NOUN	I
and	O	CCONJ	O
height	O	NOUN	B
distribution	O	NOUN	B
of	O	ADP	O
134	O	NUM	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
patients	O	NOUN	B
correlated	O	VERB	B
significantly	O	ADV	O
with	O	ADP	O
the	O	DET	O
specific	O	ADJ	O
mutations	O	NOUN	B
present	O	ADJ	O
in	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
.	O	PUNCT	O


Mutation	O	NOUN	B
analysis	O	NOUN	I
at	O	ADP	O
the	O	DET	O
A	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
locus	O	NOUN	O
may	O	AUX	O
help	O	VERB	O
estimate	O	VERB	B
the	O	DET	O
prognosis	O	NOUN	B
of	O	ADP	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	I
fever	I-Disease	NOUN	I
(	O	PUNCT	O
FMF	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recessive	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
episodes	O	NOUN	B
of	O	ADP	O
fever	B-Disease	NOUN	B
with	O	ADP	O
serositis	B-Disease	NOUN	B
or	O	CCONJ	O
synovitis	B-Disease	NOUN	B
.	O	PUNCT	O


2	O	NUM	O
domain	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
which	O	DET	O
most	O	ADJ	O
FMF	B-Disease	PROPN	B
-	O	PUNCT	O
associated	O	VERB	B
mutations	O	NOUN	B
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
in	O	ADP	O
human	O	ADJ	B
MEFV	O	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
and	O	CCONJ	O
duplications	O	NOUN	B
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
Pelizaeus	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Merzbacher	I-Disease	PROPN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
PMD	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
second	O	ADJ	O
unrelated	O	ADJ	B
family	O	NOUN	B
with	O	ADP	O
signs	O	NOUN	O
of	O	ADP	O
PMD	B-Disease	NOUN	B
,	O	PUNCT	O
cytogenetic	O	ADJ	B
analysis	O	NOUN	I
showed	O	VERB	O
a	O	DET	O
pericentric	O	ADJ	B
inversion	O	NOUN	I
of	O	ADP	I
the	O	DET	I
X	O	NOUN	I
chromosome	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
do	O	AUX	O
this	O	DET	O
,	O	PUNCT	O
a	O	DET	O
collaborative	O	ADJ	B
screening	O	NOUN	I
study	O	NOUN	I
was	O	AUX	O
set	O	VERB	O
up	O	ADP	O
that	O	DET	O
involved	O	VERB	O
39	O	NUM	O
institutions	O	NOUN	B
from	O	ADP	O
19	O	NUM	O
countries	O	NOUN	B
and	O	CCONJ	O
included	O	VERB	O
3	O	NUM	O
,	O	PUNCT	O
580	O	NUM	O
unrelated	O	ADJ	O
individuals	O	NOUN	B
with	O	ADP	O
a	O	DET	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	I
the	O	DET	I
disease	O	NOUN	I
and	O	CCONJ	O
934	O	NUM	O
early	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
/	I-Disease	SYM	O
or	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
cases	O	NOUN	B
.	O	PUNCT	O


Von	B-Disease	PROPN	B
Hippel	I-Disease	PROPN	I
-	I-Disease	PUNCT	O
Lindau	I-Disease	PROPN	B
(	I-Disease	PUNCT	O
VHL	I-Disease	NOUN	B
)	I-Disease	PUNCT	O
disease	I-Disease	NOUN	O
is	O	AUX	O
a	O	DET	O
hereditary	B-Disease	ADJ	B
tumor	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
predisposition	O	NOUN	B
for	O	ADP	O
bilateral	B-Disease	ADJ	B
and	I-Disease	CCONJ	O
multi	I-Disease	ADJ	B
-	I-Disease	PUNCT	O
centric	I-Disease	ADJ	B
hemangioblastoma	I-Disease	NOUN	B
in	O	ADP	O
the	O	DET	O
retina	O	NOUN	B
and	O	CCONJ	O
central	O	ADJ	B
nervous	O	ADJ	I
system	O	NOUN	I
,	O	PUNCT	O
pheochromocytoma	B-Disease	NOUN	B
,	O	PUNCT	O
renal	B-Disease	ADJ	B
cell	I-Disease	NOUN	I
carcinoma	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
cysts	B-Disease	NOUN	B
in	I-Disease	ADP	O
the	I-Disease	DET	O
kidney	I-Disease	NOUN	B
,	I-Disease	PUNCT	O
pancreas	I-Disease	NOUN	B
,	I-Disease	PUNCT	O
and	I-Disease	CCONJ	O
epididymis	I-Disease	NOUN	B
.	O	PUNCT	O


Further	O	ADJ	O
molecular	O	ADJ	B
analysis	O	NOUN	I
revealed	O	VERB	O
deletions	O	NOUN	B
involving	O	VERB	O
the	O	DET	O
VHL	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
each	O	DET	O
of	O	ADP	O
these	O	DET	O
families	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
show	O	VERB	O
that	O	SCONJ	O
(	O	PUNCT	O
quantitative	O	ADJ	B
)	O	PUNCT	O
Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
is	O	AUX	O
a	O	DET	O
sensitive	O	ADJ	B
method	O	NOUN	O
for	O	ADP	O
detecting	O	VERB	O
germline	O	NOUN	B
deletions	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VHL	B-Disease	NOUN	B
gene	O	NOUN	I
and	O	CCONJ	O
should	O	AUX	O
be	O	AUX	O
implemented	O	VERB	O
in	O	ADP	O
routine	O	ADJ	B
DNA	O	NOUN	B
diagnosis	O	NOUN	I
for	O	ADP	O
VHL	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
.	O	PUNCT	O


Further	O	ADV	O
unraveling	O	NOUN	O
of	O	ADP	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlations	O	NOUN	B
in	O	ADP	O
VHL	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
has	O	AUX	O
revealed	O	VERB	O
that	O	SCONJ	O
families	O	NOUN	B
with	O	ADP	O
a	O	DET	O
full	O	ADJ	O
or	O	CCONJ	O
partial	O	ADJ	B
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VHL	B-Disease	NOUN	B
gene	O	NOUN	I
exhibit	O	VERB	O
a	O	DET	O
phenotype	O	NOUN	B
with	O	ADP	O
a	O	DET	O
preponderance	O	NOUN	B
of	O	ADP	O
central	B-Disease	ADJ	B
nervous	I-Disease	ADJ	I
system	I-Disease	NOUN	I
hemangioblastoma	I-Disease	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Friedreich	B-Disease	NOUN	B
ataxia	I-Disease	NOUN	I
(	O	PUNCT	O
FRDA	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
most	O	ADV	O
frequently	O	ADV	O
inherited	B-Disease	VERB	B
ataxia	I-Disease	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
due	O	ADJ	O
in	O	ADP	O
the	O	DET	O
vast	O	ADJ	O
majority	O	NOUN	O
of	O	ADP	O
cases	O	NOUN	B
to	O	ADP	O
a	O	DET	O
large	O	ADJ	O
expansion	O	NOUN	B
of	O	ADP	O
an	O	DET	O
intronic	O	ADJ	B
GAA	O	NOUN	I
repeat	O	NOUN	O
.	O	PUNCT	O


Functional	O	ADJ	B
link	O	NOUN	O
between	O	ADP	O
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
and	O	CCONJ	O
Nijmegen	B-Disease	NOUN	B
breakage	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
gene	O	NOUN	B
products	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
protein	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
ATM	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
member	O	NOUN	O
of	O	ADP	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
kinases	O	NOUN	B
characterized	O	VERB	B
by	O	ADP	O
a	O	DET	O
carboxy	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
phosphatidylinositol	O	NOUN	B
3	O	NUM	I
-	O	PUNCT	O
kinase	O	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
domain	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
response	O	NOUN	B
includes	O	VERB	O
S	O	NOUN	B
-	O	PUNCT	O
phase	O	NOUN	B
checkpoint	O	NOUN	I
activation	O	NOUN	I
,	O	PUNCT	O
formation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
NBS1	O	NOUN	B
/	O	SYM	O
Mrel1	O	PROPN	B
/	O	PUNCT	O
Rad50	O	NOUN	B
nuclear	O	ADJ	O
foci	O	NOUN	O
and	O	CCONJ	O
rescue	O	NOUN	B
of	O	ADP	O
hypersensitivity	B-Disease	NOUN	B
to	I-Disease	PART	O
ionizing	I-Disease	VERB	B
radiation	I-Disease	NOUN	I
.	O	PUNCT	O


Homozygosity	O	NOUN	B
mapping	O	NOUN	I
in	O	ADP	O
a	O	DET	O
family	O	NOUN	B
with	O	ADP	O
microcephaly	B-Disease	NOUN	B
,	O	PUNCT	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
short	B-Disease	ADJ	B
stature	I-Disease	NOUN	I
to	O	ADP	O
a	O	DET	O
Cohen	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
region	O	NOUN	I
on	O	ADP	O
8q21	O	NOUN	B
.	O	PUNCT	O
3	O	NUM	O
-	O	PUNCT	O
8q22	O	NOUN	B
.	O	PUNCT	O
1	O	NUM	O
:	O	PUNCT	O
redefining	O	VERB	O
a	O	DET	O
clinical	O	ADJ	B
entity	O	NOUN	I
.	O	PUNCT	O


Hypotonia	B-Disease	NOUN	B
,	O	PUNCT	O
chorioretinal	B-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
myopia	B-Disease	NOUN	B
were	O	AUX	O
also	O	ADV	O
identified	O	VERB	B
.	O	PUNCT	O


Intriguingly	O	ADV	O
enough	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
identified	O	VERB	B
gene	O	NOUN	B
region	O	NOUN	I
overlaps	O	VERB	O
the	O	DET	O
refined	O	ADJ	O
gene	O	NOUN	B
region	O	NOUN	I
for	O	ADP	O
Cohen	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
COH1	O	NOUN	B
)	O	PUNCT	O
[	O	PUNCT	O
Kolehmainen	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
1997	O	NUM	O
Euro	O	PROPN	B
J	O	PROPN	I
Hum	O	PROPN	I
Genet	O	PROPN	I
5	O	NUM	I
206	O	NUM	O
-	O	SYM	O
213	O	NUM	O
]	O	PUNCT	O
.	O	PUNCT	O


Polymorphisms	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CYP2D6	O	NOUN	B
gene	O	NOUN	I
increase	O	VERB	B
susceptibility	O	NOUN	B
to	O	PART	O
ankylosing	B-Disease	ADJ	B
spondylitis	I-Disease	NOUN	I
.	O	PUNCT	O


Previous	O	ADJ	O
linkage	O	NOUN	B
and	O	CCONJ	O
association	O	NOUN	B
studies	O	NOUN	I
have	O	AUX	O
suggested	O	VERB	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
a	O	DET	O
susceptibility	O	NOUN	B
gene	O	NOUN	I
for	O	ADP	O
AS	B-Disease	ADJ	B
close	O	ADV	O
to	O	PART	O
,	O	PUNCT	O
or	O	CCONJ	O
within	O	ADP	O
,	O	PUNCT	O
the	O	DET	O
cytochrome	O	NOUN	B
P450	O	NOUN	I
2D6	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
CYP2D6	O	NOUN	B
,	O	PUNCT	O
debrisoquine	O	NOUN	B
hydroxylase	O	NOUN	I
)	O	PUNCT	O
located	O	ADJ	O
at	O	ADP	O
chromosome	O	NOUN	B
22q13	O	NOUN	I
.	O	PUNCT	O
1	O	X	O
.	O	PUNCT	O


For	O	ADP	O
case	O	NOUN	B
-	O	PUNCT	O
control	O	NOUN	B
studies	O	NOUN	I
,	O	PUNCT	O
617	O	NUM	O
unrelated	O	ADJ	O
individuals	O	NOUN	B
with	O	ADP	O
AS	B-Disease	ADJ	B
(	O	PUNCT	O
361	O	NUM	O
probands	O	NOUN	B
from	O	ADP	O
sibling	O	NOUN	B
-	O	PUNCT	O
pair	O	NOUN	B
and	O	CCONJ	O
parent	O	NOUN	B
-	O	PUNCT	O
case	O	NOUN	B
trio	O	NOUN	B
families	O	NOUN	B
and	O	CCONJ	O
256	O	NUM	O
unrelated	O	ADJ	O
non	O	ADJ	B
-	O	PUNCT	O
familial	O	ADJ	B
sporadic	O	ADJ	B
cases	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
402	O	NUM	O
healthy	O	ADJ	B
ethnically	O	ADV	B
matched	O	VERB	O
controls	O	NOUN	O
were	O	AUX	O
employed	O	VERB	O
.	O	PUNCT	O


Heterozygosity	O	NOUN	B
for	O	ADP	O
the	O	DET	O
most	O	ADV	O
frequent	O	ADJ	B
poor	O	ADJ	B
metabolizer	O	NOUN	B
allele	O	NOUN	I
(	O	PUNCT	O
CYP2D6	O	NOUN	B
*	O	PUNCT	I
4	O	NUM	I
)	O	PUNCT	O
was	O	AUX	O
not	O	PART	O
associated	O	VERB	B
with	O	ADP	I
increased	O	VERB	B
susceptibility	O	NOUN	B
to	O	PART	O
AS	B-Disease	NOUN	B
.	O	PUNCT	O


Weak	O	ADJ	B
linkage	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
demonstrated	O	VERB	O
between	O	ADP	O
CYP2D6	O	NOUN	B
and	O	CCONJ	O
AS	B-Disease	ADJ	B
.	O	PUNCT	O


Functional	O	ADJ	B
differences	O	NOUN	O
of	O	ADP	O
the	O	DET	O
PDS	B-Disease	NOUN	B
gene	O	NOUN	I
product	O	NOUN	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
phenotypic	O	ADJ	B
variation	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
and	O	CCONJ	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
(	O	PUNCT	O
DFNB4	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
are	O	AUX	O
responsible	O	ADJ	O
for	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
and	O	CCONJ	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	I
non	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	O
at	O	ADP	O
the	O	DET	O
DFNB4	B-Disease	NOUN	B
locus	O	NOUN	B
on	O	ADP	O
chromosome	O	NOUN	B
7q31	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
whether	O	SCONJ	O
PDS	B-Disease	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
differ	O	VERB	O
functionally	O	ADV	O
from	O	ADP	O
PDS	B-Disease	PROPN	B
mutations	O	NOUN	B
in	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
compared	O	VERB	B
three	O	NUM	O
common	O	ADJ	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
allele	O	NOUN	B
variants	O	NOUN	I
(	O	PUNCT	O
L236P	O	NOUN	B
,	O	PUNCT	O
T416P	O	NOUN	B
and	O	CCONJ	O
E384G	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
three	O	NUM	O
PDS	B-Disease	PROPN	B
mutations	O	NOUN	B
reported	O	VERB	O
only	O	ADV	O
in	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
(	O	PUNCT	O
V480D	O	NOUN	O
,	O	PUNCT	O
V653A	O	NOUN	B
and	O	CCONJ	O
I490L	O	NOUN	B
/	O	SYM	O
G497S	O	PROPN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
hypothesize	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
residual	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
anion	O	NOUN	B
transport	O	NOUN	I
is	O	AUX	O
sufficient	O	ADJ	O
to	O	PART	O
eliminate	O	VERB	O
or	O	CCONJ	O
postpone	O	VERB	O
the	O	DET	O
onset	O	NOUN	O
of	O	ADP	O
goiter	B-Disease	NOUN	B
in	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
DFNB4	B-Disease	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
compare	O	VERB	B
the	O	DET	O
pattern	O	NOUN	B
of	O	ADP	O
germline	O	NOUN	B
mutation	O	NOUN	I
in	O	ADP	O
a	O	DET	O
population	O	NOUN	B
of	O	ADP	O
hemophilia	B-Disease	NOUN	B
B	I-Disease	NOUN	I
patients	O	NOUN	B
from	O	ADP	O
Mainland	O	PROPN	B
China	O	PROPN	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
66	O	NUM	O
)	O	PUNCT	O
to	O	PART	O
that	O	DET	O
in	O	ADP	O
U	O	NOUN	B
.	O	PUNCT	O


